{"Afghanistan":{},"Albania":{},"Algeria":{},"American Samoa":{},"Andorra":{},"Angola":{},"Antigua and Barbuda":{},"Argentina":{},"Armenia":{},"Aruba":{},"Australia":{"502":{"title":"Measles update (43): Asia and Pacific, Europe, demographics\r\n\t","date":["26","Aug","2017"],"url":"promedPRO/EDR> Measles update (43): Asia and Pacific, Europe, demographics\r\n\t[EXTERNAL]","summary":"<br><br><strong> Measles immunity gaps -</strong><br> 5 Role of demographics  Sat 26 Aug 2017 Source: News-Medical/Life Sciences edited Even if the incidence of measles infection has decreased by at least 90 per cent worldwide since the introduction of the vaccine, measles is still one of the major causes of death in children among vaccine-preventable diseases. Regular measles epidemics are reported in developing countries and recurrent episodic outbreaks occur in the developed world. A new study by Bocconi University and Bruno Kessler Foundation analyzing 9 countries (Australia, Ethiopia, Kenya, Ireland, Italy, South Korea, Singapore, the United Kingdom, and the United States) and published in The Lancet Infectious Diseases see reference below, highlights the role played by demographics in the spread of measles and concludes that future vaccination strategies in high-fertility countries should focus on increasing childhood immunization rates, while immunization campaigns targeting adolescents and young adults are required in low fertility countries. Using a transmission model calibrated on historical serological data the authors estimate that the susceptible proportion of the population (that is, unprotected against the infection) varies from about 3 per cent in the UK to more than 12.5 per cent in Ethiopia, with astonishing differences in its age composition, due to different vaccination strategies and divergent demographic trends. While the percentage of over-15 among susceptible individuals in Ethiopia and Kenya is, respectively, 28 per cent and 43 per cent, adolescents and young adults represent 74 per cent of unprotected individuals in South Korea, 66 per cent in Italy and 53 per cent in the US, with considerable immunity gaps in individuals aged 30-40 years. \"Every effort to increase the vaccination coverage rate among children is praiseworthy\", says Alessia Melegaro, a Bocconi professor and principal investigator of DECIDE, the ERC European Research Council-funded project which produced the article, \"but in some developed countries it's the lack of coverage among adolescents and adults that poses a serious threat to the goal of eliminating measles.\" \"Measles incidence could increase, in the next decades, in Italy, Australia, and Singapore and Ethiopia is at high risk of future large epidemics\", says Stefano Merler from Bruno Kessler Foundation, \"and this is particularly worrying considering that individuals get infected later in life when the disease is more severe. The median age at infection for 2015 was estimated to be 5-10 years in the UK, Ireland, and Ethiopia; 10-15 years in the USA, Australia, Singapore, and Kenya; and older than 20 years in Italy and South Korea\". The proposed model shows that the introduction of the measles vaccine, which occurred at different times in the 9 countries, has considerably reduced the disease burden in terms of disability-adjusted life-years (DALYs), a measure expressed as the number of years lost because of illness, disability, or early death. Every vaccine dose averts 2 or 3 weeks of DALYs in the developed world and around 20 weeks in Kenya and Ethiopia. Which translates into 2-mln years 2 million DALYs since the vaccine introduction in the UK, 13-mln 13 million DALYs in the US, and 36-mln 36 million DALYs in Ethiopia. \"Vaccination has undoubtedly achieved incredible results in terms of public health. In particular,\" continues Prof Melegaro \"our analysis showed that routine 1st dose vaccine administration has been responsible for more than 90 per cent of the overall number of vaccine-immunized individuals in most countries. In Ethiopia and Kenya, catch-up and follow-up campaigns substantially mitigated the effect of suboptimum routine vaccine coverage, generating 25-45 per cent of the immunized fraction of the population. Tailoring immunization campaigns to achieve measles eradication goals is essential and currently, for some countries, this means considering also the role of unprotected adolescents and young adults. Measles immunity gaps and the progress towards elimination: a multi-country modelling analysis. Lancet Infect Dis. 2017. pii: S1473-3099(17)30421-8. Epub ahead of print; . While it is recommended that children get 2 doses of MMR (measles, mumps, rubella) vaccine, starting with the 1st dose at 12 through 15 months of age, and the 2nd dose at 4 through 6 years of age, this study emphasizes that it is important that adolescents and young adults also are up to date on their MMR vaccination. - Mod.LK ","keywordsMatched":[]},"503":{"title":"Dengue/DHF update (10): Asia, Pacific, Africa, research, WHO\r\n\t","date":["25","Aug","2017"],"url":"promedPRO/EDR> Dengue/DHF update (10): Asia, Pacific, Africa, research, WHO\r\n\t[EXTERNAL]","summary":" 3 WHO update  The 15 Aug 2017 Source: WHO Western Pacific region edited Dengue situation update no.<br><br><strong> 523 - Northern hemisphere -</strong><br> Cambodia As of 8 Aug 2017, a total of 1604 suspected dengue fever cases were reported in 2017. The total number of reported dengue cases including dengue haemorrhagic fever and dengue shock syndrome was lower than the 3 year-threshold of the same period from 2014-2016. China As of 31 Jul 2017, there were 503 cases of dengue reported in China in 2017. This number is higher than that reported during the same period since 2012 but follows historical trend. Lao PDR People's Democratic Republic As of 4 Aug 2017, there were 5740 cases of dengue with 7 deaths reported in Lao PDR in 2017, with 406 cases reported in epi week 31 (week ending 5 Aug 2017). Dengue activity is high with the number of dengue cases reported this year 2017 being higher than the cases reported for same period since 2014. Malaysia In week 31 of 2017 (week ending 5 Aug 2017), 1899 dengue cases were reported with 2 deaths, an increase of 1.1 per cent compared with week 30. As of week 31, the cumulative number of dengue cases in 2017 were 59 521 with 135 deaths compared with 67 437 cases with 147 deaths during the same period in 2016. Philippines (no update) A total of 43 770 dengue cases were reported nationwide from 1 Jan to 1 Jul 2017. This number is 36.8 per cent lower (25 527) compared with the same time period in 2016. Singapore As of 5 Aug 2017, there were 1732 dengue cases reported in Singapore since January 2017. This is lower than the number of reported cases during the same period since 2013. During week 31, there were 61 cases reported and the number of reported cases in 2017 remains lower than those reported for the same time period in 2016 . Viet Nam As of 3 Aug 2017, there were 80 555 cases of dengue reported in Viet Nam including 22 deaths. Compared with the same period in 2016, the cumulative number of cases increased by 33.5 per cent, and the number of deaths rose by 5. Most cases were reported from the South (59 per cent). A sharp increase in the number of reported cases has been observed in the North (almost 25 times higher than the same period last year 2016), especially from Ha Noi, with about 13 440 cases.<br><br><strong> Southern hemisphere -</strong><br> Australia As of 31 Jul 2017, there were 695 laboratory-confirmed dengue cases reported in Australia in 2017. The number of cases reported is lower than that reported during the same time period in the previous years (2012-2016).<br><br><strong> Pacific Islands countries and areas -</strong><br> French Polynesia In French Polynesia, 12 cases (including 1 death) in week 29 and 12 cases in week 30 (week ending 29 Jul 2017). Among these, 15 cases were confirmed as DENV-1 infection. New Caledonia (no update) As of 1 Aug 2017, 4,452 dengue cases were reported in 2017. There is a downward trend in the number of reported cases since week 16 (week ending 22 Apr 2017).  communicated by: ProMED-mail ","keywordsMatched":[]},"512":{"title":"Septoria, wheat - Australia: (VI, SA) ","date":["24","Aug","2017"],"url":"promedPRO/PL> Septoria, wheat - Australia: (VI, SA) [EXTERNAL]","summary":"   Thu 24 Aug 2017 Source: Farm Online edited Farmers in the Victorian Wimmera and the Upper South East of South Australia are set to be confronted with a fungal disease they have not seen at damaging levels since the 1970s. Septoria tritici blotch has built up to levels that could cause significant damage this year 2017. Agriculture Victoria cereal pathologist Grant Hollaway said septoria is now the major fungal disease issue in south-west Victoria. \"It has really emerged as a problem over the past five or six years.\" He said the major threat would be in the medium rainfall zone where the disease had not been spotted for many years. \"Septoria was common in the Wimmera in low levels last year 2016 and this has provided the carryover inoculum.\" There are parallels in septoria's reappearance after a lengthy absence with that of stripe rust, which Dr Hollaway said returned to Victoria in 2003 following a 20 year hiatus. \"It is more of a stripe rust in terms of the damage it can cause,\" he said. Byline: Gregor Heard  <br><br>Communicated by: ProMED-mail\\. Septoria leaf blotch of cereals is caused by fungi in the septoria species complex, which includes _Zymoseptoria tritici_ (previously _Septoria tritici_), _Mycosphaerella graminicola_ and _Phaeosphaeria nodorum_ (previously _Stagonospora nodorum_). They affect mainly wheat, but also barley and oats and occasionally rye and some grass species. Symptoms on wheat and barley are very similar and may occur at any time during the growth cycle and on any portion of the plant. They include blotches on both leaves and glumes, which reduce the photosynthetic ability of the host. Disease development is favoured by humid conditions. Up to 50 per cent yield losses have been reported on susceptible varieties. Spores can be spread by infected plant material, wind, water (rain splash) and mechanical means. The pathogens can overwinter on crop debris and on autumn sown crops or volunteers. Disease management includes fungicide treatments aimed at preventing the disease becoming established on the upper 3 leaves of the crop canopy (where it would affect the ears most), removal of inoculum sources and use of resistant varieties. After the cereal rusts, the disease is considered the most important challenge to plant breeders (see ProMED-mail post http://promedmail.org/post/20120831.1274190) and a threat to food security worldwide. Pathogen strains with high levels of resistance to many fungicides are emerging, for example, in the UK and other parts of Europe (ProMED-mail post http://promedmail.org/post/20160516.4225677), as well as Australia and New Zealand (ProMED-mail posts http://promedmail.org/post/20161031.4598540, http://promedmail.org/post/20140417.2410219). In Australia, STB was reported as the 1st wheat disease developing fungicide resistance on that continent (ProMED-mail post http://promedmail.org/post/20140313.2329774). The possibility cannot be excluded that the re-emergence of STB in eastern Australia may be due to new fungal strains which have adapted to local conditions. Stripe rust (_Puccinia striiformis_ var. _striiformis_), also mentioned above, can result in yield losses of 40 to 100 per cent. New strains with increased virulence are emerging and this disease is currently causing the most damage to wheat crops on a global scale. (For more information see previous ProMED-mail posts in the archives and links below). life cycle) Information on wheat stripe rust:  ,  and via Taxonomy of fungal species via:  - Mod.DHA ","keywordsMatched":[]},"743":{"title":"E. coli EHEC - Australia: (QL) O157, mild disease, mutant\r\n\ttoxin, 2013 ","date":["29","Aug","2017"],"url":"promedPRO/AH/EDR> E. coli EHEC - Australia: (QL) O157, mild disease, mutant\r\n\ttoxin, 2013 [EXTERNAL]","summary":"   Tue 29 Aug 2017 Source: Emerg Infect Dis Volume 23, Number 10October 2017 edited Mild Illness during Outbreak of Shiga Toxin-Producing _E.<br><br><strong> coli_ O157 Infections Associated with Agricultural Show, Australia </strong><br> Shiga toxin producing _E. coli_ (STEC or enterohemorrhagic _E. coli_, EHEC - Mod. LL) is a major cause of serious human gastrointestinal illness and have the potential to cause life-threatening complications, such as hemolytic uremic syndrome (HUS) (1). An average of 0.4 cases of EHEC illness per 100 000 persons per year are reported to public health authorities in Australia (2). Disease severity can range from asymptomatic infection to serious and sometimes fatal illness, particularly in young children and the elderly (3,4). Healthy ruminants, particularly cattle, are the reservoir for EHEC (5). Human infection with EHEC usually occurs as a result of inadvertent ingestion of fecal matter after consumption of contaminated food, water, or unpasteurized milk; contact with animals or their environments; or secondarily, through contact with infected humans (4,5). In the largest previously reported outbreak of EHEC illness in Australia in 1995, which was associated with consumption of mettwurst (uncooked, semidry, fermented sausages), HUS developed in 23 of the 51 case-patients identified, and there was 1 death (6).<br><br><strong> The Study -</strong><br> A multidisciplinary incident management team was established to investigate an outbreak of EHEC illness associated with an annual agricultural show in Brisbane, Queensland, Australia, in August 2013. The incident management team defined primary and secondary outbreak cases. Persons with laboratory-confirmed EHEC infection associated with the outbreak and their household contacts were followed up until the point of microbiological evidence of clearance, which was defined as 2 consecutive negative stool samples collected more than 24h apart (7). Case-patients and contacts with a high risk for transmission (persons under 5 years of age; persons unable to maintain good hygiene; or childcare, healthcare, aged care, or food preparation workers) were advised to avoid childcare and work settings in accordance with Queensland Health Guidelines (7). Enhanced surveillance measures were implemented to assist with case finding. Medical practitioners were requested to avoid use of antimicrobial drugs for suspected case-patients with EHEC infections because of previously reported associations between antimicrobial drug use and HUS. We developed a case-control study to obtain additional information related to animal contact, hand hygiene, and food consumption at the agricultural show. We analyzed data by using Epi Info 7 (Centers for Disease Control and Prevention, Atlanta, GA, USA). EHEC identified from human, environmental, and animal samples were serotyped for O and H antigens. Expression of Shiga toxin 1 (stx1) and stx2 genes was determined for selected isolates. Shiga toxin gene subtyping and whole-genome sequencing (WGS) analysis was performed. During 21 Aug 2013 to 27 Sep 2013, we identified 57 outbreak-associated laboratory-confirmed case-patients with EHEC infection: 54 confirmed primary case-patients, 1 probable primary case-patient, and 2 secondary case-patients (Figure 1 for figures, see original URL - Mod. LL). Of the 57 cases-patients, 32 (56 percent) were female. Case-patients ranged in age from 1 to 77 (median 9) years; 31 (56 percent) case-patients were 3. Paton JC and Paton AW: Pathogenesis and diagnosis of Shiga toxin-producing _Escherichia coli_ infections. Clin Microbiol Rev. 1998;11: 450-479. Available at:  . 4. Tarr PI, Gordon CA and Chandler WL: Shiga-toxin-producing _Escherichia coli_ and haemolytic uraemic syndrome. Lancet. 2005;365: 1073-1086. Available at:  . 5. Farrokh C, Jordan K, Auvray F, et al: Review of Shiga-toxin-producing _Escherichia coli_ (STEC) and their significance in dairy production. Int J Food Microbiol. 2013;162: 190-212. Available at:  . 6. CDC: Community outbreak of hemolytic uremic syndrome attributable to _Escherichia coli_ O111:NMSouth Australia 1995. MMWR Morb Mortal Wkly Rep. 1995;44:550-551, 557-558. Available at:  . 7. Queensland Health: Shiga toxin-producing _Escherichia coli_ (STEC) infection. The State of Queensland 2013 cited 2016 Sep 25. Available at:  . 8. Heiman KE, Mody RK, Johnson SD, Griffin PM and Gould LH: _Escherichia coli_ O157 Outbreaks in the United States, 2003-2012. Emerg Infect Dis. 2015;21: 1293-1301. Available at:  . 9. Jelacic S, Wobbe CL, Boster DR, et al: ABO and P1 blood group antigen expression and stx genotype and outcome of childhood _Escherichia coli_ O157:H7 infections. J Infect Dis. 2002;185: 214-219. Available at:  . 10. Kim YB, Okuda J, Matsumoto C, et al: Isolation of an _Escherichia coli_ O157:H7 strain producing Shiga toxin 1 but not Shiga toxin 2 from a patient with hemolytic uremic syndrome in Korea. FEMS Microbiol Lett. 1998;166: 43-48. Available at:  . 11. Ethelberg S, Olsen KE, Scheutz F, et al: Virulence factors for hemolytic uremic syndrome, Denmark. Emerg Infect Dis. 2004;10: 842-847. Available at:  . 12. Launders N, Byrne L, Jenkins C, Harker K, Charlett A and Adak GK: Disease severity of Shiga toxin-producing _E. coli_ O157 and factors influencing the development of typical haemolytic uraemic syndrome: a retrospective cohort study, 2009-2012. BMJ Open. 2016;6:e009933. Available at:  . 13. Freedman SB, Xie J, Neufeld MS, Hamilton WL, Hartling L and Tarr PI: Alberta Provincial Pediatric Enteric Infection Team (APPETITE). Shiga toxin-producing _Escherichia coli_ infection, antibiotics, and risk of developing hemolytic uremic syndrome: a meta-analysis. Clin Infect Dis. 2016;62: 1251-1258. Available at:  . Authors: Vasant BR, Stafford RJ, Jennison AV, et al  <br><br>Communicated by: ProMED-mail\\. ProMED reported on this outbreak in 2013 when it occurred. It may well be the case that the IS1203v insertion that resulted in deletion of the first 494 bp of the stx2c subunit A gene may have been the cause of milder illness. Regarding azithromycin use, azithromycin and the carbapenem antimicrobial class are among a small group of antibacterials that do not appear to precipitate a higher risk of hemolytic uremic syndrome. Azithromycin was used for late clearance of the EHEC here and I have had anecdotal experience doing the same thing in an asymptomatic chronic carrier of EHEC O157 without any adverse effects. - Mod.LL   . ","keywordsMatched":[]}},"Austria":{},"Azerbaijan":{},"Bahamas":{},"Bahrain":{},"Bangladesh":{},"Barbados":{},"Belarus":{},"Belgium":{},"Belize":{"510":{"title":"Ciguatera fish poisoning - Belize: barracuda,\r\n\talert ","date":["26","Aug","2017"],"url":"promedPRO/AH/EDR> Ciguatera fish poisoning - Belize: barracuda,\r\n\talert [EXTERNAL]","summary":"   Sat 26 Aug 2017 Source: Amandala edited Each year, between 10 000 and 50 000 people who live in or visit tropical and subtropical areas suffer from Ciguatera Fish Poisoning (CFP), which is said to be one of the most frequently reported seafood-toxin illness in the world. Ciguatera poisoning, which causes symptoms such as tingling and numbness in fingers and toes, around lips, tongue, mouth and throat; nausea, vomiting, diarrhea and/or abdominal cramps; joint pains and headache; and breathing difficulty, has also been reported in Belize, and over the past 4 days, 2 alerts have been issued by the Ministry of Health in Belize, following reports of cases cropping up, which have been linked to the consumption of barracuda fish. In the 1st alert, issued on Fri 18 Aug 2017, the Ministry of Health reported that \"suspected fish poisoning (Ciguatera poisoning) was detected in people that had eaten fish bought from a fish vendor in Ladyville, Belize District.\" In the 2nd alert, issued on Tue 23 Aug 2017, the Ministry said that 2 further cases of suspected Ciguatera poisoning, linked to the consumption of the large predatory fish, had been identified. \"Investigations conducted so far reveal that the barracuda fish from the Turneffe Islands area has been the sole carrier of the ciguaxtoin or poison,\" the alert said. It warned that toxic fish does not have any odor or taste and cooking and freezing does not eliminate the toxin. According to the US Center for Disease Control and Prevention (CDC), ciguatera fish poisoning (or ciguatera) is an illness caused by eating fish that contain toxins produced by a marine microalgae called _Gambierdiscus toxicus_, associated with corals. Whereas the barracuda is believed to be the culprit for the most recent bouts of illness caused by the toxin, other fish may also carry the toxin, including coral trout, red snapper, donu, parrot fish, grouper, Spanish mackerel, red emperor, wrasse, reef cod, sturgeon fish, trevally and moray eel. The CDC also lists blackfin snapper, cubera snapper, dog snapper, greater amberjack, hogfish, horse-eye jack, and king mackerel among the fish which have been known to carry ciguatoxins. \"Anyone who consumes fish contaminated with the ciguatera toxin will become ill,\" the Ministry's alert said, adding that, \"The gastrointestinal or stomach symptoms normally appear within 24 hours of exposure and those of the nervous system can appear 1 to 2 days later.\" Although some symptoms may last only a few days, in some cases, the toxin can continue to affect those who ingest it for months. The CDC says people who have ciguatera may find that cold things feel hot and hot things feel cold. The Belize Ministry of Health has shared some guidelines for reducing the risk of CFP. It advises the following: - Avoid eating larger reef fish that have a greater likelihood of carrying ciguatoxins, especially the barracuda. - Limit the weight of a fish to less than 11 pounds, as ciguatera fish poisoning occurs more frequently in larger fish. - Eat other types of fish not listed above. - Avoid eating the head, roe or fish egg, liver, or other organs of the fish, as it is where the highest level of toxin is present. Byline: Adele Ramos  <br><br>Communicated by: ProMED-mail\\. A recent open access review of ciguatera fish poisoning (CFP) has been published in Marine Drugs: Friedman MA , Fernandez M, Backer LC, et al: An updated review of Ciguatera Fish Poisoning: Clinical, epidemiological, environmental, and public health management. Mar Drugs 2017, 15(3): pii: E72; doi:10.3390/md15030072; available at:  . ","keywordsMatched":[]}},"Bermuda":{},"Benin":{},"Bhutan":{},"Bolivia":{"749":{"title":"Zika virus (17): Americas, research, observations ","date":["24","Aug","2017"],"url":"promedPRO/EDR> Zika virus (17): Americas, research, observations [EXTERNAL]","summary":" 6 Vaccine update  22/29 Aug 2017 Source: Journal of the American Medical Association, JAMA edited ref: Lyon J. Vaccines protect fetus from Zika. JAMA. 2017; 318(8): 689. doi:10.1001/jama.2017.<br><br><strong>11200 </strong><br> Researchers funded in part by the National Institutes of Health have recently demonstrated that 2 experimental vaccines can restrict transmission of Zika virus from pregnant mice to their fetuses, thereby shielding offspring from congenital damage or death. Multiple candidate Zika vaccines have been shown protective against infection with the virus in animal studies, with several now in human trials, but none were tested in the context of pregnancy, according to the authors of the study published in Cell  . The 2 vaccine candidates investigated in the new study are the 1st to demonstrate efficacy in preventing vertical transmission of the virus and related fetal death in an animal model. Although the vaccines were administered to female mice prior to pregnancy, the result is considered an important step toward developing a vaccine that could be safely given to pregnant women. One of the 2 candidates is a modified messenger RNA (mRNA) vaccine encoding Zika genes, developed by the biotechnology company Moderna. It is already in safety trials in women who are not pregnant. The other is a live-attenuated Zika strain developed by researchers at the University of Texas Medical Branch (UTMB). The testing was carried out by scientists from the National Institute of Allergy and Infectious Diseases, Washington University School of Medicine, and UTMB. The researchers 1st vaccinated the mice with 1 of the vaccines or a placebo. After mating, the animals were challenged with the virus 6 days into pregnancy. A week later, more than 50 percent of placentas and fetuses from mice administered the mRNA vaccine had virtually no Zika RNA. The remainder had \"substantially lower\" levels relative to placebo. The live vaccine provided broader protection: 78 percent of placentas and 83 percent of fetuses had Zika RNA at or below the level of detection, while the placebo group exhibited significantly higher levels of placental and fetal Zika RNA. Mice vaccinated with either vaccine had significantly higher rates of fetal viability; whereas 100 percent of fetuses from mice vaccinated with the mRNA vaccine were born, none survived to term in the placebo group. A working group funded by the Wellcome Trust recently approved ethical guidelines for testing such vaccines in pregnant women, normally excluded from drug trials.  <br><br>Communicated by: ProMED-mail\\. It is reassuring to learn that at least 2 vaccines are now entering clinical trials in women. Although anti-Zika virus drugs are under development, preventing infection through vaccination seems to be the most effective measure to prevent fetal infection and adverse effects of the virus infection in adults. - Mod.TY ","keywordsMatched":[]}},"Bosnia and Herzegovina":{},"Botswana":{},"Brazil":{"749":{"title":"Zika virus (17): Americas, research, observations ","date":["24","Aug","2017"],"url":"promedPRO/EDR> Zika virus (17): Americas, research, observations [EXTERNAL]","summary":" 6 Vaccine update  22/29 Aug 2017 Source: Journal of the American Medical Association, JAMA edited ref: Lyon J. Vaccines protect fetus from Zika. JAMA. 2017; 318(8): 689. doi:10.1001/jama.2017.<br><br><strong>11200 </strong><br> Researchers funded in part by the National Institutes of Health have recently demonstrated that 2 experimental vaccines can restrict transmission of Zika virus from pregnant mice to their fetuses, thereby shielding offspring from congenital damage or death. Multiple candidate Zika vaccines have been shown protective against infection with the virus in animal studies, with several now in human trials, but none were tested in the context of pregnancy, according to the authors of the study published in Cell  . The 2 vaccine candidates investigated in the new study are the 1st to demonstrate efficacy in preventing vertical transmission of the virus and related fetal death in an animal model. Although the vaccines were administered to female mice prior to pregnancy, the result is considered an important step toward developing a vaccine that could be safely given to pregnant women. One of the 2 candidates is a modified messenger RNA (mRNA) vaccine encoding Zika genes, developed by the biotechnology company Moderna. It is already in safety trials in women who are not pregnant. The other is a live-attenuated Zika strain developed by researchers at the University of Texas Medical Branch (UTMB). The testing was carried out by scientists from the National Institute of Allergy and Infectious Diseases, Washington University School of Medicine, and UTMB. The researchers 1st vaccinated the mice with 1 of the vaccines or a placebo. After mating, the animals were challenged with the virus 6 days into pregnancy. A week later, more than 50 percent of placentas and fetuses from mice administered the mRNA vaccine had virtually no Zika RNA. The remainder had \"substantially lower\" levels relative to placebo. The live vaccine provided broader protection: 78 percent of placentas and 83 percent of fetuses had Zika RNA at or below the level of detection, while the placebo group exhibited significantly higher levels of placental and fetal Zika RNA. Mice vaccinated with either vaccine had significantly higher rates of fetal viability; whereas 100 percent of fetuses from mice vaccinated with the mRNA vaccine were born, none survived to term in the placebo group. A working group funded by the Wellcome Trust recently approved ethical guidelines for testing such vaccines in pregnant women, normally excluded from drug trials.  <br><br>Communicated by: ProMED-mail\\. It is reassuring to learn that at least 2 vaccines are now entering clinical trials in women. Although anti-Zika virus drugs are under development, preventing infection through vaccination seems to be the most effective measure to prevent fetal infection and adverse effects of the virus infection in adults. - Mod.TY ","keywordsMatched":[]}},"Brunei":{},"Bulgaria":{},"Burkina Faso":{},"Burundi":{"487":{"title":"Cholera, diarrhea & dysentery update (90): Africa ","date":["24","Aug","2017"],"url":"promedPRO/EDR> Cholera, diarrhea & dysentery update (90): Africa [EXTERNAL]","summary":"<br><br><strong> 3 Cholera - Sudan  Wed 23 Aug 2017 Source: UN Office for the Coordination of Humanitarian Affairs (OCHA), ReliefWeb, Radio Dabanga report edited South Darfur </strong><br> On Monday and Tuesday 21-22 Aug 2017 4 displaced people died of cholera and 49 others have been infected at camp Kalma in Nyala, capital of South Darfur. More deaths and infections have been reported from across the country as rates resurge along the Nile. Yagoub Abdallah, the general coordinator of displaced persons and refugee camps, told Radio Dabanga that \"the camp has seen a wide spread of cholera over the past 2 days.\" On Mon 21 Aug 2017, the camp's 2 health centers reported 1 death and 18 new cholera cases, and 3 deaths and 31 new cases on Tue 22 Aug 2017. Abdallah explained that the number of hospitalized cases in the 2 centers has amounted to 78 and pointed to the acute shortage of medicines in both centers. He appealed to the Ministry of Health and the WHO to speed up the provision of medicines and intravenous solutions.<br><br><strong> Central Darfur </strong><br> On Monday and Tuesday 21-22 Aug 2017, Nierteti in Central Darfur recorded 5 new cases of cholera. One of the Sheikhs of Nierteti camps told Radio Dabanga that 3 cases were recorded on 21 Aug 2017, 2 from the camps and 1 from neighboring villages of Nierteti. On 22 Aug 2017, 2 cases were recorded in Nierteti camps, bringing the number of hospitalized cases to 12.<br><br><strong> Sennar </strong><br> From Friday to Tuesday 18-22 Aug 2017, 18 people have been infected with cholera at El Dindir area in Sennar. Yesterday 22 Aug 2017, a medical source told Radio Dabanga that El Dindir Hospital received 2 new cases, this in addition to the existence of 6 hospitalized cases in the isolation ward. A medical source reported from El Bardana village entry of 1 case on Tue 22 Aug 2017, bringing the total number of cases in the isolation centre to 10 cases since 18 Aug 2017. Singa area reportedly witnessed a marked decrease in recent cases. The health source said Singa Hospital recorded 3 cases of cholera on Monday and Tuesday 21-22 Aug 2017.<br><br><strong> Khartoum </strong><br> Cholera in Khartoum state has re-spread after seeing a significant decrease during the past month. Yesterday 22 Aug 2017, an activist from the emergency room of Teiba El Ahamda told Radio Dabanga that El Ezba district health center has recorded 4 cases of cholera during the past 2 days. The activist attributed the emergence of cases to the rainfall and the terrible environmental degradation witnessed by the district due to the accumulation of waste. He pointed out that Bahri locality has stopped transporting the waste from Teiba El Ahamda for unknown reasons for 3 years. El Azhari Widaatallah, the chairman of the Legislative and Justice Committee of the Parliament, representative of Constituency 30 of Khartoum state of the districts of El Azhari, El Shajara, El Azozab, Lamab, Hamadab, pointed to the emergence of watery diarrhea in his constituency, especially at El Shajara. He attributed the deterioration of the health situation in the area to the lack of sewage system and the stagnation of rainwater. Health sources revealed the emergence of a number of cases of cholera in the academic hospital in Khartoum.<br><br><strong> Northern state </strong><br> In the Northern state, the isolation centre at Delgo Hospital received 3 new cases of cholera on Sun 20 Aug 2017. Nubian activist Ashraf Abdelwedoud warned in an interview with Radio Dabanga of the increasing rates of the disease following the rains and floods in the area in the past few days. He called on the authorities to make efforts to curb the spread of the disease. - Sr.Tech.Ed.MJ The mortality from cholera and most diarrheal illnesses is related to non-replacement of fluid and electrolytes from the diarrheal illness. As stated in Lutwick LI, Preis J, Choi P: Cholera. In: Chronic illness and disability: the pediatric gastrointestinal tract. Greydanus DE, Atay O, Merrick J (eds). NY: Nova Bioscience, 2017 (in press), oral rehydration therapy can be life-saving in outbreaks of cholera and other forms of diarrhea: \"As reviewed by Richard Guerrant et al (1), it was in 1831 that cholera treatment could be accomplished by intravenous replacement, and, although this therapy could produce dramatic improvements, not until 1960 was it 1st recognized that there was no true destruction of the intestinal mucosa, and gastrointestinal rehydration therapy could be effective, and the therapy could dramatically reduce the intravenous needs for rehydration. Indeed, that this rehydration could be just as effective given orally as through an orogastric tube (for example, refs 2 and 3) made it possible for oral rehydration therapy (ORT) to be used in rural remote areas and truly impact on the morbidity and mortality of cholera. Indeed, Guerrant et al (1) highlights the use of oral glucose-salt packets in war-torn Bangladeshi refugees, which reduced the mortality rate from 30 per cent to 3.6 per cent (4) and quotes sources referring to ORT as \"potentially the most important medical advance\" of the 20th century. A variety of formulations of ORT exist, generally glucose or rice powder-based, which contain a variety of micronutrients, especially zinc (5). \"The assessment of the degree of volume loss in those with diarrhea to approximate volume and fluid losses can be found in ref 6 below. Those with severe hypovolemia should be initially rehydrated intravenously with a fluid bolus of normal saline or Ringer's lactate solution of 20-30 ml/kg followed by 100 ml/kg in the 1st 4 hours and 100 ml/kg over the next 18 hours with regular reassessment. Those with lesser degrees of hypovolemia can be rehydrated orally with a glucose or rice-derived formula with up to 4 liters in the 1st 4 hours, and those with no hypovolemia can be given ORT after each liquid stool with frequent reevaluation.<br><br><strong> \"References </strong><br> 1. Guerrant RL, Carneiro-Filho BA, Dillingham RA. Cholera, diarrhea, and oral rehydration therapy: triumph and indictment. Clin Infect Dis. 2003; 37(3): 398-405; available at  . 2. Gregorio GV, Gonzales ML, Dans LF, Martinez EG. Polymer-based oral rehydration solution for treating acute watery diarrhoea. Cochrane Database Syst Rev. 2009; (2): CD006519. doi: 10.1002/14651858.CD006519.pub2; available at  . 3. Gore SM, Fontaine O, Pierce NF. Impact of rice based oral rehydration solution on stool output and duration of diarrhoea: meta-analysis of 13 clinical trials. BMJ 1992; 304(6822): 287-91; available at . 4. Mahalanabis D, Choudhuri AB, Bagchi NG, et al. Oral fluid therapy of cholera among Bangladesh refugees. Johns Hopkins Med 1973; 132(4): 197-205; available at  . 5. Atia AN, Buchman AL. Oral rehydration solutions in non-cholera diarrhea: a review. Am J Gastroenterol 2009; 104(10): 2596-604; abstract available at . 6. WHO. The treatment of diarrhoea, a manual for physicians and other senior health workers. 4th ed. 2005; available at:  . - Mod.LL ","keywordsMatched":[]}},"Cambodia":{"503":{"title":"Dengue/DHF update (10): Asia, Pacific, Africa, research, WHO\r\n\t","date":["25","Aug","2017"],"url":"promedPRO/EDR> Dengue/DHF update (10): Asia, Pacific, Africa, research, WHO\r\n\t[EXTERNAL]","summary":" 3 WHO update  The 15 Aug 2017 Source: WHO Western Pacific region edited Dengue situation update no.<br><br><strong> 523 - Northern hemisphere -</strong><br> Cambodia As of 8 Aug 2017, a total of 1604 suspected dengue fever cases were reported in 2017. The total number of reported dengue cases including dengue haemorrhagic fever and dengue shock syndrome was lower than the 3 year-threshold of the same period from 2014-2016. China As of 31 Jul 2017, there were 503 cases of dengue reported in China in 2017. This number is higher than that reported during the same period since 2012 but follows historical trend. Lao PDR People's Democratic Republic As of 4 Aug 2017, there were 5740 cases of dengue with 7 deaths reported in Lao PDR in 2017, with 406 cases reported in epi week 31 (week ending 5 Aug 2017). Dengue activity is high with the number of dengue cases reported this year 2017 being higher than the cases reported for same period since 2014. Malaysia In week 31 of 2017 (week ending 5 Aug 2017), 1899 dengue cases were reported with 2 deaths, an increase of 1.1 per cent compared with week 30. As of week 31, the cumulative number of dengue cases in 2017 were 59 521 with 135 deaths compared with 67 437 cases with 147 deaths during the same period in 2016. Philippines (no update) A total of 43 770 dengue cases were reported nationwide from 1 Jan to 1 Jul 2017. This number is 36.8 per cent lower (25 527) compared with the same time period in 2016. Singapore As of 5 Aug 2017, there were 1732 dengue cases reported in Singapore since January 2017. This is lower than the number of reported cases during the same period since 2013. During week 31, there were 61 cases reported and the number of reported cases in 2017 remains lower than those reported for the same time period in 2016 . Viet Nam As of 3 Aug 2017, there were 80 555 cases of dengue reported in Viet Nam including 22 deaths. Compared with the same period in 2016, the cumulative number of cases increased by 33.5 per cent, and the number of deaths rose by 5. Most cases were reported from the South (59 per cent). A sharp increase in the number of reported cases has been observed in the North (almost 25 times higher than the same period last year 2016), especially from Ha Noi, with about 13 440 cases.<br><br><strong> Southern hemisphere -</strong><br> Australia As of 31 Jul 2017, there were 695 laboratory-confirmed dengue cases reported in Australia in 2017. The number of cases reported is lower than that reported during the same time period in the previous years (2012-2016).<br><br><strong> Pacific Islands countries and areas -</strong><br> French Polynesia In French Polynesia, 12 cases (including 1 death) in week 29 and 12 cases in week 30 (week ending 29 Jul 2017). Among these, 15 cases were confirmed as DENV-1 infection. New Caledonia (no update) As of 1 Aug 2017, 4,452 dengue cases were reported in 2017. There is a downward trend in the number of reported cases since week 16 (week ending 22 Apr 2017).  communicated by: ProMED-mail ","keywordsMatched":[]}},"Cameroon":{},"Canada":{},"Cape Verde":{},"Cayman Islands":{},"Central African Republic":{},"Chad":{},"Chile":{"744":{"title":"Respiratory syncytial virus - Chile ","date":["28","Aug","2017"],"url":"promedPRO/EDR> Respiratory syncytial virus - Chile [EXTERNAL]","summary":"   Mon 28 Aug 2017 Source: Diario Aysen in Spanish, trans. Mod.JG, edited Last weekend, more than 20 children with severe respiratory symptoms were admitted to the Regional Hospital, and they were diagnosed with respiratory syncytial virus (RSV) infection. During the last week, 2 3-year-old children with severe respiratory illness were admitted to the intensive care unit, and one of them was waiting to be referred to Puerto Montt. Therefore, with information updated until last Sat 26 Aug 2017, more than 30 children with RSV infection have been reported, and all of them are hospitalized in pediatrics, pediatric intensive care, and neonatal intensive care units. Meanwhile, because of the severity of their condition  most of them being infants  7 children have been referred to hospitals in Santiago and Concepcion so they may receive adequate care, since Coyhaique Regional Hospital (CRH) does not have a pediatric intensive care unit (ICU). This is what Dr. Jaime Lopez-Quintana, Head of the CRH reported: \"This year 2017, RSV is behaving quite aggressively, and our adult intensive care unit is completely full with children. This is not an adequate condition for taking care of these children; this is not what our children in this region deserve,\" as he reported this situation to Ms. Gisela Alarcon-Rojas, Subsecretary of Healthcare Networks of the Chilean Ministry of Health, who verified the condition of children being taken care of in the (adult) ICU. So, with this complex situation, Dr. Lopez-Quintana added that specialists from important children referral centers, particularly from Dr. Luis Calvo-Mackenna and Dr. Exequiel Fernandez-Cortes hospitals, will soon arrive to this region. \"We hope to have for the next 2 weeks the support of pediatricians trained in intensive medicine who may help the team we have here in Coyhaique,\" emphasized Dr. Lopez-Quintana. According to information brought by the medical sub-direction from the Coyhaique Regional Hospital, the affected children are hospitalized in the following areas: pediatrics, neonatal intensive care unit, and (general) intensive care unit. There are 10 infants hospitalized in the pediatrics service, while another 11 children have already been discharged; so now there are 14 beds available. In the neonatal ICU, 7 children are hospitalized; 2 of them are severely ill, and the capacity of the unit is 2 beds; while in the general ICU, 6 infants are hospitalized, and there are 2 beds available. \"With respect to bed availability, the hospital is still able to cope with the situation. However, a working overload for the personnel has been observed, so that extra personnel have been recruited to cover the work shifts,\" explained Dr. Joaquin Garcia-Gay, Medical Subdirector of the CRH. Also, Dr. Garcia-Gay explained that if a child develops a febrile illness, respiratory distress, intercostal retraction and malaise for 2 days, these are some of the symptoms that may indicate the presence of RSV, which mainly affects infants less than 2 years old. \"So, if such symptoms occur, then the child must be brought to the Urgency Service. However, for those patients that develop mild respiratory symptoms, such as common cold or other similar conditions, it is preferable they are not brought to the Urgency Service, since they may be at risk for becoming infected with RSV from patients that are being hospitalized,\" the specialist advised.  <br><br>Communicated by: ProMED-mail\\. Most infants are infected before one year of age, and virtually everyone gets an RSV infection by 2 years of age. Each year, on average, in the United States, RSV leads to: - 57 527 hospitalizations among children younger than 5 years old - 2.1 million outpatient visits among children younger than 5 years old - 177 000 hospitalizations and 14 000 deaths among adults older than 65 years. In the United States and other areas with similar climates, RSV infections occur primarily during fall, winter, and spring  . It is currently winter in Chile. It is not clear what may have led to this current RSV outbreak in Chile. In 2001, an outbreak of RSV struck Santiago, Chile. 150 hospital admissions were registered daily during the height of the southern hemisphere winter. It was speculated that pollution may have played a role as Santiago is one of the world's most polluted cities. Chile's geography of surrounding mountains and heat inversions in winter dramatically increases the concentration of pollutants. Pollution leads to irritation of the respiratory tract making it more difficult for the immune system to respond to infections. (Excerpted from C Orellana. Respiratory syncytial virus outbreak in Chile. The Lancet Infec Dis. News desk. October 2001 DOI:  ). - Mod. ","keywordsMatched":[]}},"China":{"503":{"title":"Dengue/DHF update (10): Asia, Pacific, Africa, research, WHO\r\n\t","date":["25","Aug","2017"],"url":"promedPRO/EDR> Dengue/DHF update (10): Asia, Pacific, Africa, research, WHO\r\n\t[EXTERNAL]","summary":" 3 WHO update  The 15 Aug 2017 Source: WHO Western Pacific region edited Dengue situation update no.<br><br><strong> 523 - Northern hemisphere -</strong><br> Cambodia As of 8 Aug 2017, a total of 1604 suspected dengue fever cases were reported in 2017. The total number of reported dengue cases including dengue haemorrhagic fever and dengue shock syndrome was lower than the 3 year-threshold of the same period from 2014-2016. China As of 31 Jul 2017, there were 503 cases of dengue reported in China in 2017. This number is higher than that reported during the same period since 2012 but follows historical trend. Lao PDR People's Democratic Republic As of 4 Aug 2017, there were 5740 cases of dengue with 7 deaths reported in Lao PDR in 2017, with 406 cases reported in epi week 31 (week ending 5 Aug 2017). Dengue activity is high with the number of dengue cases reported this year 2017 being higher than the cases reported for same period since 2014. Malaysia In week 31 of 2017 (week ending 5 Aug 2017), 1899 dengue cases were reported with 2 deaths, an increase of 1.1 per cent compared with week 30. As of week 31, the cumulative number of dengue cases in 2017 were 59 521 with 135 deaths compared with 67 437 cases with 147 deaths during the same period in 2016. Philippines (no update) A total of 43 770 dengue cases were reported nationwide from 1 Jan to 1 Jul 2017. This number is 36.8 per cent lower (25 527) compared with the same time period in 2016. Singapore As of 5 Aug 2017, there were 1732 dengue cases reported in Singapore since January 2017. This is lower than the number of reported cases during the same period since 2013. During week 31, there were 61 cases reported and the number of reported cases in 2017 remains lower than those reported for the same time period in 2016 . Viet Nam As of 3 Aug 2017, there were 80 555 cases of dengue reported in Viet Nam including 22 deaths. Compared with the same period in 2016, the cumulative number of cases increased by 33.5 per cent, and the number of deaths rose by 5. Most cases were reported from the South (59 per cent). A sharp increase in the number of reported cases has been observed in the North (almost 25 times higher than the same period last year 2016), especially from Ha Noi, with about 13 440 cases.<br><br><strong> Southern hemisphere -</strong><br> Australia As of 31 Jul 2017, there were 695 laboratory-confirmed dengue cases reported in Australia in 2017. The number of cases reported is lower than that reported during the same time period in the previous years (2012-2016).<br><br><strong> Pacific Islands countries and areas -</strong><br> French Polynesia In French Polynesia, 12 cases (including 1 death) in week 29 and 12 cases in week 30 (week ending 29 Jul 2017). Among these, 15 cases were confirmed as DENV-1 infection. New Caledonia (no update) As of 1 Aug 2017, 4,452 dengue cases were reported in 2017. There is a downward trend in the number of reported cases since week 16 (week ending 22 Apr 2017).  communicated by: ProMED-mail ","keywordsMatched":[]},"762":{"title":"Avian influenza (135): China (GZ) HPAI H5N6, poultry, OIE\r\n\t","date":["28","Aug","2017"],"url":"promedPRO/AH/EDR> Avian influenza (135): China (GZ) HPAI H5N6, poultry, OIE\r\n\t[EXTERNAL]","summary":" Not calculated because of missing information Epidemiology Source of the outbreak(s) or origin of infection: unknown or inconclusive Control measures Measures applied: movement control inside the country; screening; quarantine; stamping out disinfection; vaccination permitted (if a vaccine exists); no treatment of affected animals Measures to be applied: no other measures Diagnostic test results Laboratory name and type / Species / Test / Test date / Result Harbin Veterinary Avian Influenza Reference Laboratory (OIE's Reference Laboratory) / Birds / reverse transcription-polymerase chain reaction (RT-PCR) / 18 Aug 2017 / Positive Future reporting The event is continuing. Weekly follow-up reports will be submitted.  <br><br>Communicated by: ProMED-mail\\. China reported HPAI H5N6 on 23 Aug 2014. Since that time a total of 40 outbreaks have been reported. This event is still continuing. The latest follow-up report (No. 19) is dated 15 Mar 2017; see  .- Mod.CRD ","keywordsMatched":[]}},"Colombia":{},"Comoros":{},"Democratic Republic of Congo":{},"Republic of Congo":{},"Costa Rica":{},"Cote dIvoire":{},"Croatia":{},"Cuba":{},"Curacao":{},"Cyprus":{},"Czech Republic":{},"Denmark":{},"Djibouti":{},"Dominica":{},"Dominican Republic":{},"Ecuador":{},"Egypt":{},"El Salvador":{},"Equatorial Guinea":{},"Eritrea":{},"Estonia":{},"Ethiopia":{"502":{"title":"Measles update (43): Asia and Pacific, Europe, demographics\r\n\t","date":["26","Aug","2017"],"url":"promedPRO/EDR> Measles update (43): Asia and Pacific, Europe, demographics\r\n\t[EXTERNAL]","summary":"<br><br><strong> Measles immunity gaps -</strong><br> 5 Role of demographics  Sat 26 Aug 2017 Source: News-Medical/Life Sciences edited Even if the incidence of measles infection has decreased by at least 90 per cent worldwide since the introduction of the vaccine, measles is still one of the major causes of death in children among vaccine-preventable diseases. Regular measles epidemics are reported in developing countries and recurrent episodic outbreaks occur in the developed world. A new study by Bocconi University and Bruno Kessler Foundation analyzing 9 countries (Australia, Ethiopia, Kenya, Ireland, Italy, South Korea, Singapore, the United Kingdom, and the United States) and published in The Lancet Infectious Diseases see reference below, highlights the role played by demographics in the spread of measles and concludes that future vaccination strategies in high-fertility countries should focus on increasing childhood immunization rates, while immunization campaigns targeting adolescents and young adults are required in low fertility countries. Using a transmission model calibrated on historical serological data the authors estimate that the susceptible proportion of the population (that is, unprotected against the infection) varies from about 3 per cent in the UK to more than 12.5 per cent in Ethiopia, with astonishing differences in its age composition, due to different vaccination strategies and divergent demographic trends. While the percentage of over-15 among susceptible individuals in Ethiopia and Kenya is, respectively, 28 per cent and 43 per cent, adolescents and young adults represent 74 per cent of unprotected individuals in South Korea, 66 per cent in Italy and 53 per cent in the US, with considerable immunity gaps in individuals aged 30-40 years. \"Every effort to increase the vaccination coverage rate among children is praiseworthy\", says Alessia Melegaro, a Bocconi professor and principal investigator of DECIDE, the ERC European Research Council-funded project which produced the article, \"but in some developed countries it's the lack of coverage among adolescents and adults that poses a serious threat to the goal of eliminating measles.\" \"Measles incidence could increase, in the next decades, in Italy, Australia, and Singapore and Ethiopia is at high risk of future large epidemics\", says Stefano Merler from Bruno Kessler Foundation, \"and this is particularly worrying considering that individuals get infected later in life when the disease is more severe. The median age at infection for 2015 was estimated to be 5-10 years in the UK, Ireland, and Ethiopia; 10-15 years in the USA, Australia, Singapore, and Kenya; and older than 20 years in Italy and South Korea\". The proposed model shows that the introduction of the measles vaccine, which occurred at different times in the 9 countries, has considerably reduced the disease burden in terms of disability-adjusted life-years (DALYs), a measure expressed as the number of years lost because of illness, disability, or early death. Every vaccine dose averts 2 or 3 weeks of DALYs in the developed world and around 20 weeks in Kenya and Ethiopia. Which translates into 2-mln years 2 million DALYs since the vaccine introduction in the UK, 13-mln 13 million DALYs in the US, and 36-mln 36 million DALYs in Ethiopia. \"Vaccination has undoubtedly achieved incredible results in terms of public health. In particular,\" continues Prof Melegaro \"our analysis showed that routine 1st dose vaccine administration has been responsible for more than 90 per cent of the overall number of vaccine-immunized individuals in most countries. In Ethiopia and Kenya, catch-up and follow-up campaigns substantially mitigated the effect of suboptimum routine vaccine coverage, generating 25-45 per cent of the immunized fraction of the population. Tailoring immunization campaigns to achieve measles eradication goals is essential and currently, for some countries, this means considering also the role of unprotected adolescents and young adults. Measles immunity gaps and the progress towards elimination: a multi-country modelling analysis. Lancet Infect Dis. 2017. pii: S1473-3099(17)30421-8. Epub ahead of print; . While it is recommended that children get 2 doses of MMR (measles, mumps, rubella) vaccine, starting with the 1st dose at 12 through 15 months of age, and the 2nd dose at 4 through 6 years of age, this study emphasizes that it is important that adolescents and young adults also are up to date on their MMR vaccination. - Mod.LK ","keywordsMatched":[]}},"Faeroe Islands":{},"Fiji":{"503":{"title":"Dengue/DHF update (10): Asia, Pacific, Africa, research, WHO\r\n\t","date":["25","Aug","2017"],"url":"promedPRO/EDR> Dengue/DHF update (10): Asia, Pacific, Africa, research, WHO\r\n\t[EXTERNAL]","summary":" 3 WHO update  The 15 Aug 2017 Source: WHO Western Pacific region edited Dengue situation update no.<br><br><strong> 523 - Northern hemisphere -</strong><br> Cambodia As of 8 Aug 2017, a total of 1604 suspected dengue fever cases were reported in 2017. The total number of reported dengue cases including dengue haemorrhagic fever and dengue shock syndrome was lower than the 3 year-threshold of the same period from 2014-2016. China As of 31 Jul 2017, there were 503 cases of dengue reported in China in 2017. This number is higher than that reported during the same period since 2012 but follows historical trend. Lao PDR People's Democratic Republic As of 4 Aug 2017, there were 5740 cases of dengue with 7 deaths reported in Lao PDR in 2017, with 406 cases reported in epi week 31 (week ending 5 Aug 2017). Dengue activity is high with the number of dengue cases reported this year 2017 being higher than the cases reported for same period since 2014. Malaysia In week 31 of 2017 (week ending 5 Aug 2017), 1899 dengue cases were reported with 2 deaths, an increase of 1.1 per cent compared with week 30. As of week 31, the cumulative number of dengue cases in 2017 were 59 521 with 135 deaths compared with 67 437 cases with 147 deaths during the same period in 2016. Philippines (no update) A total of 43 770 dengue cases were reported nationwide from 1 Jan to 1 Jul 2017. This number is 36.8 per cent lower (25 527) compared with the same time period in 2016. Singapore As of 5 Aug 2017, there were 1732 dengue cases reported in Singapore since January 2017. This is lower than the number of reported cases during the same period since 2013. During week 31, there were 61 cases reported and the number of reported cases in 2017 remains lower than those reported for the same time period in 2016 . Viet Nam As of 3 Aug 2017, there were 80 555 cases of dengue reported in Viet Nam including 22 deaths. Compared with the same period in 2016, the cumulative number of cases increased by 33.5 per cent, and the number of deaths rose by 5. Most cases were reported from the South (59 per cent). A sharp increase in the number of reported cases has been observed in the North (almost 25 times higher than the same period last year 2016), especially from Ha Noi, with about 13 440 cases.<br><br><strong> Southern hemisphere -</strong><br> Australia As of 31 Jul 2017, there were 695 laboratory-confirmed dengue cases reported in Australia in 2017. The number of cases reported is lower than that reported during the same time period in the previous years (2012-2016).<br><br><strong> Pacific Islands countries and areas -</strong><br> French Polynesia In French Polynesia, 12 cases (including 1 death) in week 29 and 12 cases in week 30 (week ending 29 Jul 2017). Among these, 15 cases were confirmed as DENV-1 infection. New Caledonia (no update) As of 1 Aug 2017, 4,452 dengue cases were reported in 2017. There is a downward trend in the number of reported cases since week 16 (week ending 22 Apr 2017).  communicated by: ProMED-mail ","keywordsMatched":[]}},"Finland":{},"France":{},"French Polynesia":{"503":{"title":"Dengue/DHF update (10): Asia, Pacific, Africa, research, WHO\r\n\t","date":["25","Aug","2017"],"url":"promedPRO/EDR> Dengue/DHF update (10): Asia, Pacific, Africa, research, WHO\r\n\t[EXTERNAL]","summary":" 3 WHO update  The 15 Aug 2017 Source: WHO Western Pacific region edited Dengue situation update no.<br><br><strong> 523 - Northern hemisphere -</strong><br> Cambodia As of 8 Aug 2017, a total of 1604 suspected dengue fever cases were reported in 2017. The total number of reported dengue cases including dengue haemorrhagic fever and dengue shock syndrome was lower than the 3 year-threshold of the same period from 2014-2016. China As of 31 Jul 2017, there were 503 cases of dengue reported in China in 2017. This number is higher than that reported during the same period since 2012 but follows historical trend. Lao PDR People's Democratic Republic As of 4 Aug 2017, there were 5740 cases of dengue with 7 deaths reported in Lao PDR in 2017, with 406 cases reported in epi week 31 (week ending 5 Aug 2017). Dengue activity is high with the number of dengue cases reported this year 2017 being higher than the cases reported for same period since 2014. Malaysia In week 31 of 2017 (week ending 5 Aug 2017), 1899 dengue cases were reported with 2 deaths, an increase of 1.1 per cent compared with week 30. As of week 31, the cumulative number of dengue cases in 2017 were 59 521 with 135 deaths compared with 67 437 cases with 147 deaths during the same period in 2016. Philippines (no update) A total of 43 770 dengue cases were reported nationwide from 1 Jan to 1 Jul 2017. This number is 36.8 per cent lower (25 527) compared with the same time period in 2016. Singapore As of 5 Aug 2017, there were 1732 dengue cases reported in Singapore since January 2017. This is lower than the number of reported cases during the same period since 2013. During week 31, there were 61 cases reported and the number of reported cases in 2017 remains lower than those reported for the same time period in 2016 . Viet Nam As of 3 Aug 2017, there were 80 555 cases of dengue reported in Viet Nam including 22 deaths. Compared with the same period in 2016, the cumulative number of cases increased by 33.5 per cent, and the number of deaths rose by 5. Most cases were reported from the South (59 per cent). A sharp increase in the number of reported cases has been observed in the North (almost 25 times higher than the same period last year 2016), especially from Ha Noi, with about 13 440 cases.<br><br><strong> Southern hemisphere -</strong><br> Australia As of 31 Jul 2017, there were 695 laboratory-confirmed dengue cases reported in Australia in 2017. The number of cases reported is lower than that reported during the same time period in the previous years (2012-2016).<br><br><strong> Pacific Islands countries and areas -</strong><br> French Polynesia In French Polynesia, 12 cases (including 1 death) in week 29 and 12 cases in week 30 (week ending 29 Jul 2017). Among these, 15 cases were confirmed as DENV-1 infection. New Caledonia (no update) As of 1 Aug 2017, 4,452 dengue cases were reported in 2017. There is a downward trend in the number of reported cases since week 16 (week ending 22 Apr 2017).  communicated by: ProMED-mail ","keywordsMatched":[]}},"Gabon":{},"Gambia":{},"Georgia":{},"Germany":{"502":{"title":"Measles update (43): Asia and Pacific, Europe, demographics\r\n\t","date":["26","Aug","2017"],"url":"promedPRO/EDR> Measles update (43): Asia and Pacific, Europe, demographics\r\n\t[EXTERNAL]","summary":"<br><br><strong> Measles immunity gaps -</strong><br> 5 Role of demographics  Sat 26 Aug 2017 Source: News-Medical/Life Sciences edited Even if the incidence of measles infection has decreased by at least 90 per cent worldwide since the introduction of the vaccine, measles is still one of the major causes of death in children among vaccine-preventable diseases. Regular measles epidemics are reported in developing countries and recurrent episodic outbreaks occur in the developed world. A new study by Bocconi University and Bruno Kessler Foundation analyzing 9 countries (Australia, Ethiopia, Kenya, Ireland, Italy, South Korea, Singapore, the United Kingdom, and the United States) and published in The Lancet Infectious Diseases see reference below, highlights the role played by demographics in the spread of measles and concludes that future vaccination strategies in high-fertility countries should focus on increasing childhood immunization rates, while immunization campaigns targeting adolescents and young adults are required in low fertility countries. Using a transmission model calibrated on historical serological data the authors estimate that the susceptible proportion of the population (that is, unprotected against the infection) varies from about 3 per cent in the UK to more than 12.5 per cent in Ethiopia, with astonishing differences in its age composition, due to different vaccination strategies and divergent demographic trends. While the percentage of over-15 among susceptible individuals in Ethiopia and Kenya is, respectively, 28 per cent and 43 per cent, adolescents and young adults represent 74 per cent of unprotected individuals in South Korea, 66 per cent in Italy and 53 per cent in the US, with considerable immunity gaps in individuals aged 30-40 years. \"Every effort to increase the vaccination coverage rate among children is praiseworthy\", says Alessia Melegaro, a Bocconi professor and principal investigator of DECIDE, the ERC European Research Council-funded project which produced the article, \"but in some developed countries it's the lack of coverage among adolescents and adults that poses a serious threat to the goal of eliminating measles.\" \"Measles incidence could increase, in the next decades, in Italy, Australia, and Singapore and Ethiopia is at high risk of future large epidemics\", says Stefano Merler from Bruno Kessler Foundation, \"and this is particularly worrying considering that individuals get infected later in life when the disease is more severe. The median age at infection for 2015 was estimated to be 5-10 years in the UK, Ireland, and Ethiopia; 10-15 years in the USA, Australia, Singapore, and Kenya; and older than 20 years in Italy and South Korea\". The proposed model shows that the introduction of the measles vaccine, which occurred at different times in the 9 countries, has considerably reduced the disease burden in terms of disability-adjusted life-years (DALYs), a measure expressed as the number of years lost because of illness, disability, or early death. Every vaccine dose averts 2 or 3 weeks of DALYs in the developed world and around 20 weeks in Kenya and Ethiopia. Which translates into 2-mln years 2 million DALYs since the vaccine introduction in the UK, 13-mln 13 million DALYs in the US, and 36-mln 36 million DALYs in Ethiopia. \"Vaccination has undoubtedly achieved incredible results in terms of public health. In particular,\" continues Prof Melegaro \"our analysis showed that routine 1st dose vaccine administration has been responsible for more than 90 per cent of the overall number of vaccine-immunized individuals in most countries. In Ethiopia and Kenya, catch-up and follow-up campaigns substantially mitigated the effect of suboptimum routine vaccine coverage, generating 25-45 per cent of the immunized fraction of the population. Tailoring immunization campaigns to achieve measles eradication goals is essential and currently, for some countries, this means considering also the role of unprotected adolescents and young adults. Measles immunity gaps and the progress towards elimination: a multi-country modelling analysis. Lancet Infect Dis. 2017. pii: S1473-3099(17)30421-8. Epub ahead of print; . While it is recommended that children get 2 doses of MMR (measles, mumps, rubella) vaccine, starting with the 1st dose at 12 through 15 months of age, and the 2nd dose at 4 through 6 years of age, this study emphasizes that it is important that adolescents and young adults also are up to date on their MMR vaccination. - Mod.LK ","keywordsMatched":[]},"746":{"title":"Avian influenza (133): Germany (ST) wild bird, HPAI H5N8,\r\n\tOIE ","date":["29","Aug","2017"],"url":"promedPRO/AH/EDR> Avian influenza (133): Germany (ST) wild bird, HPAI H5N8,\r\n\tOIE [EXTERNAL]","summary":"<br><br><strong>   Tue 29 Aug 2017 Source: OIE, WAHID edited Highly pathogenic influenza A viruses (infection with) (non-poultry including wild birds), Germany </strong><br> Information received on and dated 29 Aug 2017 from Dr. Karin Schwabenbauer, Ministerial Dirigentin and Chief Veterinary Officer, Directorate of Animal Health, Animal Welfare, Bundesministerium fr Ernhrung und Landwirtschaft (BMEL), Bonn, Germany Summary Report type: immediate notification Date of start of the event: 22 Aug 2017 Date of confirmation of the event: 25 Aug 2017 Reason for notification: recurrence of a listed disease Date of previous occurrence: June 2017 Manifestation of disease: clinical disease Causal agent: highly pathogenic influenza A virus Serotype: H5N8 Nature of diagnosis: laboratory (basic, advanced) This event pertains to the whole country. New outbreaks (1) Summary of outbreaks Total outbreaks: 1 Outbreak 1 (17-015-00798): Seegebiet Mansfelder Land, Mansfeld-Sudharz, Sachsen-Anhalt Date of start of the outbreak: 22 Aug 2017 Outbreak status: continuing (or date resolved not provided) Epidemiological unit: not applicable Total animals affected Species / Susceptible / Cases / Deaths / Killed and disposed of / Slaughtered _Anatidae_ (unidentified): _Anatidae_ (incognita) (_Anatidae_) / - / 3 / 2 / 1 / 0 Affected population: 3 swans Epidemiology Source of the outbreak(s) or origin of infection: unknown or inconclusive. Control measures Measures applied: surveillance within containment and/or protection zone, control of wildlife reservoirs, vaccination prohibited, no treatment of affected animals Measures to be applied: No other measures Diagnostic test results: Friedrich-Loeffler Institute (FLI) (National laboratory) Species / Test / Test date / Result _Anatidae_ (unidentified) / real-time PCR / 25 Aug 2017 / Positive Future reporting The event is continuing. Weekly follow-up reports will be submitted.  <br><br>Communicated by: ProMED-mail\\. \"Between 8 Nov 2016 and 15 May 2017, more than 1150 cases of HPAI H5N8 in wild birds and 107 outbreaks in birds kept in captivity (92 poultry holdings and 15 zoos/animal parks) were reported in Germany. In April 6 Apr 2017 as well as in May 9 May 2017, one outbreak was detected each in birds kept in captivity. Thus, the HPAI epidemic seems to be waning in Germany. However, outbreaks or infections in wild birds are sporadically reported. The current avian flu epidemic is the most severe and longest-lasting epidemic that has occurred in Europe so far. In total, 29 European states have been or still are concerned. In addition to H5N8, 2 other HPAI subtypes have been detected in Europe, i.e. HPAI H5N5 (in 7 states) and H5N6 (in Greece). Outside Europe, avian influenza outbreaks of the subtype HPAI H5N8 have been reported from Russia, Israel, Egypt, Tunisia, Nigeria, Uganda, Cameroon, Iran, Nepal, and India. HPAI H5N1 is endemic in Asia and some African countries. Moreover, further HPAIV H5N1 related H5-strains are circulating in Asia. Although the current epidemic seems to be waning, isolated outbreaks may still occur. The recent reports of HPAIV cases in birds kept in captivity, which occurred in May 2017, indicate that, at least in some countries, infectious virus is still circulating in the environment. Therefore, biosecurity measures should be maintained. These include, inter alia, wearing of stable specific protective clothing and footwear, cleaning and disinfection of equipment that has been in contact with birds, and the best possible prevention of contacts between poultry and wild birds. So far and worldwide, none of the HPAIV subtypes circulating in Europe (H5N8, H5N5, and H5N6) have caused infections in humans;\"  . - Mod.CRD   . ","keywordsMatched":[]}},"Ghana":{},"Greece":{"504":{"title":"West Nile virus - Europe (05): Greece ","date":["25","Aug","2017"],"url":"promedPRO/AH/EDR> West Nile virus - Europe (05): Greece [EXTERNAL]","summary":"   Fri 25 Aug 2017 22:30:30 Source: Xinhua News Agency edited Greek authorities said on Fri 25 Aug 2017 that 3 people in Greece infected with the West Nile virus WNV died of complications related to the illness this summer 2017. All cases were reported in August and all victims were over 70 years old, the national Center for Disease Control and Prevention (KEELPNO) noted. A total of 37 cases have been detected this year 2017, including a patient who is still in hospital in intensive care experts said. In most cases, patients suffered from mild symptoms. It was mainly elderly patients with other chronic illnesses who faced severe complications, according to KEELPNO. The West Nile virus was first detected in Greece in 2010, when 262 confirmed cases of the disease were recorded, among them, 35 fatal. No cases were recorded in 2015 and 2016. KEELPNO advised the public to take measures to protect themselves against mosquitoes which can transmit the dangerous virus. Editor: Zhou Xin  <br><br>Communicated by: ProMED-mail\\. Infection from WNV has been an important public health issue for many European countries, including Greece, since 2010. WNV circulation has been recorded in several countries across the European continent, both in Central Europe and in the Mediterranean basin. In addition to management of individual cases, strategies for vector control, community involvement, and effective risk communication are required for effective control of West Nile virus disease as for other vector borne illnesses. - Mod.UBA   . ","keywordsMatched":[]}},"Greenland":{},"Grenada":{},"Guam":{},"Guatemala":{},"Guinea":{},"Guinea-Bissau":{},"Guyana":{},"Haiti":{},"Honduras":{},"Hong Kong":{"503":{"title":"Dengue/DHF update (10): Asia, Pacific, Africa, research, WHO\r\n\t","date":["25","Aug","2017"],"url":"promedPRO/EDR> Dengue/DHF update (10): Asia, Pacific, Africa, research, WHO\r\n\t[EXTERNAL]","summary":" 3 WHO update  The 15 Aug 2017 Source: WHO Western Pacific region edited Dengue situation update no.<br><br><strong> 523 - Northern hemisphere -</strong><br> Cambodia As of 8 Aug 2017, a total of 1604 suspected dengue fever cases were reported in 2017. The total number of reported dengue cases including dengue haemorrhagic fever and dengue shock syndrome was lower than the 3 year-threshold of the same period from 2014-2016. China As of 31 Jul 2017, there were 503 cases of dengue reported in China in 2017. This number is higher than that reported during the same period since 2012 but follows historical trend. Lao PDR People's Democratic Republic As of 4 Aug 2017, there were 5740 cases of dengue with 7 deaths reported in Lao PDR in 2017, with 406 cases reported in epi week 31 (week ending 5 Aug 2017). Dengue activity is high with the number of dengue cases reported this year 2017 being higher than the cases reported for same period since 2014. Malaysia In week 31 of 2017 (week ending 5 Aug 2017), 1899 dengue cases were reported with 2 deaths, an increase of 1.1 per cent compared with week 30. As of week 31, the cumulative number of dengue cases in 2017 were 59 521 with 135 deaths compared with 67 437 cases with 147 deaths during the same period in 2016. Philippines (no update) A total of 43 770 dengue cases were reported nationwide from 1 Jan to 1 Jul 2017. This number is 36.8 per cent lower (25 527) compared with the same time period in 2016. Singapore As of 5 Aug 2017, there were 1732 dengue cases reported in Singapore since January 2017. This is lower than the number of reported cases during the same period since 2013. During week 31, there were 61 cases reported and the number of reported cases in 2017 remains lower than those reported for the same time period in 2016 . Viet Nam As of 3 Aug 2017, there were 80 555 cases of dengue reported in Viet Nam including 22 deaths. Compared with the same period in 2016, the cumulative number of cases increased by 33.5 per cent, and the number of deaths rose by 5. Most cases were reported from the South (59 per cent). A sharp increase in the number of reported cases has been observed in the North (almost 25 times higher than the same period last year 2016), especially from Ha Noi, with about 13 440 cases.<br><br><strong> Southern hemisphere -</strong><br> Australia As of 31 Jul 2017, there were 695 laboratory-confirmed dengue cases reported in Australia in 2017. The number of cases reported is lower than that reported during the same time period in the previous years (2012-2016).<br><br><strong> Pacific Islands countries and areas -</strong><br> French Polynesia In French Polynesia, 12 cases (including 1 death) in week 29 and 12 cases in week 30 (week ending 29 Jul 2017). Among these, 15 cases were confirmed as DENV-1 infection. New Caledonia (no update) As of 1 Aug 2017, 4,452 dengue cases were reported in 2017. There is a downward trend in the number of reported cases since week 16 (week ending 22 Apr 2017).  communicated by: ProMED-mail ","keywordsMatched":[]}},"Hungary":{},"Iceland":{},"India":{"495":{"title":"Glanders, equine - India (04): (UP) ","date":["25","Aug","2017"],"url":"promedPRO/AH/EDR> Glanders, equine - India (04): (UP) [EXTERNAL]","summary":"   Fri 25 Aug 2017, 8:53 IST Source: The Times of India (TOI), Times News Network (TNN) summarised, edited The animal husbandry department here Bijnor has sounded an alert after 2 horses in Bijnor's Najibabad succumbed to the deadly glanders disease, while 4 other equines are suspected to be suffering from the disease. As a precautionary measure, as many as 100 blood samples of horses have been taken so far and sent for testing. The infectious disease is caused by a bacterium which spreads from animal to animal. Humans who come in contact with the affected animals can also contract this disease. There are 6000 horses and other equines in the district. The detection of the disease has spread panic among owners. Giving details, deputy chief veterinary officer Yogendra Panwar said, \"In 2011, some 5 horses were diagnosed with this disease in Chandpur area of Bijnor district. They were put to sleep to save other equines. Since then, our department has been running a drive in this regard to make horse owners aware about this disease. We have been taking blood samples of horses repeatedly in the district. Last month July 2017, 2 horses were diagnosed with Glanders in Najibabad area. Both horses had to be killed by a team of veterinary doctors...\" The veterinary officer explained since there is no known treatment or vaccine for Glanders, an animal that tests positive is put to sleep to prevent the disease from spreading. It is a fatal disease. Government compensates the equine owner after killing a sick animal. The compensation for horses and mules range from Rs 16 000 to Rs 25 000 USD 250.00 to 390.00 he added. byline: Harveer Dabas  communicated by: ProMED-mail India and Brazil are known to lead the list of countries where glanders, a zoonotic, OIE-listed equids disease, is endemic. Media reports on cases of the traditionally fearsome glanders, are often published by the Indian press. This is not fully reflected in India's official reports to the OIE. According to the recent ones, the annual numbers of recorded glanders outbreaks (in equidae) countrywide were as follows: 2010 - 1; 2011 - 3; 2012 - 1; 2013 - 1; 2014 - 0; 2015 - 5. During the 1st semester of 2016, 9 outbreaks were reported, involving 45 cases of which 36 died. India's OIE semi-annual report for the period Jul-Dec 2016 is not yet available. No statistics on the incidence of glanders in humans in India could be obtained. Glanders is a contagious and fatal disease of horses, donkeys, and mules, caused by infection with the bacterium _Burkholderia mallei_. The pathogen causes nodules and ulcerations in the upper respiratory tract and lungs. A skin form also occurs, known as 'farcy'. Control of glanders requires testing of suspect clinical cases, screening of apparently normal equids, and elimination of reactors. _B. mallei_ can be transmitted to humans, but such cases, which were known to be often fatal, have become rather uncommon (see ref 1). In view of its zoonotic potential, all infected or contaminated (or potentially infected or contaminated) material must be handled in a laboratory with appropriate biosafety and biosecurity controls following a biorisk analysis. The above and additional information on glanders, its causative agent and its diagnosis is available at  . A useful updated review on the disease, including its recent global distribution, is available in ref 1. No vaccine against this disease is available. Reference Elschner MC, Neubauer H and Sprague LD. The resurrection of glanders in a new epidemiological scenario: a beneficiary of \"global change\". Current Clinical Microbiology Reports 2017(March); 4(1): 54-60. Abstract available at  . - Mod.AS   . ","keywordsMatched":[]},"503":{"title":"Dengue/DHF update (10): Asia, Pacific, Africa, research, WHO\r\n\t","date":["25","Aug","2017"],"url":"promedPRO/EDR> Dengue/DHF update (10): Asia, Pacific, Africa, research, WHO\r\n\t[EXTERNAL]","summary":" 3 WHO update  The 15 Aug 2017 Source: WHO Western Pacific region edited Dengue situation update no.<br><br><strong> 523 - Northern hemisphere -</strong><br> Cambodia As of 8 Aug 2017, a total of 1604 suspected dengue fever cases were reported in 2017. The total number of reported dengue cases including dengue haemorrhagic fever and dengue shock syndrome was lower than the 3 year-threshold of the same period from 2014-2016. China As of 31 Jul 2017, there were 503 cases of dengue reported in China in 2017. This number is higher than that reported during the same period since 2012 but follows historical trend. Lao PDR People's Democratic Republic As of 4 Aug 2017, there were 5740 cases of dengue with 7 deaths reported in Lao PDR in 2017, with 406 cases reported in epi week 31 (week ending 5 Aug 2017). Dengue activity is high with the number of dengue cases reported this year 2017 being higher than the cases reported for same period since 2014. Malaysia In week 31 of 2017 (week ending 5 Aug 2017), 1899 dengue cases were reported with 2 deaths, an increase of 1.1 per cent compared with week 30. As of week 31, the cumulative number of dengue cases in 2017 were 59 521 with 135 deaths compared with 67 437 cases with 147 deaths during the same period in 2016. Philippines (no update) A total of 43 770 dengue cases were reported nationwide from 1 Jan to 1 Jul 2017. This number is 36.8 per cent lower (25 527) compared with the same time period in 2016. Singapore As of 5 Aug 2017, there were 1732 dengue cases reported in Singapore since January 2017. This is lower than the number of reported cases during the same period since 2013. During week 31, there were 61 cases reported and the number of reported cases in 2017 remains lower than those reported for the same time period in 2016 . Viet Nam As of 3 Aug 2017, there were 80 555 cases of dengue reported in Viet Nam including 22 deaths. Compared with the same period in 2016, the cumulative number of cases increased by 33.5 per cent, and the number of deaths rose by 5. Most cases were reported from the South (59 per cent). A sharp increase in the number of reported cases has been observed in the North (almost 25 times higher than the same period last year 2016), especially from Ha Noi, with about 13 440 cases.<br><br><strong> Southern hemisphere -</strong><br> Australia As of 31 Jul 2017, there were 695 laboratory-confirmed dengue cases reported in Australia in 2017. The number of cases reported is lower than that reported during the same time period in the previous years (2012-2016).<br><br><strong> Pacific Islands countries and areas -</strong><br> French Polynesia In French Polynesia, 12 cases (including 1 death) in week 29 and 12 cases in week 30 (week ending 29 Jul 2017). Among these, 15 cases were confirmed as DENV-1 infection. New Caledonia (no update) As of 1 Aug 2017, 4,452 dengue cases were reported in 2017. There is a downward trend in the number of reported cases since week 16 (week ending 22 Apr 2017).  communicated by: ProMED-mail ","keywordsMatched":[]}},"Indonesia":{"503":{"title":"Dengue/DHF update (10): Asia, Pacific, Africa, research, WHO\r\n\t","date":["25","Aug","2017"],"url":"promedPRO/EDR> Dengue/DHF update (10): Asia, Pacific, Africa, research, WHO\r\n\t[EXTERNAL]","summary":" 3 WHO update  The 15 Aug 2017 Source: WHO Western Pacific region edited Dengue situation update no.<br><br><strong> 523 - Northern hemisphere -</strong><br> Cambodia As of 8 Aug 2017, a total of 1604 suspected dengue fever cases were reported in 2017. The total number of reported dengue cases including dengue haemorrhagic fever and dengue shock syndrome was lower than the 3 year-threshold of the same period from 2014-2016. China As of 31 Jul 2017, there were 503 cases of dengue reported in China in 2017. This number is higher than that reported during the same period since 2012 but follows historical trend. Lao PDR People's Democratic Republic As of 4 Aug 2017, there were 5740 cases of dengue with 7 deaths reported in Lao PDR in 2017, with 406 cases reported in epi week 31 (week ending 5 Aug 2017). Dengue activity is high with the number of dengue cases reported this year 2017 being higher than the cases reported for same period since 2014. Malaysia In week 31 of 2017 (week ending 5 Aug 2017), 1899 dengue cases were reported with 2 deaths, an increase of 1.1 per cent compared with week 30. As of week 31, the cumulative number of dengue cases in 2017 were 59 521 with 135 deaths compared with 67 437 cases with 147 deaths during the same period in 2016. Philippines (no update) A total of 43 770 dengue cases were reported nationwide from 1 Jan to 1 Jul 2017. This number is 36.8 per cent lower (25 527) compared with the same time period in 2016. Singapore As of 5 Aug 2017, there were 1732 dengue cases reported in Singapore since January 2017. This is lower than the number of reported cases during the same period since 2013. During week 31, there were 61 cases reported and the number of reported cases in 2017 remains lower than those reported for the same time period in 2016 . Viet Nam As of 3 Aug 2017, there were 80 555 cases of dengue reported in Viet Nam including 22 deaths. Compared with the same period in 2016, the cumulative number of cases increased by 33.5 per cent, and the number of deaths rose by 5. Most cases were reported from the South (59 per cent). A sharp increase in the number of reported cases has been observed in the North (almost 25 times higher than the same period last year 2016), especially from Ha Noi, with about 13 440 cases.<br><br><strong> Southern hemisphere -</strong><br> Australia As of 31 Jul 2017, there were 695 laboratory-confirmed dengue cases reported in Australia in 2017. The number of cases reported is lower than that reported during the same time period in the previous years (2012-2016).<br><br><strong> Pacific Islands countries and areas -</strong><br> French Polynesia In French Polynesia, 12 cases (including 1 death) in week 29 and 12 cases in week 30 (week ending 29 Jul 2017). Among these, 15 cases were confirmed as DENV-1 infection. New Caledonia (no update) As of 1 Aug 2017, 4,452 dengue cases were reported in 2017. There is a downward trend in the number of reported cases since week 16 (week ending 22 Apr 2017).  communicated by: ProMED-mail ","keywordsMatched":[]}},"Iran":{},"Iraq":{},"Ireland":{"502":{"title":"Measles update (43): Asia and Pacific, Europe, demographics\r\n\t","date":["26","Aug","2017"],"url":"promedPRO/EDR> Measles update (43): Asia and Pacific, Europe, demographics\r\n\t[EXTERNAL]","summary":"<br><br><strong> Measles immunity gaps -</strong><br> 5 Role of demographics  Sat 26 Aug 2017 Source: News-Medical/Life Sciences edited Even if the incidence of measles infection has decreased by at least 90 per cent worldwide since the introduction of the vaccine, measles is still one of the major causes of death in children among vaccine-preventable diseases. Regular measles epidemics are reported in developing countries and recurrent episodic outbreaks occur in the developed world. A new study by Bocconi University and Bruno Kessler Foundation analyzing 9 countries (Australia, Ethiopia, Kenya, Ireland, Italy, South Korea, Singapore, the United Kingdom, and the United States) and published in The Lancet Infectious Diseases see reference below, highlights the role played by demographics in the spread of measles and concludes that future vaccination strategies in high-fertility countries should focus on increasing childhood immunization rates, while immunization campaigns targeting adolescents and young adults are required in low fertility countries. Using a transmission model calibrated on historical serological data the authors estimate that the susceptible proportion of the population (that is, unprotected against the infection) varies from about 3 per cent in the UK to more than 12.5 per cent in Ethiopia, with astonishing differences in its age composition, due to different vaccination strategies and divergent demographic trends. While the percentage of over-15 among susceptible individuals in Ethiopia and Kenya is, respectively, 28 per cent and 43 per cent, adolescents and young adults represent 74 per cent of unprotected individuals in South Korea, 66 per cent in Italy and 53 per cent in the US, with considerable immunity gaps in individuals aged 30-40 years. \"Every effort to increase the vaccination coverage rate among children is praiseworthy\", says Alessia Melegaro, a Bocconi professor and principal investigator of DECIDE, the ERC European Research Council-funded project which produced the article, \"but in some developed countries it's the lack of coverage among adolescents and adults that poses a serious threat to the goal of eliminating measles.\" \"Measles incidence could increase, in the next decades, in Italy, Australia, and Singapore and Ethiopia is at high risk of future large epidemics\", says Stefano Merler from Bruno Kessler Foundation, \"and this is particularly worrying considering that individuals get infected later in life when the disease is more severe. The median age at infection for 2015 was estimated to be 5-10 years in the UK, Ireland, and Ethiopia; 10-15 years in the USA, Australia, Singapore, and Kenya; and older than 20 years in Italy and South Korea\". The proposed model shows that the introduction of the measles vaccine, which occurred at different times in the 9 countries, has considerably reduced the disease burden in terms of disability-adjusted life-years (DALYs), a measure expressed as the number of years lost because of illness, disability, or early death. Every vaccine dose averts 2 or 3 weeks of DALYs in the developed world and around 20 weeks in Kenya and Ethiopia. Which translates into 2-mln years 2 million DALYs since the vaccine introduction in the UK, 13-mln 13 million DALYs in the US, and 36-mln 36 million DALYs in Ethiopia. \"Vaccination has undoubtedly achieved incredible results in terms of public health. In particular,\" continues Prof Melegaro \"our analysis showed that routine 1st dose vaccine administration has been responsible for more than 90 per cent of the overall number of vaccine-immunized individuals in most countries. In Ethiopia and Kenya, catch-up and follow-up campaigns substantially mitigated the effect of suboptimum routine vaccine coverage, generating 25-45 per cent of the immunized fraction of the population. Tailoring immunization campaigns to achieve measles eradication goals is essential and currently, for some countries, this means considering also the role of unprotected adolescents and young adults. Measles immunity gaps and the progress towards elimination: a multi-country modelling analysis. Lancet Infect Dis. 2017. pii: S1473-3099(17)30421-8. Epub ahead of print; . While it is recommended that children get 2 doses of MMR (measles, mumps, rubella) vaccine, starting with the 1st dose at 12 through 15 months of age, and the 2nd dose at 4 through 6 years of age, this study emphasizes that it is important that adolescents and young adults also are up to date on their MMR vaccination. - Mod.LK ","keywordsMatched":[]},"761":{"title":"Hepatitis B - Ireland (02): post-transfusion, seronegative blood,\r\n\tcomment ","date":["30","Aug","2017"],"url":"promedPRO> Hepatitis B - Ireland (02): post-transfusion, seronegative blood,\r\n\tcomment [EXTERNAL]","summary":"   Wed 30 Aug 2017 From: F. Blaine Hollinger MD 1. There is also a seronegative window period that precedes the first detection of HBV DNA and prior to the appearance of HBsAg following acute infection. However, the level of virus may not be sufficient to cause HBV based on the HBV genotype (Hsia et al, 2006). 2. Is minipool NAT or ID NAT being done for HBV DNA detection by blood banks in Ireland? And if minipool NAT, how many samples were in the minipool since this could compromise sensitivity? 3. Was the archived donor specimen also tested for total anti-HBc, a test done in US blood facilities, but not in Ireland? 4. What is the evidence that the recipient was not previously infected with HBV, while bearing in mind that patients with chronic hepatitis B may be positive for IgM anti-HBc during acute reactivation of their disease. And if the recipient was IgM positive, what was the ratio of the anti-HBc test result based on the cutoff value and the patient's value? 5. Fortunately, the outcome is usually favorable with limited risk of chronicity in immunocompetent patients who acquire acute hepatitis B.  F. Blaine Hollinger, M.D. Professor of Medicine, Molecular Virology & Epidemiology Director, Eugene B. Casey Hepatitis Research Center Baylor College of Medicine Houston, TX It is always an honor to receive comments from Dr. Hollinger, a long time leader in viral hepatitis research. Regarding his questions/comments: 1. As I noted in the moderation of the original post, there is a lesser discussed \"window period\" occurring in the incubation period of acute hepatitis B prior to the development of HBsAg and before the development of anti-HBc (IgM and then IgG). The more classical \"window period\" occurs towards the end of acute hepatitis B, whether clinically overt or not, when HBsAg is not longer detectable by standard assays but before anti-HBs is detectable. The only serologic evidence of HBV is anti-HBc and IgM anti-HBc should be positive. HBV DNA is also detectable. It has been shown that blood transfused during this period can be infectious for HBV. 2-4. All good questions which I cannot supply answers to. 5. Most patients who are not immunosuppressed will clear HBV within 3-6 months. 10 percent will not although half of these are usually clear within a year. No information regarding the patient in this case was supplied. - Mod.LL   . ","keywordsMatched":[]}},"Israel":{"492":{"title":"Koi herpesvirus disease - Canada: (BC) 1st rep ","date":["25","Aug","2017"],"url":"promedPRO/AH> Koi herpesvirus disease - Canada: (BC) 1st rep [EXTERNAL]","summary":"   Fri 25 Aug 2017 Source: Canadian Food Inspection Industry edited The Canadian Food Inspection Agency (CFIA) has confirmed the presence of koi herpesvirus disease (KHVD) in cultured koi carp (_Cyprinus carpio koi_) in British Columbia (BC). This is the 1st detection of KHVD in BC by the CFIA, but the disease has been previously detected in Manitoba and Ontario. The disease detection was associated with an import of koi from Israel by a wholesaler who distributed fish to greenhouses, pet stores and garden centres within BC for sale to private individuals. As a result of this detection, the import of all susceptible species of aquatic animals from Israel for the following end uses will be suspended until further notice: - aquarium - commercial; - aquarium - private; - outdoor holding unit - commercial; and - outdoor holding unit - private. The CFIA is committed to working with Israel to ensure that Canada's aquatic animal health import requirements are met and the suspended zoosanitary export certificate, which applies to all exports from Israel for the aforementioned end uses, can be renegotiated as quickly as possible in order to minimize any impact on trade. KHVD poses no risk to human health or food safety; however, this virus can infect other susceptible species and is reportable under Canada's Reportable Diseases Regulations. Individuals or businesses that are concerned that their fish may have koi herpesvirus disease should contact their local CFIA area and district office immediately. Sick or dead fish should not be disposed of in natural waterways. The disease is transmitted by fish to fish contact and it is also possible that the disease can spread through contaminated water, nets and other equipment. As other herpesvirus, KHD has the capacity to remain latent in the infected fish and become activated and cause disease when some stressors trigger it. More information on KHD is found in OIE Aquatic Manual chapter (2009 update), which is available at  . - Mod.PMB   . ","keywordsMatched":[]}},"Italy":{"501":{"title":"Invasive mosquito - Gibraltar ","date":["24","Aug","2017"],"url":"promedPRO/AH> Invasive mosquito - Gibraltar [EXTERNAL]","summary":"   Thu 24 Aug 2017 Source: Gibraltar Chronicle edited An aggressive species of mosquito known to transmit viral diseases has been detected in Gibraltar, but public health officials insist there is no cause for alarm. Public Health Gibraltar and the Environmental Agency confirmed that the mosquito of the species _Aedes albopictus_, also known as the tiger mosquito, has been found in Gibraltar. Last June 2017 after 9 months of intensive surveillance, officials said no tiger mosquito had been found in Gibraltar. But this has now changed after the 1st tiger mosquito was found in the urban domestic environment within Gibraltar. \"This finding alone does not however materially alter any health risks in Gibraltar and there is no immediate cause for public concern,\" the government said in a statement. Public Health Gibraltar was first alerted in January 2016 to the discovery of the mosquito in Mlaga and Algeciras in Andalusia, Spain. Since then, together with the Environmental Agency, it began working with international experts to mount surveillance in Gibraltar. World Health Organization experts visited Gibraltar and gave advice on setting traps and monitoring locations, but no tiger mosquito had been detected until now. The tiger mosquito is not native to Gibraltar and has not been previously found here. It is common in other countries where it transmits viral diseases like Zika, dengue, and chikungunya. It is a domestic species, breeds in water in urban areas  water butts, blocked drains, rainwater gullies  and is able to reach high abundance around residential areas. It is also a day-time mosquito, that aggressively bites humans. \"Health risks to the public only arise if the virus causing these diseases is also present, which is not the case in Gibraltar,\" the government said. \"The virus can, however, be imported by travellers returning from an overseas country and if this happens, there is a risk of spread, but only if the mosquito bites within a small window period of about a week after the fever starts.\" Public Health Gibraltar has been raising awareness of travel risk amongst travellers through its publication A Factsheet for Travellers and recommends the following precautions: - before travelling to affected areas, consult your doctor or seek advice from a travel clinic, especially if you have an immune disorder or severe chronic illness; - if you are pregnant or are considering pregnancy, consider postponing non-essential travel; - when staying in a mosquito-prone area, wear mosquito repellents and take mosquito bite prevention measures; - if you have symptoms within 3 weeks of return from an affected country, contact your doctor; - if you have been diagnosed with any of the diseases Zika, dengue, or chikungunya, take strict mosquito bite prevention measures for 10 days after the fever starts. Now it has been found in Gibraltar. The concerns are real about transmission of dengue, chikungunya, and Zika viruses should populations of _Ae. albopictus_ become established. In 2015 there were a few locally acquired cases of dengue in the south of France. This also happened on a larger scale in Emilia Romagna, Italy, when a viremic man introduced chikungunya virus into Italy and sparked an outbreak. One hopes that mosquito surveillance will continue in Gibraltar, perhaps be intensified, and help guide vector control efforts. - Mod.TY   . ","keywordsMatched":[]},"502":{"title":"Measles update (43): Asia and Pacific, Europe, demographics\r\n\t","date":["26","Aug","2017"],"url":"promedPRO/EDR> Measles update (43): Asia and Pacific, Europe, demographics\r\n\t[EXTERNAL]","summary":"<br><br><strong> Measles immunity gaps -</strong><br> 5 Role of demographics  Sat 26 Aug 2017 Source: News-Medical/Life Sciences edited Even if the incidence of measles infection has decreased by at least 90 per cent worldwide since the introduction of the vaccine, measles is still one of the major causes of death in children among vaccine-preventable diseases. Regular measles epidemics are reported in developing countries and recurrent episodic outbreaks occur in the developed world. A new study by Bocconi University and Bruno Kessler Foundation analyzing 9 countries (Australia, Ethiopia, Kenya, Ireland, Italy, South Korea, Singapore, the United Kingdom, and the United States) and published in The Lancet Infectious Diseases see reference below, highlights the role played by demographics in the spread of measles and concludes that future vaccination strategies in high-fertility countries should focus on increasing childhood immunization rates, while immunization campaigns targeting adolescents and young adults are required in low fertility countries. Using a transmission model calibrated on historical serological data the authors estimate that the susceptible proportion of the population (that is, unprotected against the infection) varies from about 3 per cent in the UK to more than 12.5 per cent in Ethiopia, with astonishing differences in its age composition, due to different vaccination strategies and divergent demographic trends. While the percentage of over-15 among susceptible individuals in Ethiopia and Kenya is, respectively, 28 per cent and 43 per cent, adolescents and young adults represent 74 per cent of unprotected individuals in South Korea, 66 per cent in Italy and 53 per cent in the US, with considerable immunity gaps in individuals aged 30-40 years. \"Every effort to increase the vaccination coverage rate among children is praiseworthy\", says Alessia Melegaro, a Bocconi professor and principal investigator of DECIDE, the ERC European Research Council-funded project which produced the article, \"but in some developed countries it's the lack of coverage among adolescents and adults that poses a serious threat to the goal of eliminating measles.\" \"Measles incidence could increase, in the next decades, in Italy, Australia, and Singapore and Ethiopia is at high risk of future large epidemics\", says Stefano Merler from Bruno Kessler Foundation, \"and this is particularly worrying considering that individuals get infected later in life when the disease is more severe. The median age at infection for 2015 was estimated to be 5-10 years in the UK, Ireland, and Ethiopia; 10-15 years in the USA, Australia, Singapore, and Kenya; and older than 20 years in Italy and South Korea\". The proposed model shows that the introduction of the measles vaccine, which occurred at different times in the 9 countries, has considerably reduced the disease burden in terms of disability-adjusted life-years (DALYs), a measure expressed as the number of years lost because of illness, disability, or early death. Every vaccine dose averts 2 or 3 weeks of DALYs in the developed world and around 20 weeks in Kenya and Ethiopia. Which translates into 2-mln years 2 million DALYs since the vaccine introduction in the UK, 13-mln 13 million DALYs in the US, and 36-mln 36 million DALYs in Ethiopia. \"Vaccination has undoubtedly achieved incredible results in terms of public health. In particular,\" continues Prof Melegaro \"our analysis showed that routine 1st dose vaccine administration has been responsible for more than 90 per cent of the overall number of vaccine-immunized individuals in most countries. In Ethiopia and Kenya, catch-up and follow-up campaigns substantially mitigated the effect of suboptimum routine vaccine coverage, generating 25-45 per cent of the immunized fraction of the population. Tailoring immunization campaigns to achieve measles eradication goals is essential and currently, for some countries, this means considering also the role of unprotected adolescents and young adults. Measles immunity gaps and the progress towards elimination: a multi-country modelling analysis. Lancet Infect Dis. 2017. pii: S1473-3099(17)30421-8. Epub ahead of print; . While it is recommended that children get 2 doses of MMR (measles, mumps, rubella) vaccine, starting with the 1st dose at 12 through 15 months of age, and the 2nd dose at 4 through 6 years of age, this study emphasizes that it is important that adolescents and young adults also are up to date on their MMR vaccination. - Mod.LK ","keywordsMatched":[]}},"Jamaica":{},"Japan":{"189":{"title":"E. coli EHEC - Japan (03): (KN) restaurant, O157, RFI\r\n\t","date":["24","Aug","2017"],"url":"promedPRO/AH/EDR> E. coli EHEC - Japan (03): (KN) restaurant, O157, RFI\r\n\t[EXTERNAL]","summary":"   Thu 24 Aug 2017 Source: The Japan Times edited The city of Yokohama has ordered a grilled-meat restaurant in the area to suspend operation Wed 23 Aug 2017, after 2 people who had dined there were infected with the O157 strain of the _Escherichia coli_ bacterium. A teenage girl and a man in his 80s had symptoms of food poisoning, including diarrhea, after eating separately at the restaurant Anrakutei on 30 Jul 2017. Both were hospitalized and are recovering, according to the local government. The O157 strain of the bacterium was found at the restaurant outlet or from the employees, it said. The announcement followed an outbreak of _E. coli_ food poisoning in Gunma and Saitama prefectures this week week of Aug 2017. The city of Takasaki, Gunma Prefecture, conducted on-site inspections at a food processing plant after potato salad produced there infected 12 people in the 2 prefectures, including a 5 year old girl who became gravely ill and temporarily lost consciousness. During the inspections, officials looked into the manufacturing processes at the plant, which shipped the potato salad that found its way to delicatessens in Gunma and Saitama prefectures, according to the city. Officials also took samples of the salad made during the same period to conduct further tests. The Takasaki Municipal Government later announced that no _E. coli_ bacteria had been found from the samples. The operator of the businesses, based in Ota, Gunma, sold bagged potato salad shipped from the plant after mixing it with ham and apple pieces, according to the Saitama Prefectural Government.  communicated by: ProMED-mail ProMED-mail would appreciate more information about the Yokohama cases (Yokohama is the capital city of Kanagawa prefecture) and to know if they are linked to the cases, now 12 in all, in Saitama and Gunma Prefectures. - Mod. - Sr.Tech.Ed.MJ ","keywordsMatched":[]},"488":{"title":"E. coli EHEC - Japan (04): O157, outbreaks ","date":["25","Aug","2017"],"url":"promedPRO/AH/EDR> E. coli EHEC - Japan (04): O157, outbreaks [EXTERNAL]","summary":" 2 News report  Fri 25 Aug 2017 Source: Food Safety News edited Japan health authorities are dealing with 2 new clusters of _Escherichia coli_ O157:H7 infections. The 1st involves a suspended grilled-meat restaurant in Yokohama Kanagawa prefecture, linked to the illnesses of a teenage girl and a man in his 80s who ate there on 30 Jul 2017. The 2nd involves a deli in the Saitama Prefecture and a potato salad product sold at the Shokusaikan Marche Kagohara supermarket in Kumagaya. The potato salad has sickened 14, including a 5 year old girl who is in a critical condition along with 2 others who are severely ill. The supermarket's deli  known as Derishasu Kagohara  purchased the potato salad from a food processing facility located outside the prefecture and then mixed it with cut pieces of ham and apples. Kumagaya Public Health has ordered the deli closed for 3 days while it investigates the source of the _E. coli_ infection and its distribution. The investigation into the illness of a boy admitted to the Gunma Prefecture hospital on 14 Aug 2017 led to the deli's contamination. The deli appears to have sold the 1st suspect potato salad on 7-8 Aug 2017, after which 8 Saitama residents reported stomach pains. Others, ages 7 to 12, were treated for diarrhea. The 5 year old has developed the kidney-threatening disease known as a hemolytic uremic syndrome or HUS. The potato salad distribution is apparently limited to the Gunma and Saitama prefectures. Businesses in Ota, Gunma apparently re-sold the bagged potato salad, also after mixing it with ham and apple pieces. Health officials from the Takasaki Municipal government took salad samples for additional testing. The teenage girl and man in his 80s both dined at the suspected restaurant on 30 Jul 2017 and both required hospitalization. Their O157 strain matched bacteria found in the suspended restaurant.  communicated by: ProMED-mail The Gunma and Saitama Prefectures outbreak is now up to 14 cases. It is not clear that the Yokohama cases are related to it. - Mod. - Sr.Tech.Ed.MJ ","keywordsMatched":[]},"502":{"title":"Measles update (43): Asia and Pacific, Europe, demographics\r\n\t","date":["26","Aug","2017"],"url":"promedPRO/EDR> Measles update (43): Asia and Pacific, Europe, demographics\r\n\t[EXTERNAL]","summary":"<br><br><strong> Measles immunity gaps -</strong><br> 5 Role of demographics  Sat 26 Aug 2017 Source: News-Medical/Life Sciences edited Even if the incidence of measles infection has decreased by at least 90 per cent worldwide since the introduction of the vaccine, measles is still one of the major causes of death in children among vaccine-preventable diseases. Regular measles epidemics are reported in developing countries and recurrent episodic outbreaks occur in the developed world. A new study by Bocconi University and Bruno Kessler Foundation analyzing 9 countries (Australia, Ethiopia, Kenya, Ireland, Italy, South Korea, Singapore, the United Kingdom, and the United States) and published in The Lancet Infectious Diseases see reference below, highlights the role played by demographics in the spread of measles and concludes that future vaccination strategies in high-fertility countries should focus on increasing childhood immunization rates, while immunization campaigns targeting adolescents and young adults are required in low fertility countries. Using a transmission model calibrated on historical serological data the authors estimate that the susceptible proportion of the population (that is, unprotected against the infection) varies from about 3 per cent in the UK to more than 12.5 per cent in Ethiopia, with astonishing differences in its age composition, due to different vaccination strategies and divergent demographic trends. While the percentage of over-15 among susceptible individuals in Ethiopia and Kenya is, respectively, 28 per cent and 43 per cent, adolescents and young adults represent 74 per cent of unprotected individuals in South Korea, 66 per cent in Italy and 53 per cent in the US, with considerable immunity gaps in individuals aged 30-40 years. \"Every effort to increase the vaccination coverage rate among children is praiseworthy\", says Alessia Melegaro, a Bocconi professor and principal investigator of DECIDE, the ERC European Research Council-funded project which produced the article, \"but in some developed countries it's the lack of coverage among adolescents and adults that poses a serious threat to the goal of eliminating measles.\" \"Measles incidence could increase, in the next decades, in Italy, Australia, and Singapore and Ethiopia is at high risk of future large epidemics\", says Stefano Merler from Bruno Kessler Foundation, \"and this is particularly worrying considering that individuals get infected later in life when the disease is more severe. The median age at infection for 2015 was estimated to be 5-10 years in the UK, Ireland, and Ethiopia; 10-15 years in the USA, Australia, Singapore, and Kenya; and older than 20 years in Italy and South Korea\". The proposed model shows that the introduction of the measles vaccine, which occurred at different times in the 9 countries, has considerably reduced the disease burden in terms of disability-adjusted life-years (DALYs), a measure expressed as the number of years lost because of illness, disability, or early death. Every vaccine dose averts 2 or 3 weeks of DALYs in the developed world and around 20 weeks in Kenya and Ethiopia. Which translates into 2-mln years 2 million DALYs since the vaccine introduction in the UK, 13-mln 13 million DALYs in the US, and 36-mln 36 million DALYs in Ethiopia. \"Vaccination has undoubtedly achieved incredible results in terms of public health. In particular,\" continues Prof Melegaro \"our analysis showed that routine 1st dose vaccine administration has been responsible for more than 90 per cent of the overall number of vaccine-immunized individuals in most countries. In Ethiopia and Kenya, catch-up and follow-up campaigns substantially mitigated the effect of suboptimum routine vaccine coverage, generating 25-45 per cent of the immunized fraction of the population. Tailoring immunization campaigns to achieve measles eradication goals is essential and currently, for some countries, this means considering also the role of unprotected adolescents and young adults. Measles immunity gaps and the progress towards elimination: a multi-country modelling analysis. Lancet Infect Dis. 2017. pii: S1473-3099(17)30421-8. Epub ahead of print; . While it is recommended that children get 2 doses of MMR (measles, mumps, rubella) vaccine, starting with the 1st dose at 12 through 15 months of age, and the 2nd dose at 4 through 6 years of age, this study emphasizes that it is important that adolescents and young adults also are up to date on their MMR vaccination. - Mod.LK ","keywordsMatched":[]},"503":{"title":"Dengue/DHF update (10): Asia, Pacific, Africa, research, WHO\r\n\t","date":["25","Aug","2017"],"url":"promedPRO/EDR> Dengue/DHF update (10): Asia, Pacific, Africa, research, WHO\r\n\t[EXTERNAL]","summary":" 3 WHO update  The 15 Aug 2017 Source: WHO Western Pacific region edited Dengue situation update no.<br><br><strong> 523 - Northern hemisphere -</strong><br> Cambodia As of 8 Aug 2017, a total of 1604 suspected dengue fever cases were reported in 2017. The total number of reported dengue cases including dengue haemorrhagic fever and dengue shock syndrome was lower than the 3 year-threshold of the same period from 2014-2016. China As of 31 Jul 2017, there were 503 cases of dengue reported in China in 2017. This number is higher than that reported during the same period since 2012 but follows historical trend. Lao PDR People's Democratic Republic As of 4 Aug 2017, there were 5740 cases of dengue with 7 deaths reported in Lao PDR in 2017, with 406 cases reported in epi week 31 (week ending 5 Aug 2017). Dengue activity is high with the number of dengue cases reported this year 2017 being higher than the cases reported for same period since 2014. Malaysia In week 31 of 2017 (week ending 5 Aug 2017), 1899 dengue cases were reported with 2 deaths, an increase of 1.1 per cent compared with week 30. As of week 31, the cumulative number of dengue cases in 2017 were 59 521 with 135 deaths compared with 67 437 cases with 147 deaths during the same period in 2016. Philippines (no update) A total of 43 770 dengue cases were reported nationwide from 1 Jan to 1 Jul 2017. This number is 36.8 per cent lower (25 527) compared with the same time period in 2016. Singapore As of 5 Aug 2017, there were 1732 dengue cases reported in Singapore since January 2017. This is lower than the number of reported cases during the same period since 2013. During week 31, there were 61 cases reported and the number of reported cases in 2017 remains lower than those reported for the same time period in 2016 . Viet Nam As of 3 Aug 2017, there were 80 555 cases of dengue reported in Viet Nam including 22 deaths. Compared with the same period in 2016, the cumulative number of cases increased by 33.5 per cent, and the number of deaths rose by 5. Most cases were reported from the South (59 per cent). A sharp increase in the number of reported cases has been observed in the North (almost 25 times higher than the same period last year 2016), especially from Ha Noi, with about 13 440 cases.<br><br><strong> Southern hemisphere -</strong><br> Australia As of 31 Jul 2017, there were 695 laboratory-confirmed dengue cases reported in Australia in 2017. The number of cases reported is lower than that reported during the same time period in the previous years (2012-2016).<br><br><strong> Pacific Islands countries and areas -</strong><br> French Polynesia In French Polynesia, 12 cases (including 1 death) in week 29 and 12 cases in week 30 (week ending 29 Jul 2017). Among these, 15 cases were confirmed as DENV-1 infection. New Caledonia (no update) As of 1 Aug 2017, 4,452 dengue cases were reported in 2017. There is a downward trend in the number of reported cases since week 16 (week ending 22 Apr 2017).  communicated by: ProMED-mail ","keywordsMatched":[]}},"Jordan":{},"Kazakhstan":{"489":{"title":"Lumpy skin disease, bovine - Kazakhstan (02): (WK) spread susp,\r\n\tRFI ","date":["24","Aug","2017"],"url":"promedPRO/AH> Lumpy skin disease, bovine - Kazakhstan (02): (WK) spread susp,\r\n\tRFI [EXTERNAL]","summary":"   Sun 20 Aug 2017 Source: Kloop (Kyrgyzstan) in Russian, machine trans., edited At least 120 head of cattle have been killed in the Atyrau region West Kazakhstan; the cause of the death of the animals is unknown. Veterinarians do not know the cause of the animal's deaths.\"Since the cattle are still in the pastures, the owners themselves bring sick animals to us. Although they do not have a high temperature, they still cannot save them,\" said veterinarian Islamgali Mardashev. The meat of the dead cows was sent for testing in the laboratories of Astana and Almaty, but so far there are no results see comment below. It is only known that before dying the temperature of the animals rises, and there is weakness and lumps under the skin. In the summer of 2016, the Atyrau oblast similarly suffered a massive loss of livestock; more than 800 cattle died. All of them had nodular dermatitis. More than 6000 cattle were infected with the disease. byline: Alexandra Titova  communicated by: ProMED-mail From 10 to 15 Jun 2016, a disease which later was recognized as lumpy skin disease (LSD) was recorded in a cattle holding on the territory adjacent to the village of Chapayevo, West Kazakhstan (see archive no. http://promedmail.org/post/20160717.4350687; at this point in time, laymen, followed by the media, erroneously related to the undiagnosed and most probably unfamiliar new disease as foot and mouth disease. Please see relevant commentary in the subsequent postings no. http://promedmail.org/post/20160722.4362368 and http://promedmail.org/post/20160723.4365082). On 7 Jul 2016, Kazakhstan reported (see archive no. http://promedmail.org/post/20160722. According to the report, the susceptible population was 3557 head including 459 clinical cases of which 34 died, the 425 remaining sick animals \"killed and disposed of\". No stamping out applied and no additional case reported in the 12 follow-up reports, the last of which, no.12, submitted on 26 Nov 2017, stated: 1. Compensation to the animals' owners for dead cattle at the market price is being developed and will be implemented soon. All 459 diseased cattle heads were destroyed and the final disinfection was carried out. 2. The event is resolved. No more reports will be submitted. Follow-up report no.12, with links to all previous reports, is available at  . Although according to media reports vaccination was applied, no details of such were included in the 12 follow-up reports nor in Kazakhstan's semi-annual summary report to the OIE (July-December 2016), which included the epidemiological statistics above; the item \"control measures\" (against LSD) did not include \"vaccination\". The current media report, from a Kyrgyz source (citing a Kazakh newspaper), says that during the 2016 event, 6000 animals were infected, of which 600 died. An earlier media report, from Kazakhstan, dated 27 Jul 2016, said that the number of diseased animals \"exceeded 2000, of which 50 head of cattle died\" (see archive no. http://promedmail.org/post/20160727.4374008). Kazakhstan is the world's largest landlocked country, and the 9th largest in the world. The belated diagnosis in 2016, and its continued absence, so far, during the current event, is puzzling; following the acquiring of independence in Dec 1991, Kazakhstan obtained support from the West, particularly USA, in the establishment of state-of-the-art laboratories for research and diagnosis of infectious diseases in man and animals. Early report on the factual circulation and distribution of LSD within Kazakhstan is anticipated. Neighboring countries may take steps to prevent its introduction; those countries include China, Kyrgyzstan and Uzbekistan. Russia is LSD-infected (last follow-up report addressing 2 new outbreaks in Saratov oblast, adjacent to West Kazakhstan, published 24 Aug 2017). For the diagnosis of LSD, samples from clinically affected animals should preferably be derived from their typical dermal lesions; organs from dead animals which should be sent for laboratory tests are specified in OIE's Manual. The submission of \"meat of dead cows\" for testing in the laboratories, as reported, may not be ideal for timely diagnosis of LSD. - Mod.AS   . ","keywordsMatched":[]},"748":{"title":"Lumpy skin disease,\r\n\tbovine - Kazakhstan (03): (AR) spread susp, \r\n\tvaccination, RFI ","date":["29","Aug","2017"],"url":"promedPRO/AH/EDR> Lumpy skin disease,\r\n\tbovine - Kazakhstan (03): (AR) spread susp, \r\n\tvaccination, RFI [EXTERNAL]","summary":"   Tue 29 Aug 2017 From: a subscriber whose identity is known to ProMED, but who preferred to remain unnamed edited In response to ProMED-mail's RFI's in postings http://promedmail.org/post/20170815.5251541 and http://promedmail.org/post/20170825.5274779 about lumpy skin disease in Kazakhstan: 1. It is understood that the government of Kazakhstan officially announced the presence, in 2017, of nodular dermatitis aka lumpy skin disease, LSD. 2. Russian and Kenyan LSD vaccines have been mentioned as the ones applied, and their effectiveness discussed. 3. Private owners of livestock suffer most, because the compensation for each sick cow is minimal. It is necessary to develop an effective compensation scheme for the smallholder livestock owners. 4. The following information on the 2016 LSD event in Kazakhstan was included in a report for the population, by the Minister of Agriculture of the Republic of Kazakhstan, AI Myrzahmetov, published on 2 Jun 2017: \"In 2016, 4 foci of nodular dermatitis outbreaks in cattle were reported in the Atyrau oblast. Amendments were made to the legislation and 185 million tenge (USD 551 300) were paid from the republican budget as compensation for the cost of animals that died from this disease. To date, all liquidation measures have been completed. Preventive vaccination of livestock in Atyrau oblast, as well as in 6 border areas of Aktobe Aqtobe (2) and West Kazakhstan (4) oblasts, are coming to an end.\"  <br><br>Communicated by: ProMED-mail\\. ProMED-mail is very grateful to the submitter of the information above, addressing 4 issues raised in earlier postings on LSD in Kazakhstan. The following comments address the issues as numbered above: 1. Additional details (link?) of the mentioned official confirmation, by Kazakhstan's authorities, of the current (2017) LSD event will be helpful. The internationally customary (in fact, required) route for such an announcement is an immediate notification to the OIE. 2. The LSD vaccine applied in Russia (and exported) is, in fact, a sheep-pox vaccine which, following a testing procedure, was recently licensed also for the vaccination of cattle against LSD (see http://promedmail.org/post/20170511.5028821). The Kenyan O-240 vaccine has been recently found to include an LSD virus which underwent a low level of attenuation which may be not sufficient for safe use in cattle. It was suspected to cause clinical disease in vaccinated animals (see in http://promedmail.org/post/20140820.2708273). EU countries currently use a live-homologous LSD vaccine (South-Africa's Neetling virus strain). A European Union LSD vaccine bank has become operational since April 2016. Trials assessing an inactivated vaccine were reportedly undertaken, currently in their final stages. For a recent assessment of LSD vaccines, please see http://promedmail.org/post/20160812.4410864, including the commentary. OIE's Manual chapter on LSD, including exhaustive updated information, is available at  . 3. This comment is of high significance. Small-holders, worldwide, may be slow, or even tempted to refrain altogether from reporting the appearance of early signs of a reportable animal disease, if they expect compensations to be under the real damages and payments delayed. Such animals may be (illegally) sold, with consequent spread of disease and  eventually  higher national losses and expenditures. 4. The original text, in Kazakh and Russian, is available in Kazakhstan's Ministry of Agriculture blog, at  . In case the recent media reports on LSD spreading in Western Kazakhstan are confirmed, it will be of interest to note if the affected farms included vaccinated animals and which vaccines were used. Kazakhstan's official reporting on the 2016 LSD event was limited to a solitary notification on a single outbreak; no details of the vaccination (numbers and vaccinated animals, geography) were included. According to the recent official update, LSD was recorded, during 2016, in 4 locations within the Atyrau oblast. Timely and detailed information on the LSD situation in Kazakhstan is essential for the entire region. This applies also for another livestock disease suspected to be spreading in central Asia, namely PPR (peste des petits ruminants) in small ruminants. - Mod. - Sr.Tech.Ed.MJ ","keywordsMatched":[]}},"Kenya":{"487":{"title":"Cholera, diarrhea & dysentery update (90): Africa ","date":["24","Aug","2017"],"url":"promedPRO/EDR> Cholera, diarrhea & dysentery update (90): Africa [EXTERNAL]","summary":"<br><br><strong> 3 Cholera - Sudan  Wed 23 Aug 2017 Source: UN Office for the Coordination of Humanitarian Affairs (OCHA), ReliefWeb, Radio Dabanga report edited South Darfur </strong><br> On Monday and Tuesday 21-22 Aug 2017 4 displaced people died of cholera and 49 others have been infected at camp Kalma in Nyala, capital of South Darfur. More deaths and infections have been reported from across the country as rates resurge along the Nile. Yagoub Abdallah, the general coordinator of displaced persons and refugee camps, told Radio Dabanga that \"the camp has seen a wide spread of cholera over the past 2 days.\" On Mon 21 Aug 2017, the camp's 2 health centers reported 1 death and 18 new cholera cases, and 3 deaths and 31 new cases on Tue 22 Aug 2017. Abdallah explained that the number of hospitalized cases in the 2 centers has amounted to 78 and pointed to the acute shortage of medicines in both centers. He appealed to the Ministry of Health and the WHO to speed up the provision of medicines and intravenous solutions.<br><br><strong> Central Darfur </strong><br> On Monday and Tuesday 21-22 Aug 2017, Nierteti in Central Darfur recorded 5 new cases of cholera. One of the Sheikhs of Nierteti camps told Radio Dabanga that 3 cases were recorded on 21 Aug 2017, 2 from the camps and 1 from neighboring villages of Nierteti. On 22 Aug 2017, 2 cases were recorded in Nierteti camps, bringing the number of hospitalized cases to 12.<br><br><strong> Sennar </strong><br> From Friday to Tuesday 18-22 Aug 2017, 18 people have been infected with cholera at El Dindir area in Sennar. Yesterday 22 Aug 2017, a medical source told Radio Dabanga that El Dindir Hospital received 2 new cases, this in addition to the existence of 6 hospitalized cases in the isolation ward. A medical source reported from El Bardana village entry of 1 case on Tue 22 Aug 2017, bringing the total number of cases in the isolation centre to 10 cases since 18 Aug 2017. Singa area reportedly witnessed a marked decrease in recent cases. The health source said Singa Hospital recorded 3 cases of cholera on Monday and Tuesday 21-22 Aug 2017.<br><br><strong> Khartoum </strong><br> Cholera in Khartoum state has re-spread after seeing a significant decrease during the past month. Yesterday 22 Aug 2017, an activist from the emergency room of Teiba El Ahamda told Radio Dabanga that El Ezba district health center has recorded 4 cases of cholera during the past 2 days. The activist attributed the emergence of cases to the rainfall and the terrible environmental degradation witnessed by the district due to the accumulation of waste. He pointed out that Bahri locality has stopped transporting the waste from Teiba El Ahamda for unknown reasons for 3 years. El Azhari Widaatallah, the chairman of the Legislative and Justice Committee of the Parliament, representative of Constituency 30 of Khartoum state of the districts of El Azhari, El Shajara, El Azozab, Lamab, Hamadab, pointed to the emergence of watery diarrhea in his constituency, especially at El Shajara. He attributed the deterioration of the health situation in the area to the lack of sewage system and the stagnation of rainwater. Health sources revealed the emergence of a number of cases of cholera in the academic hospital in Khartoum.<br><br><strong> Northern state </strong><br> In the Northern state, the isolation centre at Delgo Hospital received 3 new cases of cholera on Sun 20 Aug 2017. Nubian activist Ashraf Abdelwedoud warned in an interview with Radio Dabanga of the increasing rates of the disease following the rains and floods in the area in the past few days. He called on the authorities to make efforts to curb the spread of the disease. - Sr.Tech.Ed.MJ The mortality from cholera and most diarrheal illnesses is related to non-replacement of fluid and electrolytes from the diarrheal illness. As stated in Lutwick LI, Preis J, Choi P: Cholera. In: Chronic illness and disability: the pediatric gastrointestinal tract. Greydanus DE, Atay O, Merrick J (eds). NY: Nova Bioscience, 2017 (in press), oral rehydration therapy can be life-saving in outbreaks of cholera and other forms of diarrhea: \"As reviewed by Richard Guerrant et al (1), it was in 1831 that cholera treatment could be accomplished by intravenous replacement, and, although this therapy could produce dramatic improvements, not until 1960 was it 1st recognized that there was no true destruction of the intestinal mucosa, and gastrointestinal rehydration therapy could be effective, and the therapy could dramatically reduce the intravenous needs for rehydration. Indeed, that this rehydration could be just as effective given orally as through an orogastric tube (for example, refs 2 and 3) made it possible for oral rehydration therapy (ORT) to be used in rural remote areas and truly impact on the morbidity and mortality of cholera. Indeed, Guerrant et al (1) highlights the use of oral glucose-salt packets in war-torn Bangladeshi refugees, which reduced the mortality rate from 30 per cent to 3.6 per cent (4) and quotes sources referring to ORT as \"potentially the most important medical advance\" of the 20th century. A variety of formulations of ORT exist, generally glucose or rice powder-based, which contain a variety of micronutrients, especially zinc (5). \"The assessment of the degree of volume loss in those with diarrhea to approximate volume and fluid losses can be found in ref 6 below. Those with severe hypovolemia should be initially rehydrated intravenously with a fluid bolus of normal saline or Ringer's lactate solution of 20-30 ml/kg followed by 100 ml/kg in the 1st 4 hours and 100 ml/kg over the next 18 hours with regular reassessment. Those with lesser degrees of hypovolemia can be rehydrated orally with a glucose or rice-derived formula with up to 4 liters in the 1st 4 hours, and those with no hypovolemia can be given ORT after each liquid stool with frequent reevaluation.<br><br><strong> \"References </strong><br> 1. Guerrant RL, Carneiro-Filho BA, Dillingham RA. Cholera, diarrhea, and oral rehydration therapy: triumph and indictment. Clin Infect Dis. 2003; 37(3): 398-405; available at  . 2. Gregorio GV, Gonzales ML, Dans LF, Martinez EG. Polymer-based oral rehydration solution for treating acute watery diarrhoea. Cochrane Database Syst Rev. 2009; (2): CD006519. doi: 10.1002/14651858.CD006519.pub2; available at  . 3. Gore SM, Fontaine O, Pierce NF. Impact of rice based oral rehydration solution on stool output and duration of diarrhoea: meta-analysis of 13 clinical trials. BMJ 1992; 304(6822): 287-91; available at . 4. Mahalanabis D, Choudhuri AB, Bagchi NG, et al. Oral fluid therapy of cholera among Bangladesh refugees. Johns Hopkins Med 1973; 132(4): 197-205; available at  . 5. Atia AN, Buchman AL. Oral rehydration solutions in non-cholera diarrhea: a review. Am J Gastroenterol 2009; 104(10): 2596-604; abstract available at . 6. WHO. The treatment of diarrhoea, a manual for physicians and other senior health workers. 4th ed. 2005; available at:  . - Mod.LL ","keywordsMatched":[]},"502":{"title":"Measles update (43): Asia and Pacific, Europe, demographics\r\n\t","date":["26","Aug","2017"],"url":"promedPRO/EDR> Measles update (43): Asia and Pacific, Europe, demographics\r\n\t[EXTERNAL]","summary":"<br><br><strong> Measles immunity gaps -</strong><br> 5 Role of demographics  Sat 26 Aug 2017 Source: News-Medical/Life Sciences edited Even if the incidence of measles infection has decreased by at least 90 per cent worldwide since the introduction of the vaccine, measles is still one of the major causes of death in children among vaccine-preventable diseases. Regular measles epidemics are reported in developing countries and recurrent episodic outbreaks occur in the developed world. A new study by Bocconi University and Bruno Kessler Foundation analyzing 9 countries (Australia, Ethiopia, Kenya, Ireland, Italy, South Korea, Singapore, the United Kingdom, and the United States) and published in The Lancet Infectious Diseases see reference below, highlights the role played by demographics in the spread of measles and concludes that future vaccination strategies in high-fertility countries should focus on increasing childhood immunization rates, while immunization campaigns targeting adolescents and young adults are required in low fertility countries. Using a transmission model calibrated on historical serological data the authors estimate that the susceptible proportion of the population (that is, unprotected against the infection) varies from about 3 per cent in the UK to more than 12.5 per cent in Ethiopia, with astonishing differences in its age composition, due to different vaccination strategies and divergent demographic trends. While the percentage of over-15 among susceptible individuals in Ethiopia and Kenya is, respectively, 28 per cent and 43 per cent, adolescents and young adults represent 74 per cent of unprotected individuals in South Korea, 66 per cent in Italy and 53 per cent in the US, with considerable immunity gaps in individuals aged 30-40 years. \"Every effort to increase the vaccination coverage rate among children is praiseworthy\", says Alessia Melegaro, a Bocconi professor and principal investigator of DECIDE, the ERC European Research Council-funded project which produced the article, \"but in some developed countries it's the lack of coverage among adolescents and adults that poses a serious threat to the goal of eliminating measles.\" \"Measles incidence could increase, in the next decades, in Italy, Australia, and Singapore and Ethiopia is at high risk of future large epidemics\", says Stefano Merler from Bruno Kessler Foundation, \"and this is particularly worrying considering that individuals get infected later in life when the disease is more severe. The median age at infection for 2015 was estimated to be 5-10 years in the UK, Ireland, and Ethiopia; 10-15 years in the USA, Australia, Singapore, and Kenya; and older than 20 years in Italy and South Korea\". The proposed model shows that the introduction of the measles vaccine, which occurred at different times in the 9 countries, has considerably reduced the disease burden in terms of disability-adjusted life-years (DALYs), a measure expressed as the number of years lost because of illness, disability, or early death. Every vaccine dose averts 2 or 3 weeks of DALYs in the developed world and around 20 weeks in Kenya and Ethiopia. Which translates into 2-mln years 2 million DALYs since the vaccine introduction in the UK, 13-mln 13 million DALYs in the US, and 36-mln 36 million DALYs in Ethiopia. \"Vaccination has undoubtedly achieved incredible results in terms of public health. In particular,\" continues Prof Melegaro \"our analysis showed that routine 1st dose vaccine administration has been responsible for more than 90 per cent of the overall number of vaccine-immunized individuals in most countries. In Ethiopia and Kenya, catch-up and follow-up campaigns substantially mitigated the effect of suboptimum routine vaccine coverage, generating 25-45 per cent of the immunized fraction of the population. Tailoring immunization campaigns to achieve measles eradication goals is essential and currently, for some countries, this means considering also the role of unprotected adolescents and young adults. Measles immunity gaps and the progress towards elimination: a multi-country modelling analysis. Lancet Infect Dis. 2017. pii: S1473-3099(17)30421-8. Epub ahead of print; . While it is recommended that children get 2 doses of MMR (measles, mumps, rubella) vaccine, starting with the 1st dose at 12 through 15 months of age, and the 2nd dose at 4 through 6 years of age, this study emphasizes that it is important that adolescents and young adults also are up to date on their MMR vaccination. - Mod.LK ","keywordsMatched":[]}},"Kiribati":{},"Kosovo":{},"Kuwait":{},"Kyrgyzstan":{"489":{"title":"Lumpy skin disease, bovine - Kazakhstan (02): (WK) spread susp,\r\n\tRFI ","date":["24","Aug","2017"],"url":"promedPRO/AH> Lumpy skin disease, bovine - Kazakhstan (02): (WK) spread susp,\r\n\tRFI [EXTERNAL]","summary":"   Sun 20 Aug 2017 Source: Kloop (Kyrgyzstan) in Russian, machine trans., edited At least 120 head of cattle have been killed in the Atyrau region West Kazakhstan; the cause of the death of the animals is unknown. Veterinarians do not know the cause of the animal's deaths.\"Since the cattle are still in the pastures, the owners themselves bring sick animals to us. Although they do not have a high temperature, they still cannot save them,\" said veterinarian Islamgali Mardashev. The meat of the dead cows was sent for testing in the laboratories of Astana and Almaty, but so far there are no results see comment below. It is only known that before dying the temperature of the animals rises, and there is weakness and lumps under the skin. In the summer of 2016, the Atyrau oblast similarly suffered a massive loss of livestock; more than 800 cattle died. All of them had nodular dermatitis. More than 6000 cattle were infected with the disease. byline: Alexandra Titova  communicated by: ProMED-mail From 10 to 15 Jun 2016, a disease which later was recognized as lumpy skin disease (LSD) was recorded in a cattle holding on the territory adjacent to the village of Chapayevo, West Kazakhstan (see archive no. http://promedmail.org/post/20160717.4350687; at this point in time, laymen, followed by the media, erroneously related to the undiagnosed and most probably unfamiliar new disease as foot and mouth disease. Please see relevant commentary in the subsequent postings no. http://promedmail.org/post/20160722.4362368 and http://promedmail.org/post/20160723.4365082). On 7 Jul 2016, Kazakhstan reported (see archive no. http://promedmail.org/post/20160722. According to the report, the susceptible population was 3557 head including 459 clinical cases of which 34 died, the 425 remaining sick animals \"killed and disposed of\". No stamping out applied and no additional case reported in the 12 follow-up reports, the last of which, no.12, submitted on 26 Nov 2017, stated: 1. Compensation to the animals' owners for dead cattle at the market price is being developed and will be implemented soon. All 459 diseased cattle heads were destroyed and the final disinfection was carried out. 2. The event is resolved. No more reports will be submitted. Follow-up report no.12, with links to all previous reports, is available at  . Although according to media reports vaccination was applied, no details of such were included in the 12 follow-up reports nor in Kazakhstan's semi-annual summary report to the OIE (July-December 2016), which included the epidemiological statistics above; the item \"control measures\" (against LSD) did not include \"vaccination\". The current media report, from a Kyrgyz source (citing a Kazakh newspaper), says that during the 2016 event, 6000 animals were infected, of which 600 died. An earlier media report, from Kazakhstan, dated 27 Jul 2016, said that the number of diseased animals \"exceeded 2000, of which 50 head of cattle died\" (see archive no. http://promedmail.org/post/20160727.4374008). Kazakhstan is the world's largest landlocked country, and the 9th largest in the world. The belated diagnosis in 2016, and its continued absence, so far, during the current event, is puzzling; following the acquiring of independence in Dec 1991, Kazakhstan obtained support from the West, particularly USA, in the establishment of state-of-the-art laboratories for research and diagnosis of infectious diseases in man and animals. Early report on the factual circulation and distribution of LSD within Kazakhstan is anticipated. Neighboring countries may take steps to prevent its introduction; those countries include China, Kyrgyzstan and Uzbekistan. Russia is LSD-infected (last follow-up report addressing 2 new outbreaks in Saratov oblast, adjacent to West Kazakhstan, published 24 Aug 2017). For the diagnosis of LSD, samples from clinically affected animals should preferably be derived from their typical dermal lesions; organs from dead animals which should be sent for laboratory tests are specified in OIE's Manual. The submission of \"meat of dead cows\" for testing in the laboratories, as reported, may not be ideal for timely diagnosis of LSD. - Mod.AS   . ","keywordsMatched":[]}},"Laos":{"503":{"title":"Dengue/DHF update (10): Asia, Pacific, Africa, research, WHO\r\n\t","date":["25","Aug","2017"],"url":"promedPRO/EDR> Dengue/DHF update (10): Asia, Pacific, Africa, research, WHO\r\n\t[EXTERNAL]","summary":" 3 WHO update  The 15 Aug 2017 Source: WHO Western Pacific region edited Dengue situation update no.<br><br><strong> 523 - Northern hemisphere -</strong><br> Cambodia As of 8 Aug 2017, a total of 1604 suspected dengue fever cases were reported in 2017. The total number of reported dengue cases including dengue haemorrhagic fever and dengue shock syndrome was lower than the 3 year-threshold of the same period from 2014-2016. China As of 31 Jul 2017, there were 503 cases of dengue reported in China in 2017. This number is higher than that reported during the same period since 2012 but follows historical trend. Lao PDR People's Democratic Republic As of 4 Aug 2017, there were 5740 cases of dengue with 7 deaths reported in Lao PDR in 2017, with 406 cases reported in epi week 31 (week ending 5 Aug 2017). Dengue activity is high with the number of dengue cases reported this year 2017 being higher than the cases reported for same period since 2014. Malaysia In week 31 of 2017 (week ending 5 Aug 2017), 1899 dengue cases were reported with 2 deaths, an increase of 1.1 per cent compared with week 30. As of week 31, the cumulative number of dengue cases in 2017 were 59 521 with 135 deaths compared with 67 437 cases with 147 deaths during the same period in 2016. Philippines (no update) A total of 43 770 dengue cases were reported nationwide from 1 Jan to 1 Jul 2017. This number is 36.8 per cent lower (25 527) compared with the same time period in 2016. Singapore As of 5 Aug 2017, there were 1732 dengue cases reported in Singapore since January 2017. This is lower than the number of reported cases during the same period since 2013. During week 31, there were 61 cases reported and the number of reported cases in 2017 remains lower than those reported for the same time period in 2016 . Viet Nam As of 3 Aug 2017, there were 80 555 cases of dengue reported in Viet Nam including 22 deaths. Compared with the same period in 2016, the cumulative number of cases increased by 33.5 per cent, and the number of deaths rose by 5. Most cases were reported from the South (59 per cent). A sharp increase in the number of reported cases has been observed in the North (almost 25 times higher than the same period last year 2016), especially from Ha Noi, with about 13 440 cases.<br><br><strong> Southern hemisphere -</strong><br> Australia As of 31 Jul 2017, there were 695 laboratory-confirmed dengue cases reported in Australia in 2017. The number of cases reported is lower than that reported during the same time period in the previous years (2012-2016).<br><br><strong> Pacific Islands countries and areas -</strong><br> French Polynesia In French Polynesia, 12 cases (including 1 death) in week 29 and 12 cases in week 30 (week ending 29 Jul 2017). Among these, 15 cases were confirmed as DENV-1 infection. New Caledonia (no update) As of 1 Aug 2017, 4,452 dengue cases were reported in 2017. There is a downward trend in the number of reported cases since week 16 (week ending 22 Apr 2017).  communicated by: ProMED-mail ","keywordsMatched":[]}},"Latvia":{},"Lebanon":{},"Lesotho":{},"Liberia":{},"Libya":{},"Liechtenstein":{},"Lithuania":{},"Luxembourg":{},"Macao":{},"Macedonia":{},"Madagascar":{},"Malawi":{},"Malaysia":{},"Maldives":{},"Mali":{},"Malta":{},"Marshall Islands":{"749":{"title":"Zika virus (17): Americas, research, observations ","date":["24","Aug","2017"],"url":"promedPRO/EDR> Zika virus (17): Americas, research, observations [EXTERNAL]","summary":" 6 Vaccine update  22/29 Aug 2017 Source: Journal of the American Medical Association, JAMA edited ref: Lyon J. Vaccines protect fetus from Zika. JAMA. 2017; 318(8): 689. doi:10.1001/jama.2017.<br><br><strong>11200 </strong><br> Researchers funded in part by the National Institutes of Health have recently demonstrated that 2 experimental vaccines can restrict transmission of Zika virus from pregnant mice to their fetuses, thereby shielding offspring from congenital damage or death. Multiple candidate Zika vaccines have been shown protective against infection with the virus in animal studies, with several now in human trials, but none were tested in the context of pregnancy, according to the authors of the study published in Cell  . The 2 vaccine candidates investigated in the new study are the 1st to demonstrate efficacy in preventing vertical transmission of the virus and related fetal death in an animal model. Although the vaccines were administered to female mice prior to pregnancy, the result is considered an important step toward developing a vaccine that could be safely given to pregnant women. One of the 2 candidates is a modified messenger RNA (mRNA) vaccine encoding Zika genes, developed by the biotechnology company Moderna. It is already in safety trials in women who are not pregnant. The other is a live-attenuated Zika strain developed by researchers at the University of Texas Medical Branch (UTMB). The testing was carried out by scientists from the National Institute of Allergy and Infectious Diseases, Washington University School of Medicine, and UTMB. The researchers 1st vaccinated the mice with 1 of the vaccines or a placebo. After mating, the animals were challenged with the virus 6 days into pregnancy. A week later, more than 50 percent of placentas and fetuses from mice administered the mRNA vaccine had virtually no Zika RNA. The remainder had \"substantially lower\" levels relative to placebo. The live vaccine provided broader protection: 78 percent of placentas and 83 percent of fetuses had Zika RNA at or below the level of detection, while the placebo group exhibited significantly higher levels of placental and fetal Zika RNA. Mice vaccinated with either vaccine had significantly higher rates of fetal viability; whereas 100 percent of fetuses from mice vaccinated with the mRNA vaccine were born, none survived to term in the placebo group. A working group funded by the Wellcome Trust recently approved ethical guidelines for testing such vaccines in pregnant women, normally excluded from drug trials.  <br><br>Communicated by: ProMED-mail\\. It is reassuring to learn that at least 2 vaccines are now entering clinical trials in women. Although anti-Zika virus drugs are under development, preventing infection through vaccination seems to be the most effective measure to prevent fetal infection and adverse effects of the virus infection in adults. - Mod.TY ","keywordsMatched":[]}},"Mauritania":{"739":{"title":"Undiagnosed hemorrhagic illness - Mauritania: (TR) RFI\r\n\t","date":["24","Aug","2017"],"url":"promedPRO/AH/EDR> Undiagnosed hemorrhagic illness - Mauritania: (TR) RFI\r\n\t[EXTERNAL]","summary":"   Thu 24 Aug 2017 10:38 Source: APA (Agence de Presse Africaine) News in French, trans. Corr.SB, edited A case of confirmed haemorrhagic fever has been detected in Mauritania, medical sources said Thu 24 Aug 2017 in Nouakchott. A male patient is currently hospitalized at Hamed Ben Khalifa hospital in Boutilimit Trarza region, 160 km 99 mi southeast of Nouakchott, the same sources added, without specifying what type of haemorrhagic fever. The patient was evacuated Tue 22 Aug 2017 from an area located 140 km 87 mi south of Boutilimit and some 30 km 19 mi north of the town of Bogh Brakna region on the Senegal River. After suspecting the illness, the attending medical staff sent a sample of the patient's blood to Nouakchott for further analysis and eventually confirmed the existence of the virus which virus? - Mod.TY The Mauritanian Ministry of Health immediately dispatched a mission to Boutilimit, which carried out investigations to verify that no other person had been reached by the virus in the area from which the patient came. The investigations also seek to ensure that there was no contamination infection among the persons who had been in contact with the patient before the diagnosis of his case. This wintering period in Mauritania is generally conducive to the appearance of several types of diseases, including haemorrhagic fevers.  <br><br>Communicated by: ProMED-mail\\. Several viruses are possible, including Rift Valley fever, yellow fever, Lassa fever, and the Ebola-related viruses. Apparently, no other individuals have been affected in the area from which the patient came. The current clinical status of the patient is not stated. ProMED-mail would appreciate receiving additional information about the symptoms that the patient is presenting and the identification of the virus involved. There is a 3 Jun 2017 reported case of Rift Valley fever virus (RVFV) infection in Mauritania. That case appears to have occurred 2 months prior to the case reported above, but it raises the possibility that RVFV is responsible for this latest case (see Rift Valley fever - Mauritania: RFI http://promedmail.org/post/20170605.5085590). - Mod.TY ","keywordsMatched":[]},"758":{"title":"Crimean-Congo hem. fever - Mauritania: (BT) ","date":["28","Aug","2017"],"url":"promedPRO/AH/EDR> Crimean-Congo hem. fever - Mauritania: (BT) [EXTERNAL]","summary":"   28 Aug 2017 Source: Outbreak News Today edited On 24 Aug 2017, the Mauritania Ministry of Health notified WHO of a confirmed case of Crimean-Congo hemorrhagic fever (CCHF) in a 47-year-old shepherd, from Arafat Village in Mohammedia, Boutilimit Prefecture, located about 150 km southeast of the capital, Nouakchott. In May 2017, health officials reported 2 imported cases of Crimean-Congo hemorrhagic fever (CCHF) in Senegal imported from Mauritania. A 3rd imported case was reported in June 2017. He developed headache, muscle and joints pains and diarrhea on 20 Aug 2017 and sought medical attention. He was treated with anti-malarial medicines and analgesics. After 2 days, he returned for medical care as his condition worsened. He was tested for CCHF because of bleeding manifestations and was IgM positive for Crimean-Congo haemorrhagic fever by enzyme-linked immunosorbent assay (ELISA). The patient is still hospitalized and in stable clinical condition. Mauritania experienced a fairly large CCHF outbreak in 2003, involving 38 cases with a case fatality rate of 28.6 percent. According to the WHO, Crimean-Congo hemorrhagic fever is a widespread disease caused by a tick-borne virus (Nairovirus) of the Bunyaviridae family. The CCHF virus causes severe viral hemorrhagic fever outbreaks, with a case fatality rate of 10-40 percent. CCHF is endemic in Africa, the Balkans, the Middle East and Asian countries south of the 50th parallel north, the geographical limit of the principal tick vector. The hosts of the CCHF virus include a wide range of wild and domestic animals such as cattle, sheep and goats. Animals become infected by the bite of infected ticks, and the virus remains in their bloodstream for about one week after infection, allowing the tick-animal-tick cycle to continue when another tick bites. Although a number of tick genera are capable of becoming infected with CCHF virus, ticks of the genus _Hyalomma_ are the principal vectors. The CCHF virus is transmitted to people either by tick bites or through contact with infected animal blood or tissues during and immediately after slaughter. The majority of cases have occurred in people involved in the livestock industry, such as agricultural workers, slaughterhouse workers and veterinarians. Human-to-human transmission is possible. Byline: Robert Herriman  <br><br>Communicated by: ProMED-mail\\. An outbreak of Crimean-Congo hemorrhagic fever was documented in Nouakchott, the capital of Mauritania in 2003. The index case was detected on 18 Feb 2003. By 21 Mar 2003, the Ministry of Health of Mauritania had reported a total of 35 cases (18 laboratory confirmed) of Crimean-Congo haemorrhagic fever (CCHF), including 6 deaths Crimean-Congo hemorrhagic fever - Mauritania (04) http://promedmail.org/post/20030324.0732. In the period from February to August 2003, 38 persons were infected with Crimean-Congo hemorrhagic fever (CCHF) virus; 35 of these persons were residents of Nouakchott. The 1st patient was a young woman who became ill shortly after butchering a goat. She transmitted the infection to 15 persons in the hospital where she was admitted and 4 members of her family. In Nouakchott, 2 disease clusters and 11 isolated cases were identified. Of the patients not infected by the 1st case-patient, almost half were butchers, which suggests that the primary mode of animal-to-human transmission was direct contact with blood of infected animals. Cattle heavily infested with ticks were more likely to be CCHFV seropositive, and vector control to reduce the tick burden can result in reduced seroprevalence. Cattle are noted as the most sensitive indicator of low-level CCHFV circulation because they tend to be highly infested with _Hyalomma_ spp. ticks, which are the most common vectors of CCHF  . The circulation of CCHF virus and the high prevalence of infected animals and ticks have been well documented in Mauritanian farming areas since 1983 Crimean-Congo haemorrhagic fever and Rift Valley fever in south-eastern Mauritania. Saluzzo JF, Digoutte JP, Camicas JL, Chauvancy G Lancet. 1985 Jan 12; 1(8420):116. Since then, this is the latest case reported from that country, with history of exposure to livestock. - Mod.UBA   . ","keywordsMatched":[]}},"Mauritius":{},"Mexico":{"749":{"title":"Zika virus (17): Americas, research, observations ","date":["24","Aug","2017"],"url":"promedPRO/EDR> Zika virus (17): Americas, research, observations [EXTERNAL]","summary":" 6 Vaccine update  22/29 Aug 2017 Source: Journal of the American Medical Association, JAMA edited ref: Lyon J. Vaccines protect fetus from Zika. JAMA. 2017; 318(8): 689. doi:10.1001/jama.2017.<br><br><strong>11200 </strong><br> Researchers funded in part by the National Institutes of Health have recently demonstrated that 2 experimental vaccines can restrict transmission of Zika virus from pregnant mice to their fetuses, thereby shielding offspring from congenital damage or death. Multiple candidate Zika vaccines have been shown protective against infection with the virus in animal studies, with several now in human trials, but none were tested in the context of pregnancy, according to the authors of the study published in Cell  . The 2 vaccine candidates investigated in the new study are the 1st to demonstrate efficacy in preventing vertical transmission of the virus and related fetal death in an animal model. Although the vaccines were administered to female mice prior to pregnancy, the result is considered an important step toward developing a vaccine that could be safely given to pregnant women. One of the 2 candidates is a modified messenger RNA (mRNA) vaccine encoding Zika genes, developed by the biotechnology company Moderna. It is already in safety trials in women who are not pregnant. The other is a live-attenuated Zika strain developed by researchers at the University of Texas Medical Branch (UTMB). The testing was carried out by scientists from the National Institute of Allergy and Infectious Diseases, Washington University School of Medicine, and UTMB. The researchers 1st vaccinated the mice with 1 of the vaccines or a placebo. After mating, the animals were challenged with the virus 6 days into pregnancy. A week later, more than 50 percent of placentas and fetuses from mice administered the mRNA vaccine had virtually no Zika RNA. The remainder had \"substantially lower\" levels relative to placebo. The live vaccine provided broader protection: 78 percent of placentas and 83 percent of fetuses had Zika RNA at or below the level of detection, while the placebo group exhibited significantly higher levels of placental and fetal Zika RNA. Mice vaccinated with either vaccine had significantly higher rates of fetal viability; whereas 100 percent of fetuses from mice vaccinated with the mRNA vaccine were born, none survived to term in the placebo group. A working group funded by the Wellcome Trust recently approved ethical guidelines for testing such vaccines in pregnant women, normally excluded from drug trials.  <br><br>Communicated by: ProMED-mail\\. It is reassuring to learn that at least 2 vaccines are now entering clinical trials in women. Although anti-Zika virus drugs are under development, preventing infection through vaccination seems to be the most effective measure to prevent fetal infection and adverse effects of the virus infection in adults. - Mod.TY ","keywordsMatched":[]}},"Mayotte":{},"Micronesia":{},"Moldova":{},"Monaco":{},"Mongolia":{},"Montenegro":{},"Morocco":{},"Mozambique":{},"Myanmar":{"503":{"title":"Dengue/DHF update (10): Asia, Pacific, Africa, research, WHO\r\n\t","date":["25","Aug","2017"],"url":"promedPRO/EDR> Dengue/DHF update (10): Asia, Pacific, Africa, research, WHO\r\n\t[EXTERNAL]","summary":" 3 WHO update  The 15 Aug 2017 Source: WHO Western Pacific region edited Dengue situation update no.<br><br><strong> 523 - Northern hemisphere -</strong><br> Cambodia As of 8 Aug 2017, a total of 1604 suspected dengue fever cases were reported in 2017. The total number of reported dengue cases including dengue haemorrhagic fever and dengue shock syndrome was lower than the 3 year-threshold of the same period from 2014-2016. China As of 31 Jul 2017, there were 503 cases of dengue reported in China in 2017. This number is higher than that reported during the same period since 2012 but follows historical trend. Lao PDR People's Democratic Republic As of 4 Aug 2017, there were 5740 cases of dengue with 7 deaths reported in Lao PDR in 2017, with 406 cases reported in epi week 31 (week ending 5 Aug 2017). Dengue activity is high with the number of dengue cases reported this year 2017 being higher than the cases reported for same period since 2014. Malaysia In week 31 of 2017 (week ending 5 Aug 2017), 1899 dengue cases were reported with 2 deaths, an increase of 1.1 per cent compared with week 30. As of week 31, the cumulative number of dengue cases in 2017 were 59 521 with 135 deaths compared with 67 437 cases with 147 deaths during the same period in 2016. Philippines (no update) A total of 43 770 dengue cases were reported nationwide from 1 Jan to 1 Jul 2017. This number is 36.8 per cent lower (25 527) compared with the same time period in 2016. Singapore As of 5 Aug 2017, there were 1732 dengue cases reported in Singapore since January 2017. This is lower than the number of reported cases during the same period since 2013. During week 31, there were 61 cases reported and the number of reported cases in 2017 remains lower than those reported for the same time period in 2016 . Viet Nam As of 3 Aug 2017, there were 80 555 cases of dengue reported in Viet Nam including 22 deaths. Compared with the same period in 2016, the cumulative number of cases increased by 33.5 per cent, and the number of deaths rose by 5. Most cases were reported from the South (59 per cent). A sharp increase in the number of reported cases has been observed in the North (almost 25 times higher than the same period last year 2016), especially from Ha Noi, with about 13 440 cases.<br><br><strong> Southern hemisphere -</strong><br> Australia As of 31 Jul 2017, there were 695 laboratory-confirmed dengue cases reported in Australia in 2017. The number of cases reported is lower than that reported during the same time period in the previous years (2012-2016).<br><br><strong> Pacific Islands countries and areas -</strong><br> French Polynesia In French Polynesia, 12 cases (including 1 death) in week 29 and 12 cases in week 30 (week ending 29 Jul 2017). Among these, 15 cases were confirmed as DENV-1 infection. New Caledonia (no update) As of 1 Aug 2017, 4,452 dengue cases were reported in 2017. There is a downward trend in the number of reported cases since week 16 (week ending 22 Apr 2017).  communicated by: ProMED-mail ","keywordsMatched":[]}},"Namibia":{},"Nauru":{},"Nepal":{"750":{"title":"Scrub typhus - Nepal (09): (KT) urban cases ","date":["30","Aug","2017"],"url":"promedPRO/AH/EDR> Scrub typhus - Nepal (09): (KT) urban cases [EXTERNAL]","summary":"   Wed 30 Aug 2017 From: Sher Bahadur Pun edited During a 2-week period (15 through 29 Aug 2017), at least 86 scrub typhus (ST) cases (including 9 children) have been identified by laboratory testing at Sukraraj Tropical & Infectious Disease Hospital (STIDH). Majority of these patients are being treated in different hospitals in Kathmandu. 9 children with laboratory confirmed ST received treatment at STIDH and recovered uneventfully. It is quite surprising for me observing such a large number of ST cases being detected in Kathmandu, the biggest and most densely populated area of Nepal. Because ST has previously been almost exclusively detected in rural areas of Nepal. What is not yet clear is the impact of ST between the years 2004 and 2015. ST was first well documented in 2004 in Kathmandu (1), while the significant number of ST cases has only been detected since 2015. The widespread use of antibiotics, such as ciprofloxacin, could be one possible explanation. In other words, healthcare workers in Nepal usually view any fever as typhoid fever, thus used to treat febrile patients with ciprofloxacin, which might have also worked simultaneously against ST too. However, nowadays, cefixime has become the drug of choice for typhoid fever, and it may, however, not work effectively against ST, resulting in emergence of ST in Nepal.<br><br><strong> Reference -</strong><br> 1. Murdoch DR, Woods CW, Zimmerman MD et al. The etiology of febrile illness in adults presenting to Patan Hospital in Kathmandu. Nepal. Am J Trop Med Hyg. 2004; 70(6): 670-5; .  Dr Sher Bahadur Pun, MD, PhD Clinical Research Unit Sukraraj Tropical and Infectious Disease Hospital Kathmandu Nepal ProMED-mail thanks Dr Sher Bahadur Pun for his continued contributions on scrub typhus in Nepal. Doxycycline is the drug of choice and it is preferred over other tetracyclines for treatment of scrub typhus; it is rarely associated with staining of teeth in children younger than 8 years (1). Macrolides, such as azithromycin, are also reported to be efficacious (2). Fluoroquinolones, such as ciprofloxacin and ofloxacin, have been reported to be clinically effective in the treatment of scrub typhus in a few patients. However, some clinical studies suggest that fluoroquinolones are not as effective in patients with scrub typhus as other antibiotics (3,4). In vitro testing of some strains of _Orientia tsutsugamushi_, the cause of scrub typhus, has been reported to show resistance to ciprofloxacin and ofloxacin (minimum inhibitory concentration=8 micrograms/mL) (5) and mutation in the quinolone resistance-determining region (QRDR) of the gyrA gene associated with fluoroquinolone resistance has been found (3,5). These findings suggest that fluoroquinolones are likely not appropriate for the treatment of scrub typhus.<br><br><strong> References </strong><br> 1. Panpanich R, Garner P. Antibiotics for treating scrub typhus. Cochrane Database Syst Rev. 2000; (2): CD002150. Available at  . 2. Kim YS, Yun HJ, Shim SK, et al. A comparative trial of a single dose of azithromycin versus doxycycline for the treatment of mild scrub typhus. Clin Infect Dis. 2004; 39(9): 1329-35 Epub 2004 Oct 11. Available at  . 3. Jang HC, Choi SM, Jang MO, et al. Inappropriateness of quinolone in scrub typhus treatment due to gyrA mutation in _Orientia tsutsugamushi_ Boryong strain. J Korean Med Sci. 2013; 28(5): 667-71. doi: 10.3346/jkms.2013.28.5.667. Epub 2013 May 2. Available at  . 4. Tsai CC, Lay CJ, Wang CL, et al. Levofloxacin versus tetracycline antibiotics for the treatment of scrub typhus. Int J Infect Dis. 2010; 14(1): e62-7. doi: 10.1016/j.ijid.2009.03.012. Epub 2009 Jun 4. Available at  . 5. Tantibhedhyangkul W, Angelakis E, Tongyoo N, et al. Intrinsic fluoroquinolone resistance in _Orientia tsutsugamushi_. Int J Antimicrob Agents. 2010; 35(4): 338-41. Available at  . - Mod.ML ","keywordsMatched":[]}},"Netherlands":{},"New Caledonia":{},"New Zealand":{},"Nicaragua":{},"Niger":{},"Nigeria":{},"North Korea":{},"Northern Mariana Island":{},"Norway":{},"Oman":{},"Pakistan":{"503":{"title":"Dengue/DHF update (10): Asia, Pacific, Africa, research, WHO\r\n\t","date":["25","Aug","2017"],"url":"promedPRO/EDR> Dengue/DHF update (10): Asia, Pacific, Africa, research, WHO\r\n\t[EXTERNAL]","summary":" 3 WHO update  The 15 Aug 2017 Source: WHO Western Pacific region edited Dengue situation update no.<br><br><strong> 523 - Northern hemisphere -</strong><br> Cambodia As of 8 Aug 2017, a total of 1604 suspected dengue fever cases were reported in 2017. The total number of reported dengue cases including dengue haemorrhagic fever and dengue shock syndrome was lower than the 3 year-threshold of the same period from 2014-2016. China As of 31 Jul 2017, there were 503 cases of dengue reported in China in 2017. This number is higher than that reported during the same period since 2012 but follows historical trend. Lao PDR People's Democratic Republic As of 4 Aug 2017, there were 5740 cases of dengue with 7 deaths reported in Lao PDR in 2017, with 406 cases reported in epi week 31 (week ending 5 Aug 2017). Dengue activity is high with the number of dengue cases reported this year 2017 being higher than the cases reported for same period since 2014. Malaysia In week 31 of 2017 (week ending 5 Aug 2017), 1899 dengue cases were reported with 2 deaths, an increase of 1.1 per cent compared with week 30. As of week 31, the cumulative number of dengue cases in 2017 were 59 521 with 135 deaths compared with 67 437 cases with 147 deaths during the same period in 2016. Philippines (no update) A total of 43 770 dengue cases were reported nationwide from 1 Jan to 1 Jul 2017. This number is 36.8 per cent lower (25 527) compared with the same time period in 2016. Singapore As of 5 Aug 2017, there were 1732 dengue cases reported in Singapore since January 2017. This is lower than the number of reported cases during the same period since 2013. During week 31, there were 61 cases reported and the number of reported cases in 2017 remains lower than those reported for the same time period in 2016 . Viet Nam As of 3 Aug 2017, there were 80 555 cases of dengue reported in Viet Nam including 22 deaths. Compared with the same period in 2016, the cumulative number of cases increased by 33.5 per cent, and the number of deaths rose by 5. Most cases were reported from the South (59 per cent). A sharp increase in the number of reported cases has been observed in the North (almost 25 times higher than the same period last year 2016), especially from Ha Noi, with about 13 440 cases.<br><br><strong> Southern hemisphere -</strong><br> Australia As of 31 Jul 2017, there were 695 laboratory-confirmed dengue cases reported in Australia in 2017. The number of cases reported is lower than that reported during the same time period in the previous years (2012-2016).<br><br><strong> Pacific Islands countries and areas -</strong><br> French Polynesia In French Polynesia, 12 cases (including 1 death) in week 29 and 12 cases in week 30 (week ending 29 Jul 2017). Among these, 15 cases were confirmed as DENV-1 infection. New Caledonia (no update) As of 1 Aug 2017, 4,452 dengue cases were reported in 2017. There is a downward trend in the number of reported cases since week 16 (week ending 22 Apr 2017).  communicated by: ProMED-mail ","keywordsMatched":[]}},"Palau":{},"Panama":{"496":{"title":"Hantavirus - Americas (46): Panama (LS) ","date":["25","Aug","2017"],"url":"promedPRO/AH/EDR> Hantavirus - Americas (46): Panama (LS) [EXTERNAL]","summary":"   Fri 25 Aug 2017, 8:45 AM Source: Panam Amrica in Spanish, trans. Mod. TY The number of cases of hantavirus infections has risen to 14, since the Ministry of Health confirmed 3 new cases of fever and hantavirus cardiopulmonary syndrome. Carlos Muoz, regional coordinator of epidemiology in Los Santos, stated that the 3 latest cases registered are a girl whose illness is yet to be confirmed as hantavirus fever, a 44 year old woman resident of Via Hacia Santo Domingo with hantavirus cardiopulmonary syndrome admitted yesterday Thu 24 Aug 2017, and a 23 year old young man with hantavirus cardiopulmonary syndrome. Muoz indicated that the young man is from El Cocal but for the past 6 months has resided in El Cacao in Tonosi, and yesterday Thu 24 Aug 2017 was taken from the Tonosi Rural Hospital to the Joaqun Pablo Franco Hospital in Las Tablas. There is no indication of which hantavirus is involved in these 3 cases or in previous cases in Panama. As noted in comments on previous posts, Los Santos and adjoining provinces are endemic for Choclo hantavirus. Although no data on this or the previous cases in earlier years include an indication of which hantavirus is responsible, Choclo is the only one of the 3 hantaviruses known to be endemic in Panama that causes HPS (hantavirus cardiopulmonary syndrome) or hantavirus fever. No vaccine is available for Choclo virus. The rodent host of Choclo virus is the pygmy rice rat (_Oligoryzomys fulvescens_), a photograph of which can be accessed at  . These rodents occur in and around agricultural areas and adjacent houses and buildings. - Mod.TY   . ","keywordsMatched":[]}},"Papua New Guinea":{},"Paraguay":{},"Peru":{},"Philippines":{"503":{"title":"Dengue/DHF update (10): Asia, Pacific, Africa, research, WHO\r\n\t","date":["25","Aug","2017"],"url":"promedPRO/EDR> Dengue/DHF update (10): Asia, Pacific, Africa, research, WHO\r\n\t[EXTERNAL]","summary":" 3 WHO update  The 15 Aug 2017 Source: WHO Western Pacific region edited Dengue situation update no.<br><br><strong> 523 - Northern hemisphere -</strong><br> Cambodia As of 8 Aug 2017, a total of 1604 suspected dengue fever cases were reported in 2017. The total number of reported dengue cases including dengue haemorrhagic fever and dengue shock syndrome was lower than the 3 year-threshold of the same period from 2014-2016. China As of 31 Jul 2017, there were 503 cases of dengue reported in China in 2017. This number is higher than that reported during the same period since 2012 but follows historical trend. Lao PDR People's Democratic Republic As of 4 Aug 2017, there were 5740 cases of dengue with 7 deaths reported in Lao PDR in 2017, with 406 cases reported in epi week 31 (week ending 5 Aug 2017). Dengue activity is high with the number of dengue cases reported this year 2017 being higher than the cases reported for same period since 2014. Malaysia In week 31 of 2017 (week ending 5 Aug 2017), 1899 dengue cases were reported with 2 deaths, an increase of 1.1 per cent compared with week 30. As of week 31, the cumulative number of dengue cases in 2017 were 59 521 with 135 deaths compared with 67 437 cases with 147 deaths during the same period in 2016. Philippines (no update) A total of 43 770 dengue cases were reported nationwide from 1 Jan to 1 Jul 2017. This number is 36.8 per cent lower (25 527) compared with the same time period in 2016. Singapore As of 5 Aug 2017, there were 1732 dengue cases reported in Singapore since January 2017. This is lower than the number of reported cases during the same period since 2013. During week 31, there were 61 cases reported and the number of reported cases in 2017 remains lower than those reported for the same time period in 2016 . Viet Nam As of 3 Aug 2017, there were 80 555 cases of dengue reported in Viet Nam including 22 deaths. Compared with the same period in 2016, the cumulative number of cases increased by 33.5 per cent, and the number of deaths rose by 5. Most cases were reported from the South (59 per cent). A sharp increase in the number of reported cases has been observed in the North (almost 25 times higher than the same period last year 2016), especially from Ha Noi, with about 13 440 cases.<br><br><strong> Southern hemisphere -</strong><br> Australia As of 31 Jul 2017, there were 695 laboratory-confirmed dengue cases reported in Australia in 2017. The number of cases reported is lower than that reported during the same time period in the previous years (2012-2016).<br><br><strong> Pacific Islands countries and areas -</strong><br> French Polynesia In French Polynesia, 12 cases (including 1 death) in week 29 and 12 cases in week 30 (week ending 29 Jul 2017). Among these, 15 cases were confirmed as DENV-1 infection. New Caledonia (no update) As of 1 Aug 2017, 4,452 dengue cases were reported in 2017. There is a downward trend in the number of reported cases since week 16 (week ending 22 Apr 2017).  communicated by: ProMED-mail ","keywordsMatched":[]},"751":{"title":"Japanese encephalitis - Philippines (02): (LG) ","date":["29","Aug","2017"],"url":"promedPRO/AH/EDR> Japanese encephalitis - Philippines (02): (LG) [EXTERNAL]","summary":"   Tue 29 Aug 2017 5:19 PM PHT Source: Inquirer edited The provincial health office in Laguna said 2 children succumbed to Japanese encephalitis, the 1st confirmed cases of the mosquito-borne disease in the Southern Tagalog province this year 2017. On Tue 29 Aug 2017, Dr Rene Bagamasbad, Laguna health officer, said the victims were a 9-year-old boy in Calauan town and a 6-year-old boy in San Pablo City. He said the children died around 2 weeks ago. Calauan and San Pablo City, being adjacent to each other, were also placed under investigation by the health office. Only the Calauan case has so far reached the Calabarzon office of the Department of Health, according to Dr Rio Magpantay, DOH regional director. The regional office, however, had also started monitoring \"signs and symptoms\" of possible Japanese encephalitis incidence in other parts of Laguna. Calabarzon stands for the provinces of Cavite, Laguna, Batangas, Rizal, and Quezon. The disease, which is transmitted by the _Culex_ mosquito, commonly causes abdominal pains, fever, and seizures. It may also cause a part of the brain to swell. Vaccines are available. But there is no cure yet for the disease. Vaccines are currently not part of the government's immunization program. Magpantay said there was no declaration of an outbreak. But the DOH regional office would strengthen the surveillance of communities and hospitals. It usually takes some time to confirm a case of Japanese encephalitis because specimens, such as the patient's blood sample, would have to be collected and submitted for testing at the Research Institute for Tropical Medicine in Muntinlupa in Metro Manila. Byline: Maricar Cinco  <br><br>Communicated by: ProMED-mail\\. There have been relatively few reports of human Japanese encephalitis (JE) cases in the Philippines in recent years, although the islands are within the JE virus endemic zone. The report above is of 2 cases. Also on Luzon Island this year (2017), the Department of Health (DOH) has recorded a total of 149 cases of JE with at least 22 cases in noted Pampanga, the highest in the Central Luzon region (see Japanese encephalitis - Philippines: (PM) http://promedmail.org/post/20170818.5257940). A report from the World Health Organization (WHO) said that JE is an illness that is endemic in the Philippines and is fatal in almost 3 out of 10 serious cases. The report also said that nearly all survivors of this mosquito-borne disease experience permanent damage, including physical disabilities, cognitive and language problems, learning disabilities and behavioral problems. - Mod.TY ","keywordsMatched":[]}},"Poland":{},"Portugal":{},"Puerto Rico":{"749":{"title":"Zika virus (17): Americas, research, observations ","date":["24","Aug","2017"],"url":"promedPRO/EDR> Zika virus (17): Americas, research, observations [EXTERNAL]","summary":" 6 Vaccine update  22/29 Aug 2017 Source: Journal of the American Medical Association, JAMA edited ref: Lyon J. Vaccines protect fetus from Zika. JAMA. 2017; 318(8): 689. doi:10.1001/jama.2017.<br><br><strong>11200 </strong><br> Researchers funded in part by the National Institutes of Health have recently demonstrated that 2 experimental vaccines can restrict transmission of Zika virus from pregnant mice to their fetuses, thereby shielding offspring from congenital damage or death. Multiple candidate Zika vaccines have been shown protective against infection with the virus in animal studies, with several now in human trials, but none were tested in the context of pregnancy, according to the authors of the study published in Cell  . The 2 vaccine candidates investigated in the new study are the 1st to demonstrate efficacy in preventing vertical transmission of the virus and related fetal death in an animal model. Although the vaccines were administered to female mice prior to pregnancy, the result is considered an important step toward developing a vaccine that could be safely given to pregnant women. One of the 2 candidates is a modified messenger RNA (mRNA) vaccine encoding Zika genes, developed by the biotechnology company Moderna. It is already in safety trials in women who are not pregnant. The other is a live-attenuated Zika strain developed by researchers at the University of Texas Medical Branch (UTMB). The testing was carried out by scientists from the National Institute of Allergy and Infectious Diseases, Washington University School of Medicine, and UTMB. The researchers 1st vaccinated the mice with 1 of the vaccines or a placebo. After mating, the animals were challenged with the virus 6 days into pregnancy. A week later, more than 50 percent of placentas and fetuses from mice administered the mRNA vaccine had virtually no Zika RNA. The remainder had \"substantially lower\" levels relative to placebo. The live vaccine provided broader protection: 78 percent of placentas and 83 percent of fetuses had Zika RNA at or below the level of detection, while the placebo group exhibited significantly higher levels of placental and fetal Zika RNA. Mice vaccinated with either vaccine had significantly higher rates of fetal viability; whereas 100 percent of fetuses from mice vaccinated with the mRNA vaccine were born, none survived to term in the placebo group. A working group funded by the Wellcome Trust recently approved ethical guidelines for testing such vaccines in pregnant women, normally excluded from drug trials.  <br><br>Communicated by: ProMED-mail\\. It is reassuring to learn that at least 2 vaccines are now entering clinical trials in women. Although anti-Zika virus drugs are under development, preventing infection through vaccination seems to be the most effective measure to prevent fetal infection and adverse effects of the virus infection in adults. - Mod.TY ","keywordsMatched":[]}},"Qatar":{},"Romania":{"502":{"title":"Measles update (43): Asia and Pacific, Europe, demographics\r\n\t","date":["26","Aug","2017"],"url":"promedPRO/EDR> Measles update (43): Asia and Pacific, Europe, demographics\r\n\t[EXTERNAL]","summary":"<br><br><strong> Measles immunity gaps -</strong><br> 5 Role of demographics  Sat 26 Aug 2017 Source: News-Medical/Life Sciences edited Even if the incidence of measles infection has decreased by at least 90 per cent worldwide since the introduction of the vaccine, measles is still one of the major causes of death in children among vaccine-preventable diseases. Regular measles epidemics are reported in developing countries and recurrent episodic outbreaks occur in the developed world. A new study by Bocconi University and Bruno Kessler Foundation analyzing 9 countries (Australia, Ethiopia, Kenya, Ireland, Italy, South Korea, Singapore, the United Kingdom, and the United States) and published in The Lancet Infectious Diseases see reference below, highlights the role played by demographics in the spread of measles and concludes that future vaccination strategies in high-fertility countries should focus on increasing childhood immunization rates, while immunization campaigns targeting adolescents and young adults are required in low fertility countries. Using a transmission model calibrated on historical serological data the authors estimate that the susceptible proportion of the population (that is, unprotected against the infection) varies from about 3 per cent in the UK to more than 12.5 per cent in Ethiopia, with astonishing differences in its age composition, due to different vaccination strategies and divergent demographic trends. While the percentage of over-15 among susceptible individuals in Ethiopia and Kenya is, respectively, 28 per cent and 43 per cent, adolescents and young adults represent 74 per cent of unprotected individuals in South Korea, 66 per cent in Italy and 53 per cent in the US, with considerable immunity gaps in individuals aged 30-40 years. \"Every effort to increase the vaccination coverage rate among children is praiseworthy\", says Alessia Melegaro, a Bocconi professor and principal investigator of DECIDE, the ERC European Research Council-funded project which produced the article, \"but in some developed countries it's the lack of coverage among adolescents and adults that poses a serious threat to the goal of eliminating measles.\" \"Measles incidence could increase, in the next decades, in Italy, Australia, and Singapore and Ethiopia is at high risk of future large epidemics\", says Stefano Merler from Bruno Kessler Foundation, \"and this is particularly worrying considering that individuals get infected later in life when the disease is more severe. The median age at infection for 2015 was estimated to be 5-10 years in the UK, Ireland, and Ethiopia; 10-15 years in the USA, Australia, Singapore, and Kenya; and older than 20 years in Italy and South Korea\". The proposed model shows that the introduction of the measles vaccine, which occurred at different times in the 9 countries, has considerably reduced the disease burden in terms of disability-adjusted life-years (DALYs), a measure expressed as the number of years lost because of illness, disability, or early death. Every vaccine dose averts 2 or 3 weeks of DALYs in the developed world and around 20 weeks in Kenya and Ethiopia. Which translates into 2-mln years 2 million DALYs since the vaccine introduction in the UK, 13-mln 13 million DALYs in the US, and 36-mln 36 million DALYs in Ethiopia. \"Vaccination has undoubtedly achieved incredible results in terms of public health. In particular,\" continues Prof Melegaro \"our analysis showed that routine 1st dose vaccine administration has been responsible for more than 90 per cent of the overall number of vaccine-immunized individuals in most countries. In Ethiopia and Kenya, catch-up and follow-up campaigns substantially mitigated the effect of suboptimum routine vaccine coverage, generating 25-45 per cent of the immunized fraction of the population. Tailoring immunization campaigns to achieve measles eradication goals is essential and currently, for some countries, this means considering also the role of unprotected adolescents and young adults. Measles immunity gaps and the progress towards elimination: a multi-country modelling analysis. Lancet Infect Dis. 2017. pii: S1473-3099(17)30421-8. Epub ahead of print; . While it is recommended that children get 2 doses of MMR (measles, mumps, rubella) vaccine, starting with the 1st dose at 12 through 15 months of age, and the 2nd dose at 4 through 6 years of age, this study emphasizes that it is important that adolescents and young adults also are up to date on their MMR vaccination. - Mod.LK ","keywordsMatched":[]}},"Russia":{},"Russian Federation":{},"Rwanda":{},"St Kitts and Nevis":{},"St Lucia":{},"St Martin":{},"Saint Vincent and the Grenadines":{},"Samoa":{"503":{"title":"Dengue/DHF update (10): Asia, Pacific, Africa, research, WHO\r\n\t","date":["25","Aug","2017"],"url":"promedPRO/EDR> Dengue/DHF update (10): Asia, Pacific, Africa, research, WHO\r\n\t[EXTERNAL]","summary":" 3 WHO update  The 15 Aug 2017 Source: WHO Western Pacific region edited Dengue situation update no.<br><br><strong> 523 - Northern hemisphere -</strong><br> Cambodia As of 8 Aug 2017, a total of 1604 suspected dengue fever cases were reported in 2017. The total number of reported dengue cases including dengue haemorrhagic fever and dengue shock syndrome was lower than the 3 year-threshold of the same period from 2014-2016. China As of 31 Jul 2017, there were 503 cases of dengue reported in China in 2017. This number is higher than that reported during the same period since 2012 but follows historical trend. Lao PDR People's Democratic Republic As of 4 Aug 2017, there were 5740 cases of dengue with 7 deaths reported in Lao PDR in 2017, with 406 cases reported in epi week 31 (week ending 5 Aug 2017). Dengue activity is high with the number of dengue cases reported this year 2017 being higher than the cases reported for same period since 2014. Malaysia In week 31 of 2017 (week ending 5 Aug 2017), 1899 dengue cases were reported with 2 deaths, an increase of 1.1 per cent compared with week 30. As of week 31, the cumulative number of dengue cases in 2017 were 59 521 with 135 deaths compared with 67 437 cases with 147 deaths during the same period in 2016. Philippines (no update) A total of 43 770 dengue cases were reported nationwide from 1 Jan to 1 Jul 2017. This number is 36.8 per cent lower (25 527) compared with the same time period in 2016. Singapore As of 5 Aug 2017, there were 1732 dengue cases reported in Singapore since January 2017. This is lower than the number of reported cases during the same period since 2013. During week 31, there were 61 cases reported and the number of reported cases in 2017 remains lower than those reported for the same time period in 2016 . Viet Nam As of 3 Aug 2017, there were 80 555 cases of dengue reported in Viet Nam including 22 deaths. Compared with the same period in 2016, the cumulative number of cases increased by 33.5 per cent, and the number of deaths rose by 5. Most cases were reported from the South (59 per cent). A sharp increase in the number of reported cases has been observed in the North (almost 25 times higher than the same period last year 2016), especially from Ha Noi, with about 13 440 cases.<br><br><strong> Southern hemisphere -</strong><br> Australia As of 31 Jul 2017, there were 695 laboratory-confirmed dengue cases reported in Australia in 2017. The number of cases reported is lower than that reported during the same time period in the previous years (2012-2016).<br><br><strong> Pacific Islands countries and areas -</strong><br> French Polynesia In French Polynesia, 12 cases (including 1 death) in week 29 and 12 cases in week 30 (week ending 29 Jul 2017). Among these, 15 cases were confirmed as DENV-1 infection. New Caledonia (no update) As of 1 Aug 2017, 4,452 dengue cases were reported in 2017. There is a downward trend in the number of reported cases since week 16 (week ending 22 Apr 2017).  communicated by: ProMED-mail ","keywordsMatched":[]}},"San Marino":{},"Sao Tome and Principe":{},"Saudi Arabia":{"742":{"title":"MERS-CoV (56): UAE, Saudi Arabia (JF, HA, RI),\r\n\tWHO ","date":["29","Aug","2017"],"url":"promedPRO/AH/EDR> MERS-CoV (56): UAE, Saudi Arabia (JF, HA, RI),\r\n\tWHO [EXTERNAL]","summary":" 2 Saudi Arabia, 7 new cases - Saudi MOH 19-29 Aug 2017  Tue 29 Aug 2017 Source: Saudi MOH 19-29 Aug 2017 edited As of Tue 29 Aug 2017, there have been a total of: 1708 laboratory-confirmed cases of MERS-CoV infection, including 688 deaths reported case fatality rate 40.3 percent, 997 recoveries, and 22 currently active cases/infections. As previously mentioned, the numbers of deaths, recoveries, and currently active cases come from my spreadsheet tallies and differ from those listed on the Saudi MOH website; my spreadsheet counts asymptomatic infections. One complication is the reporting of cases as either recoveries or deaths that cannot be confirmed as previously reported newly confirmed cases. - Mod.MPP Since the last ProMED-mail update Fri 18 Aug 2017, there have been a total of: 7 newly confirmed cases 1 newly reported fatality, and 6 newly reported recoveries. Information on newly reported cases (7 cases):  27 Aug 2017 (1 case) 1- A 33-year-old Saudi female, non-healthcare worker from Dawmat Aljandal Al Jawf region noted to be in stable condition. Classified as a primary case with high risk exposure history still under investigation at time of report.  26 Aug 2017 (3 cases) 2- A 10-year-old Saudi female, non-healthcare worker from Dawmat Aljandal Al Jawf region noted to be in stable condition, having been identified as an asymptomatic contact of a previously confirmed case. Classified as a secondary case in a household contact. 3- A 14-year-old Saudi female, non-healthcare worker from Dawmat Aljandal Al Jawf region noted to be in stable condition, having been identified as an asymptomatic contact of a previously confirmed case. Classified as a secondary case in a household contact. 4- A 50-year-old Saudi male, non-healthcare worker from Dawmat Aljandal Al Jawf region noted to be in stable condition. Classified as a secondary case in a household contact.  24 Aug 2017 (2 cases) 5- A 40-year-old Saudi female, non-healthcare worker from Dawmat Aljandal Al Jawf region noted to be in stable condition. Classified as a primary case with high risk exposure history still under investigation. 6- A 46-year-old Saudi male, non-healthcare worker from Hayel 'il region, noted to be in critical condition. Classification still under review at the time of initial report.  21 Aug 2017 (1 case) 7- A 48-year-old Saudi male, non-healthcare worker from Alaflaj Riyadh region noted to be in stable condition. Classified as a primary case with a history of direct contact with camels in the 14 days preceding onset of illness. Information on newly reported fatality (1 fatality)  27 Aug 2017 - A 67-year-old expat male, non-healthcare worker from Madinah Al Madinah region with a history of pre-existing co-morbidities reported as a newly confirmed case on 15 Aug 2017 noted to be in stable condition. Classified as a primary case with a history of indirect contact with camels in the 14 days preceding onset of illness. - Mod.MPP Information on newly reported recoveries (6 recoveries)  25 Aug 2017 (1 recovery) 1- A 17-year-old Saudi male, non-healthcare worker from Dawmat Aljandal Al Jawd region with no history of co-morbidities. reported as a newly confirmed case on 7 Aug 2017 at which time he was noted to be in stable condition. Classified as a secondary case in a household contact. - Mod.MPP  24 Aug 2017 (1 recovery) 2- A 12-year-old Saudi male, non-healthcare worker from Dawmat Aljandal Al Jawd region with no history of co-morbidities. reported as a newly confirmed case on 7 Aug 2017 at which time he was noted to be in stable condition having been identified as an asymptomatic contact of a previously confirmed case. Classified as a secondary infection in a household contact. - Mod.MPP  21 Aug 2017 (3 recoveries) 3- A 25-year-old expat female, healthcare worker from Dawmat Aljandal Al Jawd region with no history of co-morbidities. reported as a newly confirmed case on 6 Aug 2017 at which time she was noted to be in stable condition having been identified as an asymptomatic contact of a previously confirmed case. Classified as a secondary healthcare acquired infection in a healthcare worker. - Mod.MPP 4- A 27-year-old expat female, healthcare worker from Dawmat Aljandal Al Jawd region with no history of co-morbidities. reported as a newly confirmed case on 8 Aug 2017 at which time she was noted to be in stable condition having been identified as an asymptomatic contact of a previously confirmed case. Classified as a secondary healthcare acquired infection in a healthcare worker. - Mod.MPP 5- A 49-year-old expat male, healthcare worker from Dawmat Aljandal Al Jawd region with no history of co-morbidities. reported as a newly confirmed case on 8 Aug 2017 at which time he was noted to be in stable condition having been identified as an asymptomatic contact of a previously confirmed case. Classified as a secondary healthcare acquired infection in a healthcare worker. - Mod.MPP  20 Aug 2017 (1 recovery) 6- A 44-year-old expat female, non-healthcare worker from Jeddah Makkah region with a history of pre-existing co-morbidities. reported as a newly confirmed case on 4 Aug 2017 at which time she was noted to be in stable condition. Classified as a secondary case in a household contact. Note that there was a recovery reported in a 44-year-old expat female on 15 Aug 2017, suggesting either this is a duplicate report or there was a 2nd 44 year old expat female from Jeddah reported that did not appear on the newly confirmed case reports on the Saudi MOH website. - Mod.MPP  <br><br>Communicated by: ProMED-mail\\. In the 11 day period since the last update, there have been 7 newly confirmed cases reported of whom 5 were from Dawmat Aljandal (Al Jawf region), the location that had nosocomial transmission identified since the beginning of this past month July 2017. Clearly transmission is continuing in this area, with 3 newly confirmed secondary cases in household contacts - at least 2 of whom were identified through screening of asymptomatic household contacts, and 2 additional cases in which high risk exposures are still under investigation. We do not know if these household contacts are associated with the earlier identified transmission chain in Dawmat Aljandal or if these are newly identified chains of transmission. The other 2 newly confirmed cases involve \"sporadic\" cases - an individual in Hail whose high risk exposure history is still under investigation, and an individual from Alaflaj (Riyadh region) with a history of direct contact with camels in the 14 days preceding onset of illness. As to be expected, concern is being voiced on the international level with the upcoming Hajj and this recent increase in cases reported both in Saudi Arabia and in the UAE. We now have gone through 5 Hajj periods since the identification of the MERS-CoV and to date there have been no cases of MERS-CoV infection identified in returning Hajjis. The case in the UAE (see section 1 above) actually had onset of illness over 1 month ago with no secondary cases/infections identified among known contacts of this case. As for the cases in Saudi Arabia, and more specifically the Hajj, population movement is very well defined during the Hajj, no camels are permitted in the areas where Hajjis are congregated, and there are Hajj specific health services that are separate from those that are available for the general Saudi population, all factors that are reducing the likelihood of Hajjis having inadvertent (or intentional) high risk exposures. Hopefully my optimism is well placed and we will pass through a 6th Hajj period without impact on international transmission of the MERS-CoV associated with this Hajj. - Mod.MPP ","keywordsMatched":[]}},"Senegal":{},"Serbia":{},"Seychelles":{},"Sierra Leone":{},"Singapore":{"502":{"title":"Measles update (43): Asia and Pacific, Europe, demographics\r\n\t","date":["26","Aug","2017"],"url":"promedPRO/EDR> Measles update (43): Asia and Pacific, Europe, demographics\r\n\t[EXTERNAL]","summary":"<br><br><strong> Measles immunity gaps -</strong><br> 5 Role of demographics  Sat 26 Aug 2017 Source: News-Medical/Life Sciences edited Even if the incidence of measles infection has decreased by at least 90 per cent worldwide since the introduction of the vaccine, measles is still one of the major causes of death in children among vaccine-preventable diseases. Regular measles epidemics are reported in developing countries and recurrent episodic outbreaks occur in the developed world. A new study by Bocconi University and Bruno Kessler Foundation analyzing 9 countries (Australia, Ethiopia, Kenya, Ireland, Italy, South Korea, Singapore, the United Kingdom, and the United States) and published in The Lancet Infectious Diseases see reference below, highlights the role played by demographics in the spread of measles and concludes that future vaccination strategies in high-fertility countries should focus on increasing childhood immunization rates, while immunization campaigns targeting adolescents and young adults are required in low fertility countries. Using a transmission model calibrated on historical serological data the authors estimate that the susceptible proportion of the population (that is, unprotected against the infection) varies from about 3 per cent in the UK to more than 12.5 per cent in Ethiopia, with astonishing differences in its age composition, due to different vaccination strategies and divergent demographic trends. While the percentage of over-15 among susceptible individuals in Ethiopia and Kenya is, respectively, 28 per cent and 43 per cent, adolescents and young adults represent 74 per cent of unprotected individuals in South Korea, 66 per cent in Italy and 53 per cent in the US, with considerable immunity gaps in individuals aged 30-40 years. \"Every effort to increase the vaccination coverage rate among children is praiseworthy\", says Alessia Melegaro, a Bocconi professor and principal investigator of DECIDE, the ERC European Research Council-funded project which produced the article, \"but in some developed countries it's the lack of coverage among adolescents and adults that poses a serious threat to the goal of eliminating measles.\" \"Measles incidence could increase, in the next decades, in Italy, Australia, and Singapore and Ethiopia is at high risk of future large epidemics\", says Stefano Merler from Bruno Kessler Foundation, \"and this is particularly worrying considering that individuals get infected later in life when the disease is more severe. The median age at infection for 2015 was estimated to be 5-10 years in the UK, Ireland, and Ethiopia; 10-15 years in the USA, Australia, Singapore, and Kenya; and older than 20 years in Italy and South Korea\". The proposed model shows that the introduction of the measles vaccine, which occurred at different times in the 9 countries, has considerably reduced the disease burden in terms of disability-adjusted life-years (DALYs), a measure expressed as the number of years lost because of illness, disability, or early death. Every vaccine dose averts 2 or 3 weeks of DALYs in the developed world and around 20 weeks in Kenya and Ethiopia. Which translates into 2-mln years 2 million DALYs since the vaccine introduction in the UK, 13-mln 13 million DALYs in the US, and 36-mln 36 million DALYs in Ethiopia. \"Vaccination has undoubtedly achieved incredible results in terms of public health. In particular,\" continues Prof Melegaro \"our analysis showed that routine 1st dose vaccine administration has been responsible for more than 90 per cent of the overall number of vaccine-immunized individuals in most countries. In Ethiopia and Kenya, catch-up and follow-up campaigns substantially mitigated the effect of suboptimum routine vaccine coverage, generating 25-45 per cent of the immunized fraction of the population. Tailoring immunization campaigns to achieve measles eradication goals is essential and currently, for some countries, this means considering also the role of unprotected adolescents and young adults. Measles immunity gaps and the progress towards elimination: a multi-country modelling analysis. Lancet Infect Dis. 2017. pii: S1473-3099(17)30421-8. Epub ahead of print; . While it is recommended that children get 2 doses of MMR (measles, mumps, rubella) vaccine, starting with the 1st dose at 12 through 15 months of age, and the 2nd dose at 4 through 6 years of age, this study emphasizes that it is important that adolescents and young adults also are up to date on their MMR vaccination. - Mod.LK ","keywordsMatched":[]},"503":{"title":"Dengue/DHF update (10): Asia, Pacific, Africa, research, WHO\r\n\t","date":["25","Aug","2017"],"url":"promedPRO/EDR> Dengue/DHF update (10): Asia, Pacific, Africa, research, WHO\r\n\t[EXTERNAL]","summary":" 3 WHO update  The 15 Aug 2017 Source: WHO Western Pacific region edited Dengue situation update no.<br><br><strong> 523 - Northern hemisphere -</strong><br> Cambodia As of 8 Aug 2017, a total of 1604 suspected dengue fever cases were reported in 2017. The total number of reported dengue cases including dengue haemorrhagic fever and dengue shock syndrome was lower than the 3 year-threshold of the same period from 2014-2016. China As of 31 Jul 2017, there were 503 cases of dengue reported in China in 2017. This number is higher than that reported during the same period since 2012 but follows historical trend. Lao PDR People's Democratic Republic As of 4 Aug 2017, there were 5740 cases of dengue with 7 deaths reported in Lao PDR in 2017, with 406 cases reported in epi week 31 (week ending 5 Aug 2017). Dengue activity is high with the number of dengue cases reported this year 2017 being higher than the cases reported for same period since 2014. Malaysia In week 31 of 2017 (week ending 5 Aug 2017), 1899 dengue cases were reported with 2 deaths, an increase of 1.1 per cent compared with week 30. As of week 31, the cumulative number of dengue cases in 2017 were 59 521 with 135 deaths compared with 67 437 cases with 147 deaths during the same period in 2016. Philippines (no update) A total of 43 770 dengue cases were reported nationwide from 1 Jan to 1 Jul 2017. This number is 36.8 per cent lower (25 527) compared with the same time period in 2016. Singapore As of 5 Aug 2017, there were 1732 dengue cases reported in Singapore since January 2017. This is lower than the number of reported cases during the same period since 2013. During week 31, there were 61 cases reported and the number of reported cases in 2017 remains lower than those reported for the same time period in 2016 . Viet Nam As of 3 Aug 2017, there were 80 555 cases of dengue reported in Viet Nam including 22 deaths. Compared with the same period in 2016, the cumulative number of cases increased by 33.5 per cent, and the number of deaths rose by 5. Most cases were reported from the South (59 per cent). A sharp increase in the number of reported cases has been observed in the North (almost 25 times higher than the same period last year 2016), especially from Ha Noi, with about 13 440 cases.<br><br><strong> Southern hemisphere -</strong><br> Australia As of 31 Jul 2017, there were 695 laboratory-confirmed dengue cases reported in Australia in 2017. The number of cases reported is lower than that reported during the same time period in the previous years (2012-2016).<br><br><strong> Pacific Islands countries and areas -</strong><br> French Polynesia In French Polynesia, 12 cases (including 1 death) in week 29 and 12 cases in week 30 (week ending 29 Jul 2017). Among these, 15 cases were confirmed as DENV-1 infection. New Caledonia (no update) As of 1 Aug 2017, 4,452 dengue cases were reported in 2017. There is a downward trend in the number of reported cases since week 16 (week ending 22 Apr 2017).  communicated by: ProMED-mail ","keywordsMatched":[]}},"Slovakia":{},"Slovenia":{},"Solomon Islands":{},"Somalia":{},"Somaliland":{},"South Africa":{"493":{"title":"Avian influenza (131): South Africa (WC) HPAI H5N8,\r\n\tpoultry, other avian ","date":["26","Aug","2017"],"url":"promedPRO/AH/EDR> Avian influenza (131): South Africa (WC) HPAI H5N8,\r\n\tpoultry, other avian [EXTERNAL]","summary":"   Sat 26 Aug 2017, 7:59AM Source: IOL News edited South Africa has reported 8 more cases of the H5N8 highly pathogenic avian influenza (HPAI) to the World Organization for Animal Health (OIE), the Department of Agriculture, Forestry and Fisheries (DAFF) said. \"These new outbreaks bring the total number of outbreaks to 24 since June 2017: 10 outbreaks in commercial chickens, 3 outbreaks in commercial ostrich, 5 outbreaks in wild birds, 3 outbreak in birds that were kept as a hobby and 3 outbreaks in backyard poultry,\" spokesperson Bomikazi Molapo said in a statement on Fri 25 Aug 2017. \"All affected properties have been placed under quarantine and disease control measures have commenced. The continued cooperation of the public and the poultry industry, in the timely reporting of sick and dying birds to Government Veterinary Services, is vital for the effectiveness of disease control measures instituted. DAFF therefore thanks the public and the poultry industry for their support in this regard.\" Molapo said that in his meeting with the industry on Mon 21 Aug 2017, Minister Senzeni Zokwana, they raised concerns on compensation and guidelines relating to the principles and guidelines of compensating affected farms sic. He said that the draft guidelines had been completed and were subject to ministerial approval. The approved guidelines would be released to the industry and public by 1 Sep 2017. \"The industry also requested to be given permission to import fertile eggs to close the supply gap as a result of culled birds. Only 1 company has submitted an application on 24 Aug 2017 for the importation of hatching eggs; the department is still performing the prescribed risk analyses to determine the appropriate level of risk,\" Molapo said. \"We need to conduct a thorough risk assessment in order to avoid exposing the country to other disease risks. The basic work has been conducted and there are 2 options which will be presented to the poultry industry. The 1st one is for the risk mitigation to be conducted in South Africa through stringent quarantine measures on arrival of the hatching eggs from their country of origin.\" Molapo said that the 2nd option would be for stringent quarantine measures in the country of origin where eggs will come from compartments free of specified diseases that DAFF would approve, with less stringent post arrival quarantine measures. It addresses 2 new outbreaks. In one of them, on an ostrich commercial farm in Hessequa, Western province, 22 out of a population of 1069 ostriches were clinically affected without death; culling or slaughter have not been applied. The other outbreak was recorded on a poultry farm in the City of Cape Town, Western Cape province, where out of a population of 140 000 \"birds\", 10 000 died, with or without clinically signs observed. - Mod.AS   . ","keywordsMatched":[]},"503":{"title":"Dengue/DHF update (10): Asia, Pacific, Africa, research, WHO\r\n\t","date":["25","Aug","2017"],"url":"promedPRO/EDR> Dengue/DHF update (10): Asia, Pacific, Africa, research, WHO\r\n\t[EXTERNAL]","summary":" 3 WHO update  The 15 Aug 2017 Source: WHO Western Pacific region edited Dengue situation update no.<br><br><strong> 523 - Northern hemisphere -</strong><br> Cambodia As of 8 Aug 2017, a total of 1604 suspected dengue fever cases were reported in 2017. The total number of reported dengue cases including dengue haemorrhagic fever and dengue shock syndrome was lower than the 3 year-threshold of the same period from 2014-2016. China As of 31 Jul 2017, there were 503 cases of dengue reported in China in 2017. This number is higher than that reported during the same period since 2012 but follows historical trend. Lao PDR People's Democratic Republic As of 4 Aug 2017, there were 5740 cases of dengue with 7 deaths reported in Lao PDR in 2017, with 406 cases reported in epi week 31 (week ending 5 Aug 2017). Dengue activity is high with the number of dengue cases reported this year 2017 being higher than the cases reported for same period since 2014. Malaysia In week 31 of 2017 (week ending 5 Aug 2017), 1899 dengue cases were reported with 2 deaths, an increase of 1.1 per cent compared with week 30. As of week 31, the cumulative number of dengue cases in 2017 were 59 521 with 135 deaths compared with 67 437 cases with 147 deaths during the same period in 2016. Philippines (no update) A total of 43 770 dengue cases were reported nationwide from 1 Jan to 1 Jul 2017. This number is 36.8 per cent lower (25 527) compared with the same time period in 2016. Singapore As of 5 Aug 2017, there were 1732 dengue cases reported in Singapore since January 2017. This is lower than the number of reported cases during the same period since 2013. During week 31, there were 61 cases reported and the number of reported cases in 2017 remains lower than those reported for the same time period in 2016 . Viet Nam As of 3 Aug 2017, there were 80 555 cases of dengue reported in Viet Nam including 22 deaths. Compared with the same period in 2016, the cumulative number of cases increased by 33.5 per cent, and the number of deaths rose by 5. Most cases were reported from the South (59 per cent). A sharp increase in the number of reported cases has been observed in the North (almost 25 times higher than the same period last year 2016), especially from Ha Noi, with about 13 440 cases.<br><br><strong> Southern hemisphere -</strong><br> Australia As of 31 Jul 2017, there were 695 laboratory-confirmed dengue cases reported in Australia in 2017. The number of cases reported is lower than that reported during the same time period in the previous years (2012-2016).<br><br><strong> Pacific Islands countries and areas -</strong><br> French Polynesia In French Polynesia, 12 cases (including 1 death) in week 29 and 12 cases in week 30 (week ending 29 Jul 2017). Among these, 15 cases were confirmed as DENV-1 infection. New Caledonia (no update) As of 1 Aug 2017, 4,452 dengue cases were reported in 2017. There is a downward trend in the number of reported cases since week 16 (week ending 22 Apr 2017).  communicated by: ProMED-mail ","keywordsMatched":[]},"741":{"title":"Avian influenza (132): South Africa (WC) HPAI H5 poultry,\r\n\tH5N8 susp ","date":["28","Aug","2017"],"url":"promedPRO/AH/EDR> Avian influenza (132): South Africa (WC) HPAI H5 poultry,\r\n\tH5N8 susp [EXTERNAL]","summary":"   Mon 28 Aug 2017, 00:11 AM Source: IOL edited Avian flu has spread to a commercial layer poultry farm in the Western Cape province, killing at least 30 000 chickens. There are 140 000 chickens on the affected farm in the Paardeberg region, according to the provincial department of agriculture head of communication, Petro van Rhyn. She confirmed that at least 30 000 have died and said the rest would be culled. The virus has not yet been confirmed as the highly pathogenic avian influenza (HPAI) type H5N8, which is the strain in outbreaks in other parts of the country. However, the H5 typing, and the nature of its effect on chickens, is indicative of it being the H5N8 strain, according to the department. The poultry industry raised concerns related to the principles and guidelines of compensating affected farms during a meeting with Zokwana last week. The draft guidelines have been completed and are subject to ministerial approval, Molapo said. The approved guidelines will be released by 1 Sep 2017. \"The industry also requested to be given permission to import fertile eggs to close the supply gap as a result of culled birds. \"Only one company has submitted an application for the importation of hatching eggs; the department is still performing the prescribed risk analyses to determine the appropriate level of risk. \"We need to conduct a thorough risk assessment in order to avoid exposing the country to other disease risks,\" Molapo said. There are 2 options which will be presented to the poultry industry - the 1st is for risk mitigation to be conducted in SA through stringent quarantine measures on arrival of the hatching eggs from their country of origin. The 2nd option is for stringent quarantine measures in the country of origin where eggs will come from compartments free of specified diseases that Daff will approve, with less stringent post-arrival quarantine measures. In Heidelberg a Western Cape town, 3 ostrich farms have tested positive for avian flu. No birds have died on the farms but they remain under quarantine. The 2 farms each have about 1000 ostriches. Van Rhyn said no decision to cull ostriches has been taken yet. She also said chicken in stores was safe for consumption. Bronwynne Jooste, spokesperson for Tourism, Economic Development and Agriculture MEC Alan Winde, said culling of the rest of the chickens and composting of mortalities had already been started. Last week, the department's Veterinary Services programme confirmed the disease had spread to the farm. \"The cause is most likely through contact with wild birds. Since then, meetings with poultry veterinarians and stakeholders such as the National Institute for Communicable Diseases have taken place,\" Jooste said. The farm has been placed under quarantine. She said farms within a 3 km approx 1.8 mi zone of an infected farm would be monitored closely and subjected to the control measures as laid out by the national Department of Agriculture, Fisheries and Forestry (Daff) \"It is strongly recommended that any movement of pet birds, racing pigeons, breeding birds and show birds be limited as far as possible and covered by a movement permit if coming from within 30 km approx 18 mi of an infected farm,\" said Jooste. Sick or dead birds - both wild birds and poultry - must be reported to local state vets, and exports of poultry and poultry products have been suspended except from poultry compartments registered with Daff, or where a country's import permit contains clauses that are able to be signed by a certifying veterinarian. Winde said the virus presented a challenge to control, but the vets were working hard to contain the spread. \"This is a priority for the poultry industry, and the entire agriculture sector. The outbreak and the current drought have made agriculture a tough space to be in. \"This is a particularly difficult time for those affected farms, which are important employers. This is why we ask all stakeholders to continue working with us to mitigate the impact of this outbreak on our economy,\" Winde said. Avian flu is a viral respiratory disease among birds, believed to be transmitted by wild migratory birds. The H5N8 strain of the disease has already wreaked havoc in the poultry industry in Zimbabwe, where thousands of commercial birds have died or had to be culled. Bomikazi Molapo, spokesperson for Daff Minister Senzeni Zokwana, said South Africa had reported 8 further cases of HPAI H5N8 to the World Organisation for Animal Health see comment. This brings the total number of outbreaks to 24 since June this year 2017. \"All affected properties have been placed under quarantine and disease control measures have commenced,\" she said. Byline: Lisa Isaacs  <br><br>Communicated by: ProMED-mail\\. Since the start of the HPAI H5N8 epizootic in South Africa, in June 2017, the identified foci have been reported to the OIE in 2 separate threads: one addresses outbreaks involving \"poultry\", which is defined as \"all domesticated birds, including backyard poultry, used for the production of meat or eggs for consumption, for the production of other commercial products, for restocking supplies of game, or for breeding these categories of birds, as well as fighting cocks used for any purpose\". This thread includes, as of today 29 Aug 2017, an accumulated total of 16 outbreaks. The other thread addresses \"non-poultry including wild birds\". \"Non poultry\" are defined as \"Birds that are kept in captivity for any reason other than those reasons referred to in the preceding paragraph, including those that are kept for shows, races, exhibitions, competitions or for breeding or selling these categories of birds as well as pet birds, are not considered to be poultry\". This thread includes, as of today 29 Aug 2017, has a total of 8 \"outbreaks\". OIE's updated summary of HPAI H5N8 in \"poultry\" (ostriches, layers, chickens): Total outbreaks = 16 (submitted) Species / Susceptible / Cases / Deaths / Killed and disposed of / Slaughtered Birds / 2 131 804 / 47 843 / 47 766 / 622 278 / 0 OIE's updated summary of HPAI H5N8 in \"non-poultry and wild birds\": Total outbreaks = 8 (submitted) Species / Susceptible / Cases / Deaths / Killed and disposed of / Slaughtered 1. \"Non poultry\": Birds / 121 / 35 / 33 / 0/ 0 Southern Masked-Weaver / - / 4 / 2 / 0 / 0 2. Wild birds Yellow-billed Duck / - / 1 / 1 / 0 / 0 Egyptian Goose / - / 1 / 0 / 0 / 0 House Sparrow / - / 3 / 1 / 0 / 0 Sacred Ibis / - / 1 / 1 / 0 / 0 In case the HPAI H5 virus, found as the cause of the current event , is eventually identified as H5N8, this outbreak on a commercial layers farm will become South Africa's 25th outbreak in \"poultry, non-poultry and wild birds\" since 19 Jun 2017. - Mod.AS Heidelberg is a town in the Western Cape, located near South Africa's south coast . - CopyEd.AO   . ","keywordsMatched":[]},"760":{"title":"Foot & mouth disease - South Africa (02): (LP) bovine,\r\n\tserotype SAT 1, OIE ","date":["30","Aug","2017"],"url":"promedPRO/AH/EDR> Foot & mouth disease - South Africa (02): (LP) bovine,\r\n\tserotype SAT 1, OIE [EXTERNAL]","summary":"Removed from the susceptible population through death, destruction, and/or slaughter Epidemiology Source of the outbreak(s) or origin of infection: Contact with wild species Epidemiological comments: Outbreak is within South Africa's FMD protection zone, close to the Kruger National Park and does not affect the status of South Africa's FMD free zone. Coordinates have been modified to protect privacy as required by South African legislation. Control measures Measures applied: movement control inside the country; surveillance within containment and/or protection zone; screening; quarantine; vaccination prohibited no treatment of affected animals. Measures to be applied: vaccination in response to the outbreak(s). Diagnostic test results Laboratory name and type / Species / Test / Test date / Result Agricultural Research Council - Onderstepoort Veterinary Institute (ARC - OVI) (OIE Reference Laboratory) / Cattle / polymerase chain reaction (PCR) / 24 Aug 2017 / Positive Future reporting The event is continuing. Weekly follow-up reports will be submitted.  <br><br>Communicated by: ProMED-mail\\. According to South Africa's Animal Disease Status report dated 6 Apr 2017, FMD is limited to wildlife in the FMD control area of Kruger National Park and surrounding game reserves. The rest of South Africa is an OIE declared FMD-free zone.  . - Mod.CRD   . ","keywordsMatched":[]}},"South Korea":{"502":{"title":"Measles update (43): Asia and Pacific, Europe, demographics\r\n\t","date":["26","Aug","2017"],"url":"promedPRO/EDR> Measles update (43): Asia and Pacific, Europe, demographics\r\n\t[EXTERNAL]","summary":"<br><br><strong> Measles immunity gaps -</strong><br> 5 Role of demographics  Sat 26 Aug 2017 Source: News-Medical/Life Sciences edited Even if the incidence of measles infection has decreased by at least 90 per cent worldwide since the introduction of the vaccine, measles is still one of the major causes of death in children among vaccine-preventable diseases. Regular measles epidemics are reported in developing countries and recurrent episodic outbreaks occur in the developed world. A new study by Bocconi University and Bruno Kessler Foundation analyzing 9 countries (Australia, Ethiopia, Kenya, Ireland, Italy, South Korea, Singapore, the United Kingdom, and the United States) and published in The Lancet Infectious Diseases see reference below, highlights the role played by demographics in the spread of measles and concludes that future vaccination strategies in high-fertility countries should focus on increasing childhood immunization rates, while immunization campaigns targeting adolescents and young adults are required in low fertility countries. Using a transmission model calibrated on historical serological data the authors estimate that the susceptible proportion of the population (that is, unprotected against the infection) varies from about 3 per cent in the UK to more than 12.5 per cent in Ethiopia, with astonishing differences in its age composition, due to different vaccination strategies and divergent demographic trends. While the percentage of over-15 among susceptible individuals in Ethiopia and Kenya is, respectively, 28 per cent and 43 per cent, adolescents and young adults represent 74 per cent of unprotected individuals in South Korea, 66 per cent in Italy and 53 per cent in the US, with considerable immunity gaps in individuals aged 30-40 years. \"Every effort to increase the vaccination coverage rate among children is praiseworthy\", says Alessia Melegaro, a Bocconi professor and principal investigator of DECIDE, the ERC European Research Council-funded project which produced the article, \"but in some developed countries it's the lack of coverage among adolescents and adults that poses a serious threat to the goal of eliminating measles.\" \"Measles incidence could increase, in the next decades, in Italy, Australia, and Singapore and Ethiopia is at high risk of future large epidemics\", says Stefano Merler from Bruno Kessler Foundation, \"and this is particularly worrying considering that individuals get infected later in life when the disease is more severe. The median age at infection for 2015 was estimated to be 5-10 years in the UK, Ireland, and Ethiopia; 10-15 years in the USA, Australia, Singapore, and Kenya; and older than 20 years in Italy and South Korea\". The proposed model shows that the introduction of the measles vaccine, which occurred at different times in the 9 countries, has considerably reduced the disease burden in terms of disability-adjusted life-years (DALYs), a measure expressed as the number of years lost because of illness, disability, or early death. Every vaccine dose averts 2 or 3 weeks of DALYs in the developed world and around 20 weeks in Kenya and Ethiopia. Which translates into 2-mln years 2 million DALYs since the vaccine introduction in the UK, 13-mln 13 million DALYs in the US, and 36-mln 36 million DALYs in Ethiopia. \"Vaccination has undoubtedly achieved incredible results in terms of public health. In particular,\" continues Prof Melegaro \"our analysis showed that routine 1st dose vaccine administration has been responsible for more than 90 per cent of the overall number of vaccine-immunized individuals in most countries. In Ethiopia and Kenya, catch-up and follow-up campaigns substantially mitigated the effect of suboptimum routine vaccine coverage, generating 25-45 per cent of the immunized fraction of the population. Tailoring immunization campaigns to achieve measles eradication goals is essential and currently, for some countries, this means considering also the role of unprotected adolescents and young adults. Measles immunity gaps and the progress towards elimination: a multi-country modelling analysis. Lancet Infect Dis. 2017. pii: S1473-3099(17)30421-8. Epub ahead of print; . While it is recommended that children get 2 doses of MMR (measles, mumps, rubella) vaccine, starting with the 1st dose at 12 through 15 months of age, and the 2nd dose at 4 through 6 years of age, this study emphasizes that it is important that adolescents and young adults also are up to date on their MMR vaccination. - Mod.LK ","keywordsMatched":[]}},"South Sudan":{"487":{"title":"Cholera, diarrhea & dysentery update (90): Africa ","date":["24","Aug","2017"],"url":"promedPRO/EDR> Cholera, diarrhea & dysentery update (90): Africa [EXTERNAL]","summary":"<br><br><strong> 3 Cholera - Sudan  Wed 23 Aug 2017 Source: UN Office for the Coordination of Humanitarian Affairs (OCHA), ReliefWeb, Radio Dabanga report edited South Darfur </strong><br> On Monday and Tuesday 21-22 Aug 2017 4 displaced people died of cholera and 49 others have been infected at camp Kalma in Nyala, capital of South Darfur. More deaths and infections have been reported from across the country as rates resurge along the Nile. Yagoub Abdallah, the general coordinator of displaced persons and refugee camps, told Radio Dabanga that \"the camp has seen a wide spread of cholera over the past 2 days.\" On Mon 21 Aug 2017, the camp's 2 health centers reported 1 death and 18 new cholera cases, and 3 deaths and 31 new cases on Tue 22 Aug 2017. Abdallah explained that the number of hospitalized cases in the 2 centers has amounted to 78 and pointed to the acute shortage of medicines in both centers. He appealed to the Ministry of Health and the WHO to speed up the provision of medicines and intravenous solutions.<br><br><strong> Central Darfur </strong><br> On Monday and Tuesday 21-22 Aug 2017, Nierteti in Central Darfur recorded 5 new cases of cholera. One of the Sheikhs of Nierteti camps told Radio Dabanga that 3 cases were recorded on 21 Aug 2017, 2 from the camps and 1 from neighboring villages of Nierteti. On 22 Aug 2017, 2 cases were recorded in Nierteti camps, bringing the number of hospitalized cases to 12.<br><br><strong> Sennar </strong><br> From Friday to Tuesday 18-22 Aug 2017, 18 people have been infected with cholera at El Dindir area in Sennar. Yesterday 22 Aug 2017, a medical source told Radio Dabanga that El Dindir Hospital received 2 new cases, this in addition to the existence of 6 hospitalized cases in the isolation ward. A medical source reported from El Bardana village entry of 1 case on Tue 22 Aug 2017, bringing the total number of cases in the isolation centre to 10 cases since 18 Aug 2017. Singa area reportedly witnessed a marked decrease in recent cases. The health source said Singa Hospital recorded 3 cases of cholera on Monday and Tuesday 21-22 Aug 2017.<br><br><strong> Khartoum </strong><br> Cholera in Khartoum state has re-spread after seeing a significant decrease during the past month. Yesterday 22 Aug 2017, an activist from the emergency room of Teiba El Ahamda told Radio Dabanga that El Ezba district health center has recorded 4 cases of cholera during the past 2 days. The activist attributed the emergence of cases to the rainfall and the terrible environmental degradation witnessed by the district due to the accumulation of waste. He pointed out that Bahri locality has stopped transporting the waste from Teiba El Ahamda for unknown reasons for 3 years. El Azhari Widaatallah, the chairman of the Legislative and Justice Committee of the Parliament, representative of Constituency 30 of Khartoum state of the districts of El Azhari, El Shajara, El Azozab, Lamab, Hamadab, pointed to the emergence of watery diarrhea in his constituency, especially at El Shajara. He attributed the deterioration of the health situation in the area to the lack of sewage system and the stagnation of rainwater. Health sources revealed the emergence of a number of cases of cholera in the academic hospital in Khartoum.<br><br><strong> Northern state </strong><br> In the Northern state, the isolation centre at Delgo Hospital received 3 new cases of cholera on Sun 20 Aug 2017. Nubian activist Ashraf Abdelwedoud warned in an interview with Radio Dabanga of the increasing rates of the disease following the rains and floods in the area in the past few days. He called on the authorities to make efforts to curb the spread of the disease. - Sr.Tech.Ed.MJ The mortality from cholera and most diarrheal illnesses is related to non-replacement of fluid and electrolytes from the diarrheal illness. As stated in Lutwick LI, Preis J, Choi P: Cholera. In: Chronic illness and disability: the pediatric gastrointestinal tract. Greydanus DE, Atay O, Merrick J (eds). NY: Nova Bioscience, 2017 (in press), oral rehydration therapy can be life-saving in outbreaks of cholera and other forms of diarrhea: \"As reviewed by Richard Guerrant et al (1), it was in 1831 that cholera treatment could be accomplished by intravenous replacement, and, although this therapy could produce dramatic improvements, not until 1960 was it 1st recognized that there was no true destruction of the intestinal mucosa, and gastrointestinal rehydration therapy could be effective, and the therapy could dramatically reduce the intravenous needs for rehydration. Indeed, that this rehydration could be just as effective given orally as through an orogastric tube (for example, refs 2 and 3) made it possible for oral rehydration therapy (ORT) to be used in rural remote areas and truly impact on the morbidity and mortality of cholera. Indeed, Guerrant et al (1) highlights the use of oral glucose-salt packets in war-torn Bangladeshi refugees, which reduced the mortality rate from 30 per cent to 3.6 per cent (4) and quotes sources referring to ORT as \"potentially the most important medical advance\" of the 20th century. A variety of formulations of ORT exist, generally glucose or rice powder-based, which contain a variety of micronutrients, especially zinc (5). \"The assessment of the degree of volume loss in those with diarrhea to approximate volume and fluid losses can be found in ref 6 below. Those with severe hypovolemia should be initially rehydrated intravenously with a fluid bolus of normal saline or Ringer's lactate solution of 20-30 ml/kg followed by 100 ml/kg in the 1st 4 hours and 100 ml/kg over the next 18 hours with regular reassessment. Those with lesser degrees of hypovolemia can be rehydrated orally with a glucose or rice-derived formula with up to 4 liters in the 1st 4 hours, and those with no hypovolemia can be given ORT after each liquid stool with frequent reevaluation.<br><br><strong> \"References </strong><br> 1. Guerrant RL, Carneiro-Filho BA, Dillingham RA. Cholera, diarrhea, and oral rehydration therapy: triumph and indictment. Clin Infect Dis. 2003; 37(3): 398-405; available at  . 2. Gregorio GV, Gonzales ML, Dans LF, Martinez EG. Polymer-based oral rehydration solution for treating acute watery diarrhoea. Cochrane Database Syst Rev. 2009; (2): CD006519. doi: 10.1002/14651858.CD006519.pub2; available at  . 3. Gore SM, Fontaine O, Pierce NF. Impact of rice based oral rehydration solution on stool output and duration of diarrhoea: meta-analysis of 13 clinical trials. BMJ 1992; 304(6822): 287-91; available at . 4. Mahalanabis D, Choudhuri AB, Bagchi NG, et al. Oral fluid therapy of cholera among Bangladesh refugees. Johns Hopkins Med 1973; 132(4): 197-205; available at  . 5. Atia AN, Buchman AL. Oral rehydration solutions in non-cholera diarrhea: a review. Am J Gastroenterol 2009; 104(10): 2596-604; abstract available at . 6. WHO. The treatment of diarrhoea, a manual for physicians and other senior health workers. 4th ed. 2005; available at:  . - Mod.LL ","keywordsMatched":[]}},"Spain":{},"Sri Lanka":{"503":{"title":"Dengue/DHF update (10): Asia, Pacific, Africa, research, WHO\r\n\t","date":["25","Aug","2017"],"url":"promedPRO/EDR> Dengue/DHF update (10): Asia, Pacific, Africa, research, WHO\r\n\t[EXTERNAL]","summary":" 3 WHO update  The 15 Aug 2017 Source: WHO Western Pacific region edited Dengue situation update no.<br><br><strong> 523 - Northern hemisphere -</strong><br> Cambodia As of 8 Aug 2017, a total of 1604 suspected dengue fever cases were reported in 2017. The total number of reported dengue cases including dengue haemorrhagic fever and dengue shock syndrome was lower than the 3 year-threshold of the same period from 2014-2016. China As of 31 Jul 2017, there were 503 cases of dengue reported in China in 2017. This number is higher than that reported during the same period since 2012 but follows historical trend. Lao PDR People's Democratic Republic As of 4 Aug 2017, there were 5740 cases of dengue with 7 deaths reported in Lao PDR in 2017, with 406 cases reported in epi week 31 (week ending 5 Aug 2017). Dengue activity is high with the number of dengue cases reported this year 2017 being higher than the cases reported for same period since 2014. Malaysia In week 31 of 2017 (week ending 5 Aug 2017), 1899 dengue cases were reported with 2 deaths, an increase of 1.1 per cent compared with week 30. As of week 31, the cumulative number of dengue cases in 2017 were 59 521 with 135 deaths compared with 67 437 cases with 147 deaths during the same period in 2016. Philippines (no update) A total of 43 770 dengue cases were reported nationwide from 1 Jan to 1 Jul 2017. This number is 36.8 per cent lower (25 527) compared with the same time period in 2016. Singapore As of 5 Aug 2017, there were 1732 dengue cases reported in Singapore since January 2017. This is lower than the number of reported cases during the same period since 2013. During week 31, there were 61 cases reported and the number of reported cases in 2017 remains lower than those reported for the same time period in 2016 . Viet Nam As of 3 Aug 2017, there were 80 555 cases of dengue reported in Viet Nam including 22 deaths. Compared with the same period in 2016, the cumulative number of cases increased by 33.5 per cent, and the number of deaths rose by 5. Most cases were reported from the South (59 per cent). A sharp increase in the number of reported cases has been observed in the North (almost 25 times higher than the same period last year 2016), especially from Ha Noi, with about 13 440 cases.<br><br><strong> Southern hemisphere -</strong><br> Australia As of 31 Jul 2017, there were 695 laboratory-confirmed dengue cases reported in Australia in 2017. The number of cases reported is lower than that reported during the same time period in the previous years (2012-2016).<br><br><strong> Pacific Islands countries and areas -</strong><br> French Polynesia In French Polynesia, 12 cases (including 1 death) in week 29 and 12 cases in week 30 (week ending 29 Jul 2017). Among these, 15 cases were confirmed as DENV-1 infection. New Caledonia (no update) As of 1 Aug 2017, 4,452 dengue cases were reported in 2017. There is a downward trend in the number of reported cases since week 16 (week ending 22 Apr 2017).  communicated by: ProMED-mail ","keywordsMatched":[]}},"Sudan":{"487":{"title":"Cholera, diarrhea & dysentery update (90): Africa ","date":["24","Aug","2017"],"url":"promedPRO/EDR> Cholera, diarrhea & dysentery update (90): Africa [EXTERNAL]","summary":"<br><br><strong> 3 Cholera - Sudan  Wed 23 Aug 2017 Source: UN Office for the Coordination of Humanitarian Affairs (OCHA), ReliefWeb, Radio Dabanga report edited South Darfur </strong><br> On Monday and Tuesday 21-22 Aug 2017 4 displaced people died of cholera and 49 others have been infected at camp Kalma in Nyala, capital of South Darfur. More deaths and infections have been reported from across the country as rates resurge along the Nile. Yagoub Abdallah, the general coordinator of displaced persons and refugee camps, told Radio Dabanga that \"the camp has seen a wide spread of cholera over the past 2 days.\" On Mon 21 Aug 2017, the camp's 2 health centers reported 1 death and 18 new cholera cases, and 3 deaths and 31 new cases on Tue 22 Aug 2017. Abdallah explained that the number of hospitalized cases in the 2 centers has amounted to 78 and pointed to the acute shortage of medicines in both centers. He appealed to the Ministry of Health and the WHO to speed up the provision of medicines and intravenous solutions.<br><br><strong> Central Darfur </strong><br> On Monday and Tuesday 21-22 Aug 2017, Nierteti in Central Darfur recorded 5 new cases of cholera. One of the Sheikhs of Nierteti camps told Radio Dabanga that 3 cases were recorded on 21 Aug 2017, 2 from the camps and 1 from neighboring villages of Nierteti. On 22 Aug 2017, 2 cases were recorded in Nierteti camps, bringing the number of hospitalized cases to 12.<br><br><strong> Sennar </strong><br> From Friday to Tuesday 18-22 Aug 2017, 18 people have been infected with cholera at El Dindir area in Sennar. Yesterday 22 Aug 2017, a medical source told Radio Dabanga that El Dindir Hospital received 2 new cases, this in addition to the existence of 6 hospitalized cases in the isolation ward. A medical source reported from El Bardana village entry of 1 case on Tue 22 Aug 2017, bringing the total number of cases in the isolation centre to 10 cases since 18 Aug 2017. Singa area reportedly witnessed a marked decrease in recent cases. The health source said Singa Hospital recorded 3 cases of cholera on Monday and Tuesday 21-22 Aug 2017.<br><br><strong> Khartoum </strong><br> Cholera in Khartoum state has re-spread after seeing a significant decrease during the past month. Yesterday 22 Aug 2017, an activist from the emergency room of Teiba El Ahamda told Radio Dabanga that El Ezba district health center has recorded 4 cases of cholera during the past 2 days. The activist attributed the emergence of cases to the rainfall and the terrible environmental degradation witnessed by the district due to the accumulation of waste. He pointed out that Bahri locality has stopped transporting the waste from Teiba El Ahamda for unknown reasons for 3 years. El Azhari Widaatallah, the chairman of the Legislative and Justice Committee of the Parliament, representative of Constituency 30 of Khartoum state of the districts of El Azhari, El Shajara, El Azozab, Lamab, Hamadab, pointed to the emergence of watery diarrhea in his constituency, especially at El Shajara. He attributed the deterioration of the health situation in the area to the lack of sewage system and the stagnation of rainwater. Health sources revealed the emergence of a number of cases of cholera in the academic hospital in Khartoum.<br><br><strong> Northern state </strong><br> In the Northern state, the isolation centre at Delgo Hospital received 3 new cases of cholera on Sun 20 Aug 2017. Nubian activist Ashraf Abdelwedoud warned in an interview with Radio Dabanga of the increasing rates of the disease following the rains and floods in the area in the past few days. He called on the authorities to make efforts to curb the spread of the disease. - Sr.Tech.Ed.MJ The mortality from cholera and most diarrheal illnesses is related to non-replacement of fluid and electrolytes from the diarrheal illness. As stated in Lutwick LI, Preis J, Choi P: Cholera. In: Chronic illness and disability: the pediatric gastrointestinal tract. Greydanus DE, Atay O, Merrick J (eds). NY: Nova Bioscience, 2017 (in press), oral rehydration therapy can be life-saving in outbreaks of cholera and other forms of diarrhea: \"As reviewed by Richard Guerrant et al (1), it was in 1831 that cholera treatment could be accomplished by intravenous replacement, and, although this therapy could produce dramatic improvements, not until 1960 was it 1st recognized that there was no true destruction of the intestinal mucosa, and gastrointestinal rehydration therapy could be effective, and the therapy could dramatically reduce the intravenous needs for rehydration. Indeed, that this rehydration could be just as effective given orally as through an orogastric tube (for example, refs 2 and 3) made it possible for oral rehydration therapy (ORT) to be used in rural remote areas and truly impact on the morbidity and mortality of cholera. Indeed, Guerrant et al (1) highlights the use of oral glucose-salt packets in war-torn Bangladeshi refugees, which reduced the mortality rate from 30 per cent to 3.6 per cent (4) and quotes sources referring to ORT as \"potentially the most important medical advance\" of the 20th century. A variety of formulations of ORT exist, generally glucose or rice powder-based, which contain a variety of micronutrients, especially zinc (5). \"The assessment of the degree of volume loss in those with diarrhea to approximate volume and fluid losses can be found in ref 6 below. Those with severe hypovolemia should be initially rehydrated intravenously with a fluid bolus of normal saline or Ringer's lactate solution of 20-30 ml/kg followed by 100 ml/kg in the 1st 4 hours and 100 ml/kg over the next 18 hours with regular reassessment. Those with lesser degrees of hypovolemia can be rehydrated orally with a glucose or rice-derived formula with up to 4 liters in the 1st 4 hours, and those with no hypovolemia can be given ORT after each liquid stool with frequent reevaluation.<br><br><strong> \"References </strong><br> 1. Guerrant RL, Carneiro-Filho BA, Dillingham RA. Cholera, diarrhea, and oral rehydration therapy: triumph and indictment. Clin Infect Dis. 2003; 37(3): 398-405; available at  . 2. Gregorio GV, Gonzales ML, Dans LF, Martinez EG. Polymer-based oral rehydration solution for treating acute watery diarrhoea. Cochrane Database Syst Rev. 2009; (2): CD006519. doi: 10.1002/14651858.CD006519.pub2; available at  . 3. Gore SM, Fontaine O, Pierce NF. Impact of rice based oral rehydration solution on stool output and duration of diarrhoea: meta-analysis of 13 clinical trials. BMJ 1992; 304(6822): 287-91; available at . 4. Mahalanabis D, Choudhuri AB, Bagchi NG, et al. Oral fluid therapy of cholera among Bangladesh refugees. Johns Hopkins Med 1973; 132(4): 197-205; available at  . 5. Atia AN, Buchman AL. Oral rehydration solutions in non-cholera diarrhea: a review. Am J Gastroenterol 2009; 104(10): 2596-604; abstract available at . 6. WHO. The treatment of diarrhoea, a manual for physicians and other senior health workers. 4th ed. 2005; available at:  . - Mod.LL ","keywordsMatched":[]}},"Suriname":{},"Swaziland":{},"Sweden":{},"Switzerland":{},"Syria":{},"Taiwan":{"503":{"title":"Dengue/DHF update (10): Asia, Pacific, Africa, research, WHO\r\n\t","date":["25","Aug","2017"],"url":"promedPRO/EDR> Dengue/DHF update (10): Asia, Pacific, Africa, research, WHO\r\n\t[EXTERNAL]","summary":" 3 WHO update  The 15 Aug 2017 Source: WHO Western Pacific region edited Dengue situation update no.<br><br><strong> 523 - Northern hemisphere -</strong><br> Cambodia As of 8 Aug 2017, a total of 1604 suspected dengue fever cases were reported in 2017. The total number of reported dengue cases including dengue haemorrhagic fever and dengue shock syndrome was lower than the 3 year-threshold of the same period from 2014-2016. China As of 31 Jul 2017, there were 503 cases of dengue reported in China in 2017. This number is higher than that reported during the same period since 2012 but follows historical trend. Lao PDR People's Democratic Republic As of 4 Aug 2017, there were 5740 cases of dengue with 7 deaths reported in Lao PDR in 2017, with 406 cases reported in epi week 31 (week ending 5 Aug 2017). Dengue activity is high with the number of dengue cases reported this year 2017 being higher than the cases reported for same period since 2014. Malaysia In week 31 of 2017 (week ending 5 Aug 2017), 1899 dengue cases were reported with 2 deaths, an increase of 1.1 per cent compared with week 30. As of week 31, the cumulative number of dengue cases in 2017 were 59 521 with 135 deaths compared with 67 437 cases with 147 deaths during the same period in 2016. Philippines (no update) A total of 43 770 dengue cases were reported nationwide from 1 Jan to 1 Jul 2017. This number is 36.8 per cent lower (25 527) compared with the same time period in 2016. Singapore As of 5 Aug 2017, there were 1732 dengue cases reported in Singapore since January 2017. This is lower than the number of reported cases during the same period since 2013. During week 31, there were 61 cases reported and the number of reported cases in 2017 remains lower than those reported for the same time period in 2016 . Viet Nam As of 3 Aug 2017, there were 80 555 cases of dengue reported in Viet Nam including 22 deaths. Compared with the same period in 2016, the cumulative number of cases increased by 33.5 per cent, and the number of deaths rose by 5. Most cases were reported from the South (59 per cent). A sharp increase in the number of reported cases has been observed in the North (almost 25 times higher than the same period last year 2016), especially from Ha Noi, with about 13 440 cases.<br><br><strong> Southern hemisphere -</strong><br> Australia As of 31 Jul 2017, there were 695 laboratory-confirmed dengue cases reported in Australia in 2017. The number of cases reported is lower than that reported during the same time period in the previous years (2012-2016).<br><br><strong> Pacific Islands countries and areas -</strong><br> French Polynesia In French Polynesia, 12 cases (including 1 death) in week 29 and 12 cases in week 30 (week ending 29 Jul 2017). Among these, 15 cases were confirmed as DENV-1 infection. New Caledonia (no update) As of 1 Aug 2017, 4,452 dengue cases were reported in 2017. There is a downward trend in the number of reported cases since week 16 (week ending 22 Apr 2017).  communicated by: ProMED-mail ","keywordsMatched":[]}},"Tajikistan":{},"Tanzania":{},"Thailand":{"503":{"title":"Dengue/DHF update (10): Asia, Pacific, Africa, research, WHO\r\n\t","date":["25","Aug","2017"],"url":"promedPRO/EDR> Dengue/DHF update (10): Asia, Pacific, Africa, research, WHO\r\n\t[EXTERNAL]","summary":" 3 WHO update  The 15 Aug 2017 Source: WHO Western Pacific region edited Dengue situation update no.<br><br><strong> 523 - Northern hemisphere -</strong><br> Cambodia As of 8 Aug 2017, a total of 1604 suspected dengue fever cases were reported in 2017. The total number of reported dengue cases including dengue haemorrhagic fever and dengue shock syndrome was lower than the 3 year-threshold of the same period from 2014-2016. China As of 31 Jul 2017, there were 503 cases of dengue reported in China in 2017. This number is higher than that reported during the same period since 2012 but follows historical trend. Lao PDR People's Democratic Republic As of 4 Aug 2017, there were 5740 cases of dengue with 7 deaths reported in Lao PDR in 2017, with 406 cases reported in epi week 31 (week ending 5 Aug 2017). Dengue activity is high with the number of dengue cases reported this year 2017 being higher than the cases reported for same period since 2014. Malaysia In week 31 of 2017 (week ending 5 Aug 2017), 1899 dengue cases were reported with 2 deaths, an increase of 1.1 per cent compared with week 30. As of week 31, the cumulative number of dengue cases in 2017 were 59 521 with 135 deaths compared with 67 437 cases with 147 deaths during the same period in 2016. Philippines (no update) A total of 43 770 dengue cases were reported nationwide from 1 Jan to 1 Jul 2017. This number is 36.8 per cent lower (25 527) compared with the same time period in 2016. Singapore As of 5 Aug 2017, there were 1732 dengue cases reported in Singapore since January 2017. This is lower than the number of reported cases during the same period since 2013. During week 31, there were 61 cases reported and the number of reported cases in 2017 remains lower than those reported for the same time period in 2016 . Viet Nam As of 3 Aug 2017, there were 80 555 cases of dengue reported in Viet Nam including 22 deaths. Compared with the same period in 2016, the cumulative number of cases increased by 33.5 per cent, and the number of deaths rose by 5. Most cases were reported from the South (59 per cent). A sharp increase in the number of reported cases has been observed in the North (almost 25 times higher than the same period last year 2016), especially from Ha Noi, with about 13 440 cases.<br><br><strong> Southern hemisphere -</strong><br> Australia As of 31 Jul 2017, there were 695 laboratory-confirmed dengue cases reported in Australia in 2017. The number of cases reported is lower than that reported during the same time period in the previous years (2012-2016).<br><br><strong> Pacific Islands countries and areas -</strong><br> French Polynesia In French Polynesia, 12 cases (including 1 death) in week 29 and 12 cases in week 30 (week ending 29 Jul 2017). Among these, 15 cases were confirmed as DENV-1 infection. New Caledonia (no update) As of 1 Aug 2017, 4,452 dengue cases were reported in 2017. There is a downward trend in the number of reported cases since week 16 (week ending 22 Apr 2017).  communicated by: ProMED-mail ","keywordsMatched":[]},"509":{"title":"Melioidosis - Thailand ","date":["28","Aug","2017"],"url":"promedPRO/EDR> Melioidosis - Thailand [EXTERNAL]","summary":"   Mon 28 Aug 2017, 11:39 AM Source: The Nation, Thailand portal edited People living in flooded areas have been warned to keep time spent wading through water to a minimum lest they be infected with melioidosis, a disease that has claimed 21 lives in 2017. Department of Disease Control (DDC) chief Dr Jessada Chokdamrongsuk reported on Mon 28 Aug 2017, that 1978 cases of melioidosis had been reported from 1 Jan 2017 to 22 Aug 2017. The disease, caused by the bacterium _Burkholderia pseudomallei_ and prevalent during the rainy season in the subtropics, peaks every August in Thailand and has been wider spread this year 2017, he said. \"The bacterium thrives in contaminated water and soil and infects humans and animals through direct contact. People could get infected from prolonged exposure to contaminated water or soil, especially if they have any open sores or lesions in the skin,\" Jessada said. \"Infection can also come from consuming contaminated water or food.\" Melioidosis produces a variety of acute and severe symptoms, he said, including long-lasting fever with no other apparent cause, ulcers or abscesses in the lungs, liver or spleen, and blood infections. The disease, which mainly affects adults, can be fatal, he said. Death has been known to result within 2-3 days of admission to hospital. Risk factors for infection include chronic respiratory and lung disease, tuberculosis, diabetes, chronic renal disease, thalassemia, cancer, and immune-suppressing conditions unrelated to HIV. Jessada advised people coming into regular contact with floodwater to wear boots, drink only water that has been boiled, avoid raw and partially cooked food, wash immediately after exposure and seek medical attention if a fever persists for more than 5 days or abscesses become chronic.  <br><br>Communicated by: ProMED-mail\\. Melioidosis is a disease of the rainy season in its endemic areas. It mainly affects people who have direct contact with soil and water. Many have an underlying predisposing condition such as diabetes (commonest risk factor), renal disease, cirrhosis, thalassemia, alcohol dependence, immunosuppressive therapy, chronic obstructive lung disease, cystic fibrosis, and excess kava consumption. Kava is an herbal member of the pepper family that can be associated with chronic liver disease. Melioidosis may present at any age, but peaks in the 4th and 5th decades of life, affecting men more than women. In addition, although severe fulminating infection can and does occur in healthy individuals, severe disease and fatalities are much less common in those without risk factors. The most commonly recognized presentation of melioidosis is pneumonia, associated with high fever, significant muscle aches, chest pain, and  although the cough can be nonproductive  respiratory secretions can be purulent, significant in quantity, and associated with on-and-off bright, red blood. The lung infection can be rapidly fatal  with bacteremia and shock  or somewhat more indolent. Acute melioidosis septicemia is the most severe complication of the infection. It presents as a typical sepsis syndrome with hypotension, high cardiac output, and low systemic vascular resistance. In many cases, a primary focus in the soft tissues or lung can be found. The syndrome, usually in patients with risk factor comorbidities, is characteristically associated with multiple abscesses involving the cutaneous tissues, the lung, the liver, and spleen, and a very high mortality rate of 80 to 95 percent. With prompt optimal therapy, the case fatality rate can be decreased to 40 to 50 percent. The melioidosis bacillus is intrinsically insensitive to many antimicrobials. It should be noted that bioterrorism strains may be engineered to be even more resistant. _Burkholderia pseudomallei_ is usually inhibited by tetracyclines, chloramphenicol, trimethoprim-sulfamethoxazole (SXT), antipseudomonal penicillins, carbapenems, ceftazidime, and amoxicillin/clavulanate or ampicillin/sulbactam. Ceftriaxone and cefotaxime have good in vitro activity but poor efficacy; and cefepime did not appear, as well, to be equivalent to ceftazidime in a mouse model. The unusual antimicrobial profile of resistance to colistin and polymyxin B and the aminoglycosides but sensitivity to amoxicillin/clavulanate is a useful tool to consider in treatment of infection with the organism. The randomized and quasi-randomized trials comparing melioidosis treatment have been reviewed, and it was found that the formerly standard therapy of chloramphenicol, doxycycline, and SXT combination had a higher mortality rate than therapy with ceftazidime, imipenem/cilastatin, or amoxicillin/clavulanate (or ampicillin/sulbactam). The betalactam-betalactamase inhibitor therapy, however, seemed to have a higher failure rate. Source: Tolaney P, Lutwick LI: Melioidosis. In: Lutwick LI, Lutwick SM (eds). Bioterror: the weaponization of infectious diseases. Totowa NJ: Humana Press, 2008 pp 145-58. For the microbiologists among our readers, a new (and 5th) member of the _B. pseudomallei_ complex has been described, _B. humptydooensis_ , from the Northern Territory of Australia and named after the small town of Humpty Doo near to where the isolate was found (Tuanyok A, Mayo M, Scholz H, et al: _Burkholderia humptydooensis_ sp. nov., a new species related to _Burkholderia thailandensis_ and the fifth member of the _Burkholderia pseudomallei_ complex. App Environ Microbiol 2017; 83(5): e02802-16);  . - Mod.LL   . ","keywordsMatched":[]}},"East Timor":{},"Togo":{},"Tonga":{},"Trinidad and Tobago":{},"Tunisia":{},"Turkey":{},"Turkmenistan":{},"Tuvalu":{},"Uganda":{"505":{"title":"Crimean-Congo hem. fever - Uganda: (QO, NK) ","date":["24","Aug","2017"],"url":"promedPRO/AH/EDR> Crimean-Congo hem. fever - Uganda: (QO, NK) [EXTERNAL]","summary":"   Thu 24 Aug 2017 at 15:34:33 BST Source: UN Office for the Coordination of Humanitarian Affairs (OCHA), ReliefWeb, Monitor-Uganda report edited Uganda has been placed on high alert as the Ministry of Health investigates and monitors suspected cases of the deadly Crimean-Congo haemorrhagic fever in the central districts of Kiboga and Nakaseke. On 20 Aug 2017, the ministry received blood samples of 2 patients from Kiboga and Nakaseke hospital suspected Crimean-Congo haemorrhagic fever (CCHF). According to a 21 Aug 2017 statement signed by the acting Director General, health services Dr Anthony Mbonye, the 2 victims tested positive to Crimean-Congo haemorrhagic fever CCFH. CCHF is a common disease among humans and animals caused by caused by a tick-borne virus (_Nairovirus_); the virus causes severe viral haemorrhagic fever outbreaks, with a case fatality rate of 10-40 percent. Dr Mbonye says that the general supportive care with treatment of symptoms is the main approach to managing CCFH among humans. The statement warns that while its symptoms do not appear in the infected animal, it appears in a very dangerous way in human beings. \"You are required to work with the office of the District Veterinary Officer to strengthen measures against CCHF control in animals, implement interventions to reduce the risk of CCHF infections among humans, and interventions to control CCFH in health care settings. You are also reminded to immediately report and investigate any CCFH suspected cases in your district,\" reads the statement in part signed by Dr Mbonye. CCHF virus is transmitted to people either by tick bites or through contact with infected animal blood or tissues during and immediately after slaughter. According to Ministry of health, the majority of cases have occurred in people involved in the livestock industry, such as agricultural workers, slaughterhouse workers, and veterinarians and that human-to-human transmission occurs from close contact with the blood, secretions, organs, or other bodily fluids of infected persons. Hospital-acquired infections can also occur due to improper sterilization of medical equipment, reuse of needles, and contamination of medical supplies. Records indicate that since 2000, Uganda has experienced repeated outbreaks of viral hemorrhagic fevers (VHF). Ebola VHF outbreak occurred in the districts of Gulu in 2000, Bundibugyo, 2007, Luwero, 2011, Kibaale in July 2012, Luwero in November 2012. Marburg VHF was earlier reported in Ibanda in 2007. More recently in 2012, 2 outbreaks of Marburg VHF have occurred in Ibanda and Kabale districts.<br><br><strong> Signs and symptoms of CCHF </strong><br> Sudden, with fever, myalgia, (muscle ache), dizziness, neck pain and stiffness, backache, headache, sore eyes and photophobia (sensitivity to light), nausea, vomiting, diarrhoea, abdominal pain, and sore throat early on, followed by sharp mood swings and confusion. After 2 to 4 days, the agitation may be replaced by sleepiness, depression, and lassitude, and the abdominal pain may localize to the upper right quadrant, with detectable hepatomegaly (liver enlargement). Byline: David Mafabi  <br><br>Communicated by: ProMED-mail\\. CCHF is endemic in Africa, the Balkans, the Middle East, and Asian countries south of the 50th parallel north  the geographical limit of the principal tick vector. The hosts of the CCHF virus include a wide range of wild and domestic animals such as cattle, sheep, and goats. Animals become infected by the bite of infected ticks and the virus remains in their bloodstream for about one week after infection, allowing the tick-animal-tick cycle to continue when another tick bites. Although a number of tick genera are capable of becoming infected with CCHF virus, ticks of the genus _Hyalomma_ are the principal vector. The CCHF virus is transmitted to people either by tick bites or through contact with infected animal blood or tissues during and immediately after slaughter. The majority of cases have occurred in people involved in the livestock industry, such as agricultural workers, slaughterhouse workers, and veterinarians. Human-to-human transmission is possible. The report above does not mention any clinical features of the cases. ProMED has not posted reports of cases of CCHF in Uganda since 2013. - Mod. - Sr.Tech.Ed.MJ ","keywordsMatched":[]}},"Ukraine":{},"United Arab Emirates":{"742":{"title":"MERS-CoV (56): UAE, Saudi Arabia (JF, HA, RI),\r\n\tWHO ","date":["29","Aug","2017"],"url":"promedPRO/AH/EDR> MERS-CoV (56): UAE, Saudi Arabia (JF, HA, RI),\r\n\tWHO [EXTERNAL]","summary":" 2 Saudi Arabia, 7 new cases - Saudi MOH 19-29 Aug 2017  Tue 29 Aug 2017 Source: Saudi MOH 19-29 Aug 2017 edited As of Tue 29 Aug 2017, there have been a total of: 1708 laboratory-confirmed cases of MERS-CoV infection, including 688 deaths reported case fatality rate 40.3 percent, 997 recoveries, and 22 currently active cases/infections. As previously mentioned, the numbers of deaths, recoveries, and currently active cases come from my spreadsheet tallies and differ from those listed on the Saudi MOH website; my spreadsheet counts asymptomatic infections. One complication is the reporting of cases as either recoveries or deaths that cannot be confirmed as previously reported newly confirmed cases. - Mod.MPP Since the last ProMED-mail update Fri 18 Aug 2017, there have been a total of: 7 newly confirmed cases 1 newly reported fatality, and 6 newly reported recoveries. Information on newly reported cases (7 cases):  27 Aug 2017 (1 case) 1- A 33-year-old Saudi female, non-healthcare worker from Dawmat Aljandal Al Jawf region noted to be in stable condition. Classified as a primary case with high risk exposure history still under investigation at time of report.  26 Aug 2017 (3 cases) 2- A 10-year-old Saudi female, non-healthcare worker from Dawmat Aljandal Al Jawf region noted to be in stable condition, having been identified as an asymptomatic contact of a previously confirmed case. Classified as a secondary case in a household contact. 3- A 14-year-old Saudi female, non-healthcare worker from Dawmat Aljandal Al Jawf region noted to be in stable condition, having been identified as an asymptomatic contact of a previously confirmed case. Classified as a secondary case in a household contact. 4- A 50-year-old Saudi male, non-healthcare worker from Dawmat Aljandal Al Jawf region noted to be in stable condition. Classified as a secondary case in a household contact.  24 Aug 2017 (2 cases) 5- A 40-year-old Saudi female, non-healthcare worker from Dawmat Aljandal Al Jawf region noted to be in stable condition. Classified as a primary case with high risk exposure history still under investigation. 6- A 46-year-old Saudi male, non-healthcare worker from Hayel 'il region, noted to be in critical condition. Classification still under review at the time of initial report.  21 Aug 2017 (1 case) 7- A 48-year-old Saudi male, non-healthcare worker from Alaflaj Riyadh region noted to be in stable condition. Classified as a primary case with a history of direct contact with camels in the 14 days preceding onset of illness. Information on newly reported fatality (1 fatality)  27 Aug 2017 - A 67-year-old expat male, non-healthcare worker from Madinah Al Madinah region with a history of pre-existing co-morbidities reported as a newly confirmed case on 15 Aug 2017 noted to be in stable condition. Classified as a primary case with a history of indirect contact with camels in the 14 days preceding onset of illness. - Mod.MPP Information on newly reported recoveries (6 recoveries)  25 Aug 2017 (1 recovery) 1- A 17-year-old Saudi male, non-healthcare worker from Dawmat Aljandal Al Jawd region with no history of co-morbidities. reported as a newly confirmed case on 7 Aug 2017 at which time he was noted to be in stable condition. Classified as a secondary case in a household contact. - Mod.MPP  24 Aug 2017 (1 recovery) 2- A 12-year-old Saudi male, non-healthcare worker from Dawmat Aljandal Al Jawd region with no history of co-morbidities. reported as a newly confirmed case on 7 Aug 2017 at which time he was noted to be in stable condition having been identified as an asymptomatic contact of a previously confirmed case. Classified as a secondary infection in a household contact. - Mod.MPP  21 Aug 2017 (3 recoveries) 3- A 25-year-old expat female, healthcare worker from Dawmat Aljandal Al Jawd region with no history of co-morbidities. reported as a newly confirmed case on 6 Aug 2017 at which time she was noted to be in stable condition having been identified as an asymptomatic contact of a previously confirmed case. Classified as a secondary healthcare acquired infection in a healthcare worker. - Mod.MPP 4- A 27-year-old expat female, healthcare worker from Dawmat Aljandal Al Jawd region with no history of co-morbidities. reported as a newly confirmed case on 8 Aug 2017 at which time she was noted to be in stable condition having been identified as an asymptomatic contact of a previously confirmed case. Classified as a secondary healthcare acquired infection in a healthcare worker. - Mod.MPP 5- A 49-year-old expat male, healthcare worker from Dawmat Aljandal Al Jawd region with no history of co-morbidities. reported as a newly confirmed case on 8 Aug 2017 at which time he was noted to be in stable condition having been identified as an asymptomatic contact of a previously confirmed case. Classified as a secondary healthcare acquired infection in a healthcare worker. - Mod.MPP  20 Aug 2017 (1 recovery) 6- A 44-year-old expat female, non-healthcare worker from Jeddah Makkah region with a history of pre-existing co-morbidities. reported as a newly confirmed case on 4 Aug 2017 at which time she was noted to be in stable condition. Classified as a secondary case in a household contact. Note that there was a recovery reported in a 44-year-old expat female on 15 Aug 2017, suggesting either this is a duplicate report or there was a 2nd 44 year old expat female from Jeddah reported that did not appear on the newly confirmed case reports on the Saudi MOH website. - Mod.MPP  <br><br>Communicated by: ProMED-mail\\. In the 11 day period since the last update, there have been 7 newly confirmed cases reported of whom 5 were from Dawmat Aljandal (Al Jawf region), the location that had nosocomial transmission identified since the beginning of this past month July 2017. Clearly transmission is continuing in this area, with 3 newly confirmed secondary cases in household contacts - at least 2 of whom were identified through screening of asymptomatic household contacts, and 2 additional cases in which high risk exposures are still under investigation. We do not know if these household contacts are associated with the earlier identified transmission chain in Dawmat Aljandal or if these are newly identified chains of transmission. The other 2 newly confirmed cases involve \"sporadic\" cases - an individual in Hail whose high risk exposure history is still under investigation, and an individual from Alaflaj (Riyadh region) with a history of direct contact with camels in the 14 days preceding onset of illness. As to be expected, concern is being voiced on the international level with the upcoming Hajj and this recent increase in cases reported both in Saudi Arabia and in the UAE. We now have gone through 5 Hajj periods since the identification of the MERS-CoV and to date there have been no cases of MERS-CoV infection identified in returning Hajjis. The case in the UAE (see section 1 above) actually had onset of illness over 1 month ago with no secondary cases/infections identified among known contacts of this case. As for the cases in Saudi Arabia, and more specifically the Hajj, population movement is very well defined during the Hajj, no camels are permitted in the areas where Hajjis are congregated, and there are Hajj specific health services that are separate from those that are available for the general Saudi population, all factors that are reducing the likelihood of Hajjis having inadvertent (or intentional) high risk exposures. Hopefully my optimism is well placed and we will pass through a 6th Hajj period without impact on international transmission of the MERS-CoV associated with this Hajj. - Mod.MPP ","keywordsMatched":[]}},"United Kingdom":{},"United States of America":{"749":{"title":"Zika virus (17): Americas, research, observations ","date":["24","Aug","2017"],"url":"promedPRO/EDR> Zika virus (17): Americas, research, observations [EXTERNAL]","summary":" 6 Vaccine update  22/29 Aug 2017 Source: Journal of the American Medical Association, JAMA edited ref: Lyon J. Vaccines protect fetus from Zika. JAMA. 2017; 318(8): 689. doi:10.1001/jama.2017.<br><br><strong>11200 </strong><br> Researchers funded in part by the National Institutes of Health have recently demonstrated that 2 experimental vaccines can restrict transmission of Zika virus from pregnant mice to their fetuses, thereby shielding offspring from congenital damage or death. Multiple candidate Zika vaccines have been shown protective against infection with the virus in animal studies, with several now in human trials, but none were tested in the context of pregnancy, according to the authors of the study published in Cell  . The 2 vaccine candidates investigated in the new study are the 1st to demonstrate efficacy in preventing vertical transmission of the virus and related fetal death in an animal model. Although the vaccines were administered to female mice prior to pregnancy, the result is considered an important step toward developing a vaccine that could be safely given to pregnant women. One of the 2 candidates is a modified messenger RNA (mRNA) vaccine encoding Zika genes, developed by the biotechnology company Moderna. It is already in safety trials in women who are not pregnant. The other is a live-attenuated Zika strain developed by researchers at the University of Texas Medical Branch (UTMB). The testing was carried out by scientists from the National Institute of Allergy and Infectious Diseases, Washington University School of Medicine, and UTMB. The researchers 1st vaccinated the mice with 1 of the vaccines or a placebo. After mating, the animals were challenged with the virus 6 days into pregnancy. A week later, more than 50 percent of placentas and fetuses from mice administered the mRNA vaccine had virtually no Zika RNA. The remainder had \"substantially lower\" levels relative to placebo. The live vaccine provided broader protection: 78 percent of placentas and 83 percent of fetuses had Zika RNA at or below the level of detection, while the placebo group exhibited significantly higher levels of placental and fetal Zika RNA. Mice vaccinated with either vaccine had significantly higher rates of fetal viability; whereas 100 percent of fetuses from mice vaccinated with the mRNA vaccine were born, none survived to term in the placebo group. A working group funded by the Wellcome Trust recently approved ethical guidelines for testing such vaccines in pregnant women, normally excluded from drug trials.  <br><br>Communicated by: ProMED-mail\\. It is reassuring to learn that at least 2 vaccines are now entering clinical trials in women. Although anti-Zika virus drugs are under development, preventing infection through vaccination seems to be the most effective measure to prevent fetal infection and adverse effects of the virus infection in adults. - Mod.TY ","keywordsMatched":[]}},"Uruguay":{},"Uzbekistan":{},"Vanuatu":{},"Venezuela":{},"Vietnam":{"651":{"title":["Dengue in Vietnam"],"date":["24","August","2017"],"url":"wwwnc.cdc.gov/travel/notices/watch/dengue-vietnam","summary":" Magill Partners GeoSentinel Global TravEpiNet Mobile Apps RSS Feeds  Dengue in Vietnam  Recommend on Facebook  Tweet  Share Compartir  Warning - Level 3, Avoid Nonessential Travel  Alert - Level 2, Practice Enhanced Precautions  Watch - Level 1, Practice Usual Precautions  What is the current situation?  Recently, there has been a large increase in the number of dengue cases in Vietnam, according to a World Health Organization (WHO) report. As of August 2017, more than 80,000 cases have been reported. Although most cases have been reported in the south, there has been a sharp increase in cases in the north, especially in Hanoi.  Dengue is spread through mosquito bites and can cause symptoms such as fever, headache, nausea, vomiting, rash, and pain in the eyes, joints, and muscles.  What can travelers do to prevent dengue?  Because mosquitoes transmit dengue to people, travelers to Vietnam should protect themselves against mosquito bites to avoid getting the illness. There is no vaccine or medicine currently available in the United States to prevent or treat dengue.  Learn more about dengue, how to prevent it, and what to do if you think you are infected at CDC&rsquo;s dengue page for travelers .  Traveler Information  Dengue Virus: What You Need to Know  Avoid Bug Bites  Clinician Information  Dengue in CDC Health Information for International Travel, the &ldquo;Yellow Book&rdquo;  Clinical &amp; Laboratory Guidance  File Formats Help: How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?  Adobe PDF file  Microsoft PowerPoint file  Microsoft Word file  Microsoft Excel file  Audio/Video file  Apple Quicktime file  RealPlayer file  Text file  Zip Archive file  SAS file  ePub file  Page created: August 24, 2017  Page last updated: August 24, 2017  Page last reviewed: August 24, 2017  Content source:  Centers for Disease Control and Prevention  National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)  Division of Global Migration and Quarantine (DGMQ)  Follow CDC  Email  Recommend  Tweet  Post  RSS  CDC Media  Listen  Watch  eCards  YouTube  About CDC  Employment  Newsroom  Training/Education  Funding  CDC's Organization  Mission and Vision  Using this Site  Legal  Link to Us  Policies  FOIA  Accessibility  Privacy  No FEAR Act  Inspector General  USA.gov  Contact CDC  Centers for Disease Control and Prevention  1600 Clifton Road  Atlanta ,  GA  30329-4027  USA  800-CDC-INFO (800-232-4636)  Contact CDC-INFO  TOP","keywordsMatched":[]}},"Western Sahara":{},"Yemen":{"508":{"title":"Cholera,\r\n\tdiarrhea & dysentery update (91): Asia (Yemen) ","date":["26","Aug","2017"],"url":"promedPRO/EDR> Cholera,\r\n\tdiarrhea & dysentery update (91): Asia (Yemen) [EXTERNAL]","summary":"   Sat 26 Aug 2017 Source: Anadolu Agency edited A total of 2018 people have been killed by a cholera epidemic in war-torn Yemen since late April 2017, the WHO said Sat 26 Aug 2017. In a statement, the WHO said 565 041 suspected cases of cholera have been recorded in the country since 27 Apr 2017. According to the WHO statement, the recorded suspected cases were in 22 out of 23 provinces. The UN agency said the highest number of fatalities, 382 cases, was recorded in the northwestern Hajjah province, while in western Yemen's Hudaida province only around 70 000 suspected cases were recorded. Impoverished Yemen has remained in a state of civil war since 2014, when Houthi rebels overran much of the country, including the capital Sanaa. The conflict escalated when Saudi Arabia and its Arab allies launched a massive air campaign in 2015 aimed at reversing Houthi military gains and shoring up Yemen's embattled government. According to the International Committee of the Red Cross (ICRC), over 3 million people have fled their homes since the onset of the Yemen conflict, and more than 20 million throughout the country are in need of humanitarian assistance. Byline: Mohamed al-Samei  <br><br>Communicated by: ProMED-mail\\. Although a number of sources have reported decreasing numbers of daily cases, the numbers seem to support the continuing robust number of daily cases. If the epidemic were to continue at the current rate of cases per day, by the end of 2017, there could be 700 000 more cases for a total of 1.12 million cases since the end of April 2017, with 3300 more deaths for a total of about 5500 deaths over that period. The statistics related to this record-breaking epidemic of _Vibrio cholerae_ infection in Yemen are shown below: Date (2017) / Cases / Deaths 8 May / 1360 / 25 11 May / 2752 / 51 13 May / 8595 / 115 14 May / 11 000 / 180 17 May / 17 200 / 209 19 May / 23 500 / 242 21 May / 29 300 / 315 22 May / 35 217 / 361 24 May / 42 207 / 420 27 May / 51 832 / 471 30 May / 65 300 / 532 2 Jun / 73 700 / 605 4 Jun / 86 400 / 676 5 Jun / 91 400 / 728 6 Jun / 96 000 / 746 7 Jun / 101 820 / 789 10 Jun / 116 700 / 869 12 Jun / 124 002 / 923 14 Jun / 140 116 / 989 16 Jun / 151 000 / 1054 19 Jun / 166 976 / 1146 21 Jun / 179 548 / 1205 23 Jun / 200 000 / 1310 26 Jun / 219 000 / 1400 28 Jun / 231 364 / 1439 30 Jun / 240 000 / 1500 4 Jul / 275 987 / 1634 7 Jul / 297 438 / 1706 10 Jul / 313 538 / 1732 13 Jul / 332 600 / 1759 17 Jul / 356 591 / 1802 20 Jul / 368 207 / 1828 25 Jul / 402 484 / 1880 26 Jul / 408 583 / 1885 29 Jul / 419 804 / 1912 7 Aug / 463 000 / 1940 13 Aug / 494 000 / 1966 17 Aug / 527 000 / 1997 20 Aug / 542 278 / 2003 25 Aug / 565 041 / 2018 In the last complete year of data (2015;  ), WHO reported a total of 172 454 cases worldwide in 42 countries. This continuing, record-breaking cholera disaster in Yemen is only 16 weeks old and now has more than 3 times the total number of cases of 2015 and 50 per cent more than the peak year of the Haiti outbreak (2011) of 340 311 cases. - Mod.LL   . ","keywordsMatched":[]}},"Zambia":{},"Zimbabwe":{}}